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Abstract 
 
Inactivity-related diseases (such as obesity and insulin resistance) are a burden on 
Western society, with low cardiorespiratory fitness (maximal aerobic capacity, VO2max) 
a strong independent predictor of metabolic disease and all-cause mortality. The 
etiological basis of these disorders is polygenic and highly dependent on the 
environment (i.e., existing genes interact with environmental factors to result in 
phenotypic expression of these diseases). The work undertaken for this thesis 
comprised a series of independent but related studies aimed at enhancing our 
understanding of the relationship between genetic factors and environmental stimuli in 
determining the capacity for aerobic energy production in skeletal muscle and white 
adipose tissue (WAT). Rodent models of divergent intrinsic running capacity (and, by 
association, metabolic health profile) and environmental interventions (i.e., diet and 
exercise) were employed in order to explore some of the mechanisms that determine 
the capacity for mitochondrial energy production in these two insulin-responsive 
tissues.  
 In the first investigation (Chapter 2), Long-Evans rats were given ad libitum 
access to either a Western Diet (WD; 40% energy (E) from fat, 17 % protein, and 43% 
carbohydrate (30% sucrose); n=12) or a control diet (CON; 16% E from fat, 21% 
protein, and 63% carbohydrate (10% sucrose); n=12) for 12 wk. Rats fed the WD 
consumed 23% more E than CON (P=0.0001), which was associated with greater 
increases in body mass (23%; P=0.0002) and adiposity (17%; P=0.03). There were no 
differences in fasting blood glucose concentration of glucose tolerance between diets, 
although fasting insulin was increased by 30% (P=0.007). Fasting serum triglycerides 
were also elevated in WD (86%; P=0.001). The maximal respiratory capacity of m. 
soleus (soleus) was greater following the WD (37%; P=0.02), as were the maximal 
activities of several mitochondrial enzymes (citrate synthase, CS; β-hydroxyacyl-CoA 
dehydrogenase, β-HAD; carnitine palmitoyltransferase). Protein expression of CS, 
uncoupling protein (UCP)-3, and individual respiratory complexes was greater after 
WD (all P<0.05) despite no differences in the expression of peroxisome proliferator-
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activated receptor-γ coactivator-1α (PGC-1α) mRNA or protein. The finding that the 
mitochondrial machinery was increased in skeletal muscle in response to the WD led to 
the conclusion that mitochondrial energy production pathways were up-regulated in 
order to cope with the sudden increased flux of energy substrates to metabolically active 
tissues. It was suggested that elevated skeletal muscle respiratory capacity would be, at 
least in the short term, protective against lipid-induced impairments in glycemic 
control. 
 Given that VO2max also has a genetic underpinning, the second investigation 
(Chapter 3) sought to identify whether intrinsic running capacity (and, by association, 
metabolic health) was associated with skeletal muscle mitochondrial content and/or 
oxidative capacity. Eleven-wk old genetically heterogeneous rats with inborn high- 
(HCR) and low- (LCR) running capacity were studied in the absence of exercise 
training. LCR rats (n=12) were 28% heavier (P=0.0001), and fasting serum insulin 
concentrations were 62% greater than in HCR rats (n=12; P=0.02). In contrast, HCR 
rats had better glucose tolerance (P=0.01) and reduced adiposity (P=0.02). In soleus, 
maximal respiratory capacity was 21% greater in HCR rats (P=0.001), for which the 
relative contribution of fat oxidation was 20% higher than LCR rats (P=0.02). This was 
associated with increased CS (33%; P=0.009) and β-HAD activities (33%; P=0.0003). In 
m. extensor digitorum longus (EDL), CS activity was 29% greater (P=0.01) and β-HAD 
activity was 41% greater (P=0.0004) in HCR compared to LCR rats. Mitochondrial 
DNA was also elevated in the EDL of HCR rats (35%; P=0.049) and soleus (44%; 
P=0.16). Additionally, HCR rats had increased protein abundance of individual 
mitochondrial respiratory complexes, CS, and UCP-3 in both muscle types (all P<0.05). 
The finding that both mitochondrial machinery and capacity were elevated in HCR 
compared to LCR rats is consistent with the observation that endurance trained 
individuals have a greater reliance on lipid-based fuels as an energy source, and 
explains, in part, how intrinsically determined skeletal muscle metabolism contributes 
to the phenotype of running capacity and its correlated traits.  
 WAT plays a central role in regulating whole-body lipid metabolism, with the 
metabolic activity of WAT being a crucial factor for substrate metabolism in other 
peripheral tissues. Thus, the primary aim of the third investigation (Chapter 4) was to 
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characterize the expression and activity of mitochondrial proteins important to energy 
production pathways in WAT from the LCR and HCR rat phenotypes. Additionally, 
since exercise training has recently been shown to alter important aspects of WAT 
energy metabolism (such as improved insulin action and elevated expression of PGC-
1α and UCP-1), the effect of a short-term treadmill running protocol (same cumulative 
distance (~10 km) over 6 wk) on WAT from LCR and HCR rats was also investigated. 
LCR and HCR rats (n=10 per group, 22 wk old) were studied with or without exercise 
training. In untrained rats, the abundance of individual mitochondrial respiratory 
complexes, CS, and PGC-1α was similar for both phenotypes, although, CS activity 
showed a tendency to be greater in HCR (50%; P=0.09). Exercise training increased CS 
activity in both phenotypes but did not alter mitochondrial protein content. Training 
increased the expression and phosphorylation of proteins with roles in β-adrenergic 
signaling, including the β3-adrenergic receptor (increased 16% in LCR; P<0.05), 
neuron-derived orphan receptor-1 (decreased 24% in LCR and 21% in HCR; both 
P<0.05), phosphor-adipose triglyceride lipase (increased 25% in HCR; P<0.05), 
perilipin (increased 25% in HCR; P<0.05), comparative gene identification-58 
(increased 15% in LCR; P<0.05), and the glucose transport protein GLUT4 (increased 
16% in HCR; P<0.0001). A training effect was also observed for the phosphorylation 
status of the stress kinases p38 mitogen-activated protein kinase (decreased 12% in LCR 
and 20% in HCR; both P<0.05) and c-JuN terminal kinase 1/2 (increased 29% in LCR 
and 20% in HCR; both P<0.05). It was concluded that in the LCR-HCR rat model 
system, mitochondrial protein expression in WAT is not affected by intrinsic running 
capacity or short-term exercise training. However, training does induce alterations in 
the activity and expression of several proteins that are essential to the intracellular 
regulation of WAT metabolism.  
 In summary, this thesis has identified several novel mechanisms by which 
mitochondrial function/adaptations can influence the capacity for energy substrate 
metabolism in skeletal muscle and WAT.  
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Chapter 1 
 
 
Mitochondrial function in metabolic health: A genetic and 
environmental tug of war 
Adapted, in part,  from E.J. Stephenson & J.A. Hawley BBA General Subjects  (invited review) 
In Review 
 
1.0   PHYSICAL INACTIVITY AND DISEASE: A METABOLIC CROSS-ROAD. 
The recent proliferation in the rate of diagnosis of many lifestyle-related diseases stems 
from the readiness of the vast majority of individuals from industrialized nations to 
adopt a sedentary lifestyle in the face of excess energy intake [1]. Accordingly, during 
the past 50 years there has been an explosion in the prevalence of a number of chronic 
metabolic disorders including obesity, type 2 diabetes and cardiovascular disease. The 
etiological basis of these disorders is polygenic and highly dependent on the 
environment (i.e. existing genes interact with environmental factors to result in 
phenotypic expression of these diseases). However, since no new major human gene 
mutations have occurred in the latter half of the 20th century to cause the greater 
frequency of chronic metabolic diseases, the increased incidence must principally be 
due to alterations in environmental conditions. One environmental factor to have 
changed dramatically in this time and strongly associated with a plethora of chronic 
metabolic disorders is a decline in daily physical activity [2]. In healthy individuals, 
acute but persistent sedentary behavior (inactivity for 2-7 hours/day) has been shown 
to impair whole-body insulin sensitivity and glucose tolerance [3] so, it is hardly 
surprising that an inactive lifestyle initiates a cascade of physiological events that are 
mechanistically linked to metabolic disease progression [4]. The results of several cross-
sectional and epidemiological studies provide direct evidence that a lack of physical 
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activity is strongly associated with the prevalence of a number of risk-factors associated 
with obesity and other cardio-metabolic disease states [5-10]. 
 The increased prevalence of obesity, insulin resistance and type 2 diabetes and 
their strong association with inactivity has produced an ‘exercise-deficient phenotype’ 
in which individuals with a particular combination of disease-susceptible genes (i.e. risk 
factors) interact with undefined environmental conditions (e.g., level of physical 
activity) and cross a threshold of biological significance that results in overt clinical 
conditions. Strong evidence in support of this premise comes from studies in which 
multiple genes involved in energy metabolism are coordinately down-regulated in 
individuals with obesity and associated conditions, and are linked to the pathogenesis 
of these disorders [11, 12]. As such, low cardio-metabolic fitness (i.e., whole-body 
aerobic capacity; VO2max) is now recognized as a strong independent risk-factor for not 
only several cardiovascular conditions, but also all-cause mortality [13, 14]. In line with 
this notion, it is now well accepted that regular physical exercise offers an effective 
therapeutic intervention to prevent, improve or, in some instances, reverse many of the 
hallmark features of cardio-metabolic disease [15, 16]. Thus, an understanding of the 
mechanisms that control how different biochemical pathways respond to physical 
activity (or inactivity) is critical for establishing the biological basis of obesity and its 
interrelated co-morbidities. 
 As noted earlier, obesity is central to the cardio-metabolic paradigm, with its 
progression directly linked to the development of insulin resistance, type 2 diabetes 
mellitus and cardiovascular disease [17]. Generally, the obesity sequelae promote 
disease states that are characterized by impaired regulation in the delivery, storage and 
utilization of energy substrates (primarily carbohydrate- and lipid-based fuels). The 
capacity of these substrate-related regulatory systems is highly dependent on several 
factors including the intrinsic metabolic program (as determined by genes) and 
environmental programming (Fig. 1.1) [18, 19]. Although complex interactions 
between intrinsic and environmental stimuli underpin an individual’s ability to 
respond to transient perturbations in energy availability and the ensuing hormonal 
milieu, the efficacy of this response is largely dependent upon environmental factors 
controlling energy intake and energy expenditure [20]. Thus, modulation of factors 
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linked to energy intake (i.e., the macronutrient composition of the diet) and/or energy 
expenditure (i.e., level of habitual physical activity), has the potential to enhance, or 
conversely, impair overall cardio-metabolic health [21].  
 This chapter presents a synopsis of studies that have examined the relationship 
between skeletal muscle and white adipose tissue (WAT) mitochondrial energy 
metabolism, whole-body aerobic capacity and cardio-metabolic disease risk, with a 
focus on some of the intrinsic  (genetic/epigenetic) and environmental factors that are 
strongly associated with metabolic health status.   
 
 
 
Figure 1.1  The metabolic program is determined through complex interactions between 
intrinsic factors (i.e.,  genes) and environmental stimuli.  Independent of genetic 
mechanisms, modulation of factors linked to energy intake and energy expenditure has the 
potential to influence overall cardio-metabolic health. 
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1.1   SKELETAL MUSCLE AND METABOLIC HEALTH 
Skeletal muscle comprises about 55% of individual body mass in sedentary humans and 
plays important roles in locomotion, heat production during periods of cold stress, and 
whole-body metabolism [22]. There is a remarkable capacity for skeletal muscle to 
adapt to a variety of external stimuli including habitual level of contractile activity, 
substrate availability, and the prevailing environmental conditions [23, 24]. This 
phenomenon of plasticity, common to all vertebrates [25], explains, in part, the marked 
differences observed in physical performance (such as feats of endurance or strength) 
between individuals, and also underpins the vastly divergent health profiles observed 
within a population. In this regard, skeletal muscle plays a major role in determining 
whole-body energy homeostasis because in healthy individuals it is the site of up to 80% 
of postprandial glucose disposal [26]. However, in inactivity-related conditions such as 
obesity, insulin resistance and type 2 diabetes, there is reduced insulin-stimulated 
glucose uptake into muscle, which has been associated with impairments in skeletal 
muscle mitochondrial content and/or function [27, 28]. The extent to which impaired 
skeletal muscle mitochondrial function play a causal or coincidental role in metabolic 
disease progression and whether these changes are secondary to lifestyle factors is a 
matter of current debate [29-32].  
1.2   WHITE ADIPOSE TISSUE AND METABOLIC HEALTH 
WAT was once considered an inert storage facility, however, it is now known to play a 
crucial role in metabolic regulation. Under fasting conditions, energy production in the 
skeletal muscle and other organs is almost entirely reliant on the oxidation of free fatty 
acids (FFA’s) [33] and the availability of FFA’s is largely dependent on the metabolic 
activity of WAT [34]. Although the metabolic activity of WAT is relatively low 
compared to other tissues, the major functions of WAT (i.e., lipolysis, FFA-re-
esterification, de novo lipogenesis, glucose uptake and adipokine synthesis and 
secretion; Fig. 1.2) are all energy consuming processes that rely on substrates derived 
from the co-ordinated activities of the enzymes controlling β-oxidation, the 
tricarboxylic acid (TCA) cycle and oxidative phosphorylation [34, 35]. Given that many 
of these important metabolic processes appear to be altered in the obesity sequelae, it 
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has been posited that disruptions in WAT mitochondrial metabolism may be associated 
with metabolic disease progression [35].  
 
 
 
 
 
 
Figure 1.2  Lipid cycling in WAT is dependent on mitochondrial metabolism.   
α-AR, α-adrenergic receptor; ADP, adenosine diphosphate; AMP, adenosine monophosphate; 
AMPK, AMP-activated protein kinase; ATGL, adipose triglyceride lipase; ATP, adenosine 
triphosphate; β-AR, β-adrenergic receptor; CoA, coenzyme A; cAMP, cyclic AMP; CGI-58, 
comparative gene identification-58; DAG, diacylglycerol;  DHAP, dihydroxyacetone 
phosphate; FA, fatty acid; FFA, free fatty acid; G-3-P, glyceraldehyde-3-phosphate; Gi,  
inhibitory G protein-coupled receptor; Gs, stimulatory G protein-coupled receptor; HSL, 
hormone sensitive lipase; IRS-1, insulin receptor substrate-1; MAG, monoacylglycerol; MGL, 
monoacylglycerol lipase; OA, oxaloacetate, PDE-3B, phosphodiesterase-3B; p-GA, phospho-
gluteraldehyde; PI3-K, phosphoinositide 3-kinase; PIP3, phosphatidylinositol (3,4,5)-
triphosphate; PKA, protein kinase A; PLIN1, perilipin; TAG, triacylglycerol; WAT, white 
adipose tissue.  
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2.0  MITOCHONDRIAL METABOLISM MATTERS! 
The relationship between VO2max and metabolic health highlights the importance of the 
body’s capacity to deliver and utilize O2 in energy producing pathways [14, 36-38]. 
VO2max is primarily limited by O2 delivery systems [39-41], although the capacity for 
mitochondrial energy production in peripheral tissues, especially in skeletal muscle, is 
also of major importance [40]. Indeed, while the capacity for mitochondrial energy 
production is not likely to be rate-limiting for the attainment of VO2max [39], it is a 
fundamental requirement for the tolerance of physical activity at a sustained intensity 
[42-44]. Therefore, skeletal muscle mitochondrial function indirectly influences whole-
body aerobic capacity by determining the economy of exercise at different workloads 
[45] and, subsequently, the extent to which the cardiovascular system is challenged and 
whether or not adaptations occur in the O2 delivery systems [41, 46, 47]. Moreover, this 
positive correlation between VO2max and the aerobic capacity of skeletal muscle [48] 
strongly suggests that any factor with the potential to enhance skeletal muscle 
mitochondrial content and/or function will positively affect VO2max (and possibly its 
correlated traits). Thus, an understanding of how physical activity induces favorable 
adaptations to the skeletal muscle mitochondrial network is essential to understanding 
the pathology of cardio-metabolic disease.   
2.1  MITOCHONDRIAL FUNCTION IN HEALTH  
To understand disease progression it is important to recognize what constitutes 
‘healthy’ metabolism. In healthy individuals free from metabolic disease, skeletal 
muscle has the capacity to oxidize both carbohydrate- and lipid-based fuels and to 
transition between these substrates in response to hormones (predominantly insulin), 
substrate signals (such as elevated FFA flux) and the contractile status of the muscle 
(rest versus contraction) [49]. Similarly, the WAT must coordinate between lipolytic 
and lipogenic pathways in response to hormones (primarily insulin and 
catecholamines), substrate signals and the contractile status of skeletal muscle [33]. 
This ‘metabolic flexibility’ underpins the major roles that skeletal muscle and WAT 
have in whole-body energy homeostasis, and highlights the importance of well-
coordinated mitochondrial function in maintaining metabolic control [50]. Thus, 
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functional defects in the energy producing systems of skeletal muscle and/or WAT 
mitochondria are likely to have profound systemic effects on overall metabolic health.  
 The main energy-producing processes in skeletal muscle and WAT are located in 
the mitochondria. Under fully aerobic conditions, pyruvate, (the end product of 
glycolysis) is converted to acetyl CoA in the mitochondrial matrix, where it enters the 
TCA cycle (or in the case of WAT, it may be directed toward lipogenesis, Fig. 1.2) and 
undergoes a series of reactions that reduce the co-enzymes nicatinamide adenine 
dinucleotide (NAD+) and flavin adenine dinucleotide (FAD; Fig. 1.3A) [51]. Similarly, 
the oxidation of free fatty acids occurs in the mitochondrial matrix and involves the 
reduction of NAD+ and FAD with the end product also being acetyl CoA (Fig. 1.3A) 
[52]. These reduced co-enzymes (from the TCA cycle and β-oxidation pathway) then 
pass electrons to the electron transfer system (ETS), a series of oxido-reductase 
enzymes located on the inner mitochondrial membrane where the transfer of electrons 
between enzyme complexes ultimately reduces oxygen to water in a process that is 
coupled to the production of adenosine triphosphate (ATP; Fig. 1.2B) [53]. Essentially, 
the skeletal muscle mitochondrial reticulum acts as a ‘sink’ for incoming energy 
substrates and uses them for the production of cellular energy, switching between the 
oxidation of lipid and carbohydrate substrates according to rates of supply and demand 
[54]. Conversely, the WAT mitochondrion coordinates switching between ATP 
production and lipid release/storage pathways (Fig. 1.2). Thus, rates of substrate uptake 
and the capacity for oxidation once inside the mitochondria are crucial points of 
metabolic regulation for not only skeletal muscle and WAT, but also whole-body 
metabolism.  
2.1.1 MOVING MUSCLES MAKE MORE MITOCHONDRIA  
The role and importance of skeletal muscle mitochondrial function in endurance 
training adaptation has long been recognized [55-59]. Classic work undertaken by John 
Holloszy almost 50 years ago demonstrated the potent role that exercise training plays 
in the biosynthesis of mitochondrial proteins [55]. For example, the capacity of the 
mitochondrial fraction from trained muscle to oxidize pyruvate doubled in rats 
subjected to a strenuous program of treadmill running. Mitochondria from the muscle  
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Figure 1.3  Mitochondrial energy production pathways.  Reduced coenzymes from β-
oxidation and the tricarboxylic acid cycle in the mitochondrial matrix (A) pass electrons to a 
series of oxido-reductase enzymes located on the inner membrane (B). The free energy 
released during electron transfer generates an electrochemical proton gradient between the 
matrix and the intermembrane space. Protons flow back into the matrix through CV, driving 
the synthesis of ATP [51-53].  
 
ADP, adenosine diphosphate  
ATP, adenosine triphosphate  
β-HAD, β-hydroxyacyl-CoA DH  
CI, NADH DH 
CII, succinate DH  
CIII,  cytochrome b-ca  complex  
CIV, cytochrome C oxidase  
CV, ATP synthase  
CoA, Coenzyme A  
CoQ, Coenzyme Q  
Cyt C, cytochrome C  
DH, dehydrogenase  
ETF, electron transferring flavoprotein  
FAD/FADH2, flavin adenine dinucleotide  
GDP, guanosine diphosphate  
GTP, guanosine triphosphate  
NAD+ /NADH, nicotinamide adenine dinucleotide  
P i ,  inorganic phosphate  
SH, sulfhydryl 
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of trained animals also exhibited a higher level of respiratory control and tightly 
coupled oxidative phosphorylation compared to sedentary animals. Thus, the increase 
in electron transport capacity was associated with a concomitant rise in the capacity to 
produce ATP. This training-induced adaptation in mitochondrial function accounts for 
the increase in aerobic work capacity that occurs with regularly performed, prolonged 
exercise. Of importance when examining the role of exercise training in promoting 
mitochondrial biogenesis is that a single bout of endurance exercise triggers a cascade 
of molecular signaling events that ultimately lead to mitochondrial proliferation (Fig. 
1.4 and 1.5 [60-68]) and other adaptations that favor the transport and oxidation of 
carbohydrate and lipid substrates [62, 69, 70]. Notably, a rapid but transient elevation 
in peroxisome proliferator activated receptor (PPAR)-γ coactivator-1α (PGC-1α) 
mRNA is observed following each acute bout of exercise [68], and this is accompanied 
by a steady increase in PGC-1α protein, as well as an increase in the activity of several 
oxidative enzymes over a period of training (Fig. 1.4 [68]). Thus, the cumulative 
benefits of each (acute) bout of exercise result in chronic adaptations in skeletal muscle 
(i.e., increased mitochondrial content) that favor improvements in fuel uptake and 
utilization, exercise economy and, ultimately, whole-body aerobic capacity.  
 
 
 
 
 
 
 
 
 
Figure 1.4 Early time course of exercise training-induced mitochondrial biogenesis in 
skeletal muscle. Representative figure showing that repeated transient PGC-1α  mRNA bursts 
precede increases in transcriptional- and mitochondrial- proteins (and their activities) over 
the course of a two wk high-intensity interval training period. Image from Perry et al.  (2010) 
[68].  CS, citrate synthase. PGC-1α ,  peroxisome proliferator activated receptor-γ  coactivator-
1α .  
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Figure 1.5 Contraction causes disturbances in the metabolic state of the muscle which 
leads to induction of PGC-1α  and, subsequently, mitochondrial biogenesis.  AMPK, 
adenosine monophosphate (AMP)-activated protein kinase; CaMK, Ca2 +/calmodulin-
dependent protein kinase; cAMP, cyclic AMP; CREB, cAMP response-element binding 
protein; NOR1, neuron-derived orphan receptor-1; NRF, nuclear respiratory factor; p38 
MAPK, p38 mitogen-activated protein kinase; PGC-1α ,  PPARγ- coactivator-1α ;  PPARδ ,  
peroxisome proliferator activated receptor-δ ;  TFAM, mitochondrial transcription factor A.  
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2.1.2 ADIPOCYTES IN (EXERCISE) TRAINING  
Recent advances in our understanding of WAT metabolism have indicated that this 
dynamic tissue is capable of both responding and adapting to a number of external 
stimuli. Importantly, WAT has been shown to be exercise-responsive, with a number of 
metabolic changes occurring in response to various forms of endurance exercise 
training [71-78]. In 1991, Stallknecht et al. [71] reported an increase in the activities of 
TCA cycle (malate dehydrogenase) and oxidative phosphorylation (cytochrome C 
oxidase, CIV) enzymes in epididymal WAT in response to 10 wk of swimming training 
(6 hr/d, 5 d/wk). Similarly, Laye et al. [73] showed that 40 wk of voluntary wheel 
running can induce increases in citrate synthase (CS) activity and the protein content of 
CIV in omental WAT. Taken together, these findings suggest that chronic exercise 
training may be capable of inducing mitochondrial biogenesis in WAT. In support of 
this notion, Sutherland et al. [72] report a marked increase in PGC-1α mRNA in both 
the epididymal and retroperitoneal WAT depots immediately following an acute bout 
of endurance exercise (2 hr swimming), and an increase in CS activity and the protein 
abundance of CIV after four wk of swimming training (2 hr/d, 7 d/wk). Moreover, Xu 
et al. [79] observed an increase in mitochondrial number in epididymal WAT following 
8 wk of treadmill running (40 min/d, 5 d/wk). Thus, despite the extreme nature of 
many of these training protocols [71-73], it is apparent that endurance training can 
induced mitochondrial biogenesis in WAT. However, unlike in skeletal muscle (Fig. 
1.5), the mechanisms behind exercise-induced mitochondrial biogenesis in WAT are 
not well defined. Nonetheless, increased mitochondrial content and/or oxidative 
enzyme activity as a result of exercise training is an adaptation that would likely have 
favorable effects for the metabolic partitioning of FFA’s.  
2.2 MITOCHONDRIAL (DYS)FUNCTION IN CARDIO-METABOLIC DISEASE 
Skeletal muscle and WAT energetics have long been implicated in the pathogenesis of 
obesity and other lifestyle-related metabolic disorders in both humans [27, 80-83] and 
animals [73, 84-87]. However, the extent of mitochondrial involvement in metabolic 
disease progression, and whether changes observed in mitochondria are secondary to 
lifestyle factors (such as inactivity and/or diet) is a matter of much debate [30-32, 35]. 
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One of the hallmark features of advancing cardio-metabolic disease is insulin resistance 
in peripheral tissues [26]. Insulin-resistant muscle demonstrates an impaired ability to 
transition between carbohydrate and lipid fuels and, as such, is often described as 
having ‘metabolic inflexibility’ [88]. Similarly, insulin-resistant WAT exhibits an 
inability to switch between lipolysis and re-esterification upon hormonal stimulation 
[89]. Thus, in both obesity and type 2 diabetes, the rates of both skeletal muscle lipid 
oxidation and WAT lipolysis do not suppress effectively in response to a meal (i.e., with 
insulin stimulation), whereas during the postprandial state, the rate of lipid oxidation is 
incapable of increasing sufficiently [89-91]. This leads to the accretion of triglyceride 
within both adipose and non-adipose tissues, a pathology strongly associated with both 
the insulin resistant state [92] and altered mitochondrial metabolism [35, 93]. As such, 
patients with type 2 diabetes [90], direct relatives of patients with type 2 diabetes [94, 
95] and obese individuals [91, 96, 97] display an overt reduction in the capacity for 
lipid oxidation and an impaired ability to transition between fuel sources when 
subjected to changes in substrate availability [98, 99].  
 Given that the mitochondria are almost entirely responsible for the β-oxidation of 
FFA’s and the importance of TCA cycle intermediates in lipid storage pathways, it is 
perhaps not surprising that so-called mitochondrial ‘deficiencies’ have been observed in 
the skeletal muscle and WAT of obese rodents [73, 84, 86, 87, 100, 101] and humans 
[27, 81, 82, 102, 103]. These findings have led to the notion that abnormalities in 
skeletal muscle and/or WAT lipid metabolism may play a causative role in the 
pathogenesis of obesity and insulin resistance [27, 28, 84, 85, 104-106]. However, the 
issue of whether mitochondrial deficiency and/or defective mitochondrial metabolism 
contributes to insulin resistance has been questioned in light of two lines of evidence. 
First, Boushel et al. [107] reported that when O2!flux was normalized for markers of 
mitochondrial content (such as mitochondrial DNA content or oxidative enzyme 
activity), oxidative phosphorylation and electron transport capacity in skeletal muscle 
extracts obtained from patients with type 2 diabetes were not different from those 
observed in muscle of age-matched healthy control subjects. In other words, they found 
no evidence for a decrease in the quality of the mitochondria in skeletal muscle from 
type 2 diabetic patients.!A key feature of the data presented by Boushel et al. [107] was 
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that although mitochondrial respiration was indeed lower in the muscle of patients 
with type 2 diabetes than in a healthy control group, this was due to a reduction in 
muscle oxidative capacity (i.e. the number of mitochondria) rather than mitochondrial 
function per se. Importantly, this finding highlights the significance of nomenclature 
when discussing aspects related to muscle mitochondrial function: a true mitochondrial 
‘dysfunction’ implies an inherent abnormality within the mitochondrial machinery 
rather than a decline in mitochondrial number or density (mass per unit volume)!
[108].   
 A second line of evidence that brings into question the issue of whether or not 
there is a mitochondrial ‘dysfunction’ in muscle of individuals with a range of chronic 
metabolic disease states are the recent reports demonstrating high-fat diet- (HFD) 
induced increases in mitochondrial protein abundance and enhanced oxidative enzyme 
activities [109-114]. Indeed, HFD’s cause elevated concentrations of circulating FFA’s 
which, acting as ligands to PPAR’s, can induce mitochondrial biogenesis through PGC-
1α [112, 115-117] while concomitantly causing rapid gains in whole-body adiposity and 
peripheral insulin resistance [112, 118]. However, compared to a typical rodent HFD 
(60-80% energy (E) derived from fat), a typical human obesogenic diet (i.e., a Western 
diet; WD), is only moderately high in fat (~40% of total E from fat) yet still comprises a 
substantial proportion of E from carbohydrate (particularly sugars of high glycemic 
index) and protein [119, 120]. Although diets high in fat or high in sugar may result in 
similar outcomes (i.e., rapid gains in adiposity, insulin resistance, elevated circulating 
lipids) the mechanisms underlying the development of these pathologies are likely to be 
markedly different. Indeed, unlike with high-fat feeding, Brand et al. [119] did not 
observe defects in the insulin signaling cascade after using a cafeteria diet (70% E from 
carbohydrate) to induce insulin resistance in rats. Thus, although HFD’s are often used 
to study the underlying mechanisms of obesity and its associated conditions, the 
disparity between the macronutrient breakdown of different obesogenic diets is an 
important factor to consider when studying diet-induced metabolic disease 
progression.  
 Whether or not an obesogenic WD can induce mitochondrial changes in rodent 
skeletal muscle similar to that seen with a HFD is not clear. Regardless, the results of 
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recent studies indicate that increases in mitochondrial content and/or respiratory 
capacity are likely to precede insulin resistance in both rodents [121, 122] and humans 
[123, 124]. However, it has been proposed that the increase in mitochondrial content is 
a transient phenomenon [121-123] that disappears as the insulin resistance becomes 
more severe [121, 122]. This would suggest that a reduction in the mitochondrial 
content of skeletal muscle is not likely to be a causative factor in the pathogenesis of 
insulin resistance but, rather, that it is severely impaired insulin action which disrupts 
mitochondrial biogenesis. In line with this notion, the rate of insulin-stimulated 
mitochondrial protein synthesis is blunted in obese, insulin resistant individuals when 
compared to their lean counterparts [103]. Furthermore, in rodent models of HFD-
induced obesity, attenuation of mitochondrial energy metabolism in both skeletal 
muscle and WAT appears to improve insulin action and glucose tolerance [125-133], 
whereas in WAT, insulin resistance develops prior to the down-regulation of 
mitochondrial protein expression [87]. Therefore, although diet undoubtedly plays a 
major role in the pathogenesis of obesity and insulin resistance, it is unlikely that 
‘dysfunctional’ skeletal muscle or WAT mitochondrial energy metabolism (and in 
particular, a reduced rate of lipid oxidation) induced by a HFD is the direct cause of 
insulin resistance [32]. 
 An alternative argument is that impaired lipid metabolism and reduced 
mitochondrial function is, in part, an adaptive response to an ‘inactivity cycle’, driven 
by diet-induced gains in adiposity coupled with other environmental influences which 
predispose to a reduced level of habitual physical activity. In support of this hypothesis, 
the respiratory capacity of skeletal muscle from the lower limb (m. vastus lateralis) is 
reduced in obese individuals and patients with type 2 diabetes, whereas the muscle 
from the upper limb (m. deltoideus) shows ‘normal’ mitochondrial function [134, 135]. 
Furthermore, despite differences in mitochondrial function in the leg musculature and 
a lower whole-body VO2max, obese persons and patients with type 2 diabetes have a 
normal capacity for fat oxidation during exercise [99, 134], suggesting that the reduced 
mitochondrial content observed in the leg musculature of these metabolically 
challenged individuals is likely a result of reduced habitual locomotor activity, rather 
than an intrinsic deficit per se. Indeed, exercise training increases the oxidative capacity 
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of lower limb musculature in otherwise healthy, lean individuals, obese, insulin 
resistant individuals and patients with type 2 diabetes [136-140]. Moreover, despite 
improving insulin action, non-exercise induced weight loss does not appear to improve 
mitochondrial content/function in skeletal muscle [137, 138]. Thus, it seems entirely 
possible that the low skeletal muscle oxidative capacity observed in muscle from obese 
individuals reflects the lower levels of habitual physical activity (and therefore a 
reduced rate of ATP turnover in the locomotor musculature) typically displayed by 
obese, insulin resistant persons [141]. This line of reasoning is directly supported by 
findings which suggest that the oxidative capacity of lower-limb skeletal muscle is not 
impaired in non-obese, insulin resistant (but glucose sensitive) individuals compared 
with their non-obese, insulin-sensitive counterparts [124]. Furthermore, despite 
markedly elevated skeletal muscle lipid content in type 2 diabetic patients and different 
levels of whole-body glucose disposal, the best predictor of insulin sensitivity is skeletal 
muscle oxidative capacity rather than more ‘traditional’ markers of insulin resistance 
such as lipid status or body composition [140].  
 The level of habitual contractile activity may well be the missing link connecting 
skeletal muscle and WAT mitochondrial function with metabolic disease risk factors. 
Chronic inactivity (or disuse) results in a decrease in mitochondrial number [142], 
aberrant lipid handling [92] and an impaired health profile [2]. In contrast, chronic 
activity (exercise training) results in marked mitochondrial biogenesis in both skeletal 
muscle [142] and adipose tissue [71, 79], increased whole-body lipid oxidation and 
turnover [143] and an improved overall health status [2]. It therefore follows that 
interventions that result in either an increase or decrease in mitochondrial content 
should cause reciprocal changes in health/disease outcomes. 
3.0 DO THE GENES FIT? 
Despite the accumulating evidence suggesting that it is an ‘inactivity cycle’ which leads 
to a reduction in mitochondrial content during metabolic disease progression, a 
growing body of evidence is suggestive of a genetic component underlying the 
complexity of metabolic disease [11, 12, 144]. In the last decade a number of studies 
have demonstrated that cultured myotubes isolated from the skeletal muscle of obese 
! 19!
individuals retain the metabolic program of the donor tissue [97, 145-147], even 
though most of the adaptive factors have been removed (e.g., hormone and substrate 
fluctuations, neural input, contraction). Therefore, the remaining characteristics are 
primarily inherent, rather than due to environmental influences. This important 
finding suggests that several key features of metabolic inflexibility (such as impaired 
insulin action [145, 148-150] and a reduced capacity for lipid oxidation [97, 98, 145, 
147]) may, in part, have a genetic or epigenetic origin [151]. In line with this notion, the 
heritability of endurance exercise capacity is estimated to be 40% or higher [152, 153] 
and has been linked to skeletal muscle mitochondrial gene expression [152]. However, 
familial environmental influence may also be important [154], with the heritability of 
exercise participation estimated to be as high as 70% [155]. Thus, while it is clear that a 
genetic component may underlie many of the features of cardio-metabolic disease, it is 
difficult to identify and attribute specific features to disease progression in living 
humans because of the profound environmental influence. 
 Given the polygenic nature of complex disease, another approach to study this 
problem has been to control for genetics in the hope of teasing out which facets of 
metabolic disease are primarily environmental and which are inherent. Studies in 
discordant monozygotic or same-sex dizygotic twins (where interpair differences are 
almost entirely environmental) have indicated that independent of genetic factors, 
acquired obesity and/or low aerobic capacity are associated with insulin resistance and 
a reduced expression of mitochondrial genes essential to lipid oxidation and oxidative 
phosphorylation in both muscle [156] and WAT [156, 157]. Furthermore, these reports 
have highlighted physical activity as a potent environmental modulator of body mass 
and other heritable traits linked to cardio-metabolic health [156-158]. However, the 
information obtained through these investigations is hampered by the same limitations 
as other human studies in that individuals are studied in a free-living environment 
making factors such as diet and lifestyle difficult to control. While these studies attempt 
to control genetics in order to investigate environmental factors, they provide little 
insight into the underlying genetic underpinning of cardio-metabolic health/disease.  
 The heterogeneous nature of human populations and the countless environmental 
variables make it difficult to study specific gene/environmental interactions in relation 
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to health outcomes in humans, an effort which is of utmost importance if the 
mechanistic role played by physical activity in determining cardio-metabolic health is 
to be understood [159]. Therefore, animal models that select for the phenotypic 
expression of polygenic traits provide valuable insight into the gene/environmental 
interactions that determine cardio-metabolic health. In 1996, Koch and Britton at the 
University of Michigan began a selective breeding program in a population of 
genetically heterogeneous rats, artificially selecting for high- and low- endurance 
running capacity in the absence of exercise training [160]. Selection of opposing 
phenotypic extremes has concentrated contrasting allelic variation for running capacity 
from one generation to the next, leading to two extreme divergent phenotypes. 
Remarkably, co-selecting for high- and low- running capacity also yielded divergent 
models of metabolic disease risk, with low capacity runners (LCR) displaying many 
characteristics common to metabolic disease phenotypes (such as increased body mass 
and adiposity, hyperinsulinaemia, impaired glucose tolerance and cardiovascular 
abnormalities) whereas high capacity runners (HCR) present with superior metabolic 
health, characterized by resistance to weight gain in the face of a HFD and an increased 
capacity for the uptake and utilization of both glucose and FFA’s [161-164]. 
Importantly, many of these features appear to be linked to the metabolic characteristics 
of the skeletal muscle [162, 165] and, in particular, the capacity for skeletal muscle 
oxidative energy production. However, there is some contention as to whether this is 
due to differences in the mitochondrial reticulum [165], an enhanced capacity of some 
(or all) of the oxidative enzymes [166-168], or a combination of both. Moreover, while 
the oxidative capacity of skeletal muscle is evidently a defining feature for these 
divergent phenotypes, little is known about the role played by WAT. Given the 
substantial overlap of both skeletal muscle and WAT metabolism in whole-body 
metabolic regulation, whether differences in WAT energy metabolism are associated 
with running capacity (and by association, metabolic health) is an important question 
that should be addressed in this rodent model. 
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Table 1.1  Fasting parameters for LCR and HCR rats, generation 11  
 LCR HCR % Difference 
LCR vs. HCR 
P value 
Glucose, mg/dL 110 ± 9 92 ± 5 20% 0.0007 
Insulin, pM 684 ± 195 296 ± 172 131% 0.002 
Triglycerides, mg/dL 67 ± 24 25 ± 4 168% 0.013 
Free fatty acids, meq/L 0.64 ± 0.22 0.33 ± 0.04 94% 0.031 
Visceral adiposity/body mass, % 1.55 ± 0.39 0.95 ± 0.32 63% 0.005 
Blood was drawn from 11-12 wk old male LCR and HCR rats following a 12 hr fast.  Values 
represent the mean ±  standard deviation. n=8 per group. LCR, low capacity runner; HCR, 
high capacity runner. Table adapted from Wisløff et al .  (2005) [161]. 
 
 
4.0 SCOPE OF THIS WORK 
The finding that mitochondrial adaptations occur in both skeletal muscle and WAT in 
parallel with changes in whole-body metabolic health highlights the importance of 
mitochondrial plasticity in responding to changing energy demands. However, there 
are still many gaps in our understanding of the gene/environment interactions that 
determine skeletal muscle and WAT mitochondrial metabolism. Accordingly, the aim 
of the work undertaken for this thesis was to assess the mitochondrial energy producing 
pathways in skeletal muscle and WAT, with the intention of investigating both the 
genetic and adaptive (i.e., diet and exercise training) mechanisms behind tissue 
respiratory capacity. Specifically, this thesis addresses the following questions: 
 1. Does an obesogenic WD alter the respiratory capacity of skeletal muscle 
and does it do so via the same signaling mechanisms as a HFD? 
 2. Is the difference in the respiratory capacity of LCR and HCR rat skeletal 
muscle due to increased mitochondrial number, increased oxidative 
enzyme activity or a combination of both?  
 3. Is intrinsic running capacity associated with the abundance and activity 
of oxidative enzymes in WAT? 
 4. Can exercise training alter WAT metabolism in rats with inborn high- 
and low- intrinsic running capacity? 
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Chapter 2 
 
 
Skeletal muscle respiratory capacity is enhanced in rats 
consuming an obesogenic Western diet 
Adapted from E.J. Stephenson  D.M. Camera T.A. Jenkins S. Kosari  J .S. Lee J.A. Hawley & 
N.K. Stepto (2012) Am J Physiol Endocrinol Metab  302 (12): E1541-9 
 
2.1   Introduction 
The macronutrient composition of the diet is an important factor in the pathogenesis of 
obesity [169, 170] and when combined with a sedentary lifestyle, a human obesogenic 
diet (characterised by the over-consumption of dietary fat and simple sugars [120, 
170]), results in an energy imbalance and subsequent increase in the flux of energy 
substrates to metabolically active tissues [170]. When substrate delivery exceeds a 
tissue’s needs, substrates accumulate and are eventually stored [119, 171].  
 Skeletal muscle is a major site for both fatty acid (FA) and glucose disposal [33, 
172]. In obesity, inappropriate lipid deposition in non-adipose tissues (such as skeletal 
muscle), and a concomitant reduction in the ability of cells to completely oxidize lipids 
has been frequently described [104, 173, 174]. Given that the mitochondria are entirely 
responsible for FA β-oxidation, it is not surprising that mitochondrial functional 
defects and deficiencies have been observed in the skeletal muscle of obese rodents [84, 
100, 101] and humans [27, 102]. These findings have led to the notion that lipid-
induced abnormalities in mitochondrial metabolism are a causative factor in the 
pathogenesis of obesity and its co-morbidities [27, 28, 84, 85, 104-106, 118].  
 The issue of whether mitochondrial ‘deficiency and/or dysfunction’ contributes to 
the obesity sequelae has been questioned in light of recent reports of HFD-induced 
increases in mitochondrial enzyme activities and protein expression [31, 110-112, 114]. 
Indeed, such diets cause an increase in circulating FFA [109, 112, 118, 175] which, 
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acting as ligands to the PPAR’s [115], are thought to increase mitochondrial biogenesis 
via the PGC-1α pathway (Fig. 1.5 [112, 115-117]). This suggests that certain aspects of 
mitochondrial function (i.e. β-oxidation and oxidative phosphorylation) may be up-
regulated following a HFD. 
 High-fat fed rodents rapidly gain weight while concomitantly developing insulin 
resistance [176-178]. As such, this model is used frequently to investigate the 
underlying mechanisms of obesity and its associated conditions. Investigations are 
often undertaken based on the assumption that these pathologies develop similarly in 
rodents as they do in humans. However the typical human obesogenic diet (i.e. a WD), 
is moderately high in fat (~40-45% of total energy, E) yet still comprises a substantial 
proportion of E from carbohydrate (particularly simple sugars) and protein [120]. In 
contrast, a typical rodent HFD usually contains extreme levels of fat (up to 80% of total 
available E) and very low carbohydrate [119, 120]. Given the role diet composition 
plays in the mechanistic progression of obesity and insulin resistance, the disparity 
between the macronutrient breakdown of a rodent HFD and a typical human 
obesogenic diet is an important factor to consider when interpreting results from 
animal studies [119, 171]. While diets high in fat and diets high in sugar may result in 
the similar outcomes such as rapid weight gain [119, 171], increased circulating lipids 
[119, 171] and insulin resistance [119], the mechanisms underlying these changes are 
likely to be markedly different [119].  
  In the current investigation, rats were fed a commercially available diet that 
closely mimics a human WD (a diet both high in fat and in sucrose), and the 
mitochondrial respiratory capacity of the skeletal muscle was measured using high-
resolution respirometry. It was hypothesized that 12-wk of a WD would increase the 
respiratory capacity of skeletal muscle mitochondria, via the up-regulation of PPARδ 
and PGC-1α. 
2.2    Materials and methods 
EXPERIMENTAL ANIMALS  
Eight-wk old male Long-Evans rats (n=24) were obtained from Monash Animal 
Services (Monash, Australia) and housed under a controlled 12:12 hr light/dark cycle at 
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a constant temperature of 22 °C. Animals had ad libitum access to food and water and 
were allowed to acclimate to the RMIT Animal Facility for one wk prior to 
commencement of the study. All procedures were approved by the RMIT Animal 
Ethics Committee.  
EXPERIMENTAL DIETS 
Following the acclimation period, rats were randomly assigned to one of two 12 wk 
dietary interventions; a control diet (CON, n=12; 16% of E from fat, 21% from protein 
and 63% from carbohydrate, 16.1 kJ/g; Specialty Feeds, Glen Forrest, WA, Australia) or 
a commercially available WD (n=12; 40% E from fat, 17% from protein and 43% from 
carbohydrate; 19.4 kJ/g; Specialty Feeds, Glen Forrest, WA, Australia). The 
macronutrient breakdown of each diet is presented in Table 2.1. Body mass and food 
intake were monitored twice weekly. 
GLUCOSE TOLERANCE TESTS  
After 11 wk, all rats were subjected to a glucose tolerance test (GTT) to assess glucose 
clearance. Following an overnight fast (14 hr), ~15 µL of blood was collected via tail cut 
and glucose concentration was measured on a hand-held glucometer (Roche 
Diagnostics, Castle Hill, NSW, Australia). Rats then received a single glucose bolus (2 
g/kg body mass) via intra-peritoneal injection, and blood glucose concentration was 
monitored at 30 min intervals over 120 min post-injection.  
TISSUE COLLECTION AND ANALYSES 
After 12-wk, animals were decapitated and hind-limb muscles immediately excised. To 
limit any possible differences that might occur as a result of differing cage activity, the 
m. soleus (soleus) and m. extensor digitorum longus (EDL) muscles were chosen for 
study. The soleus (~87% type I fibers and ~12% type IIA fibers) is predominantly a 
postural muscle and therefore has a high daily activity level, whereas many fibers of the 
EDL muscle (~2% type I fibers, ~42% type IIA fibers, and ~56% type IIB fibers) are 
recruited only during rapid, high-intensity tasks [179]. The left soleus was placed in ice-
cold muscle preservation media (BIOPS; K+-MES, 50 mM; taurine, 20 mM; 
dithiothreitol, 0.5 mM; MgCl2, 6.56 mM; ATP, 5.77 mM; phosphocreatine, 15 mM; 
imidazole, 20 mM; pH 7.1 adjusted with 5 N KOH at 0 °C; Ca-EGTA buffer (10 mM; 
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2.77 mM CaK2EGTA + 7.23 mM K2EGTA; 0.1 µM free calcium) [180-182], while the 
contra-lateral soleus and EDL muscles were snap-frozen in liquid N2 for later analyses. 
Epidydimal fat pads were removed and weighed as indicators of adiposity. All reagents 
used were obtained from Sigma-Aldrich (Castle Hill, NSW, Australia) unless otherwise 
specified. 
BLOOD SERUM ANALYSES 
Trunk blood was allowed to clot over ice after which it was centrifuged to obtain serum. 
Serum was analyzed using commercially available kits for insulin (#80-INSRT-E01, 
ALPCO Immunoassays, Salem, NH) and lipids (free fatty acids, NEFA-C; triglycerides, 
Triglyceride E and Cholesterol, Cholesterol E, all from WAKO Pure Chemical 
Industries Ltd., Osaka, Japan). 
HIGH-RESOLUTION RESPIROMETRY 
High-resolution respirometry provides a direct measure of mitochondrial respiratory 
capacity ex vivo, from which information about specific components in a working 
system can be obtained [180]. Soleus (n=6 per dietary treatment) was mechanically 
separated over ice using fine forceps [180], then chemically permeablized with saponin 
(50 µg.mL-1 in BIOPS) for 30 min. This was followed by a 10 min wash period in 
mitochondrial respiratory media (MiR05; sucrose, 110 mM; K-lactobionate, 60 mM, 
ACROS Organics; EGTA, 0.5 mM; MgCl2, 3 mM; taurine, 20 mM; KH2PO4, 10 mM; 
HEPES, 20 mM; adjusted to pH 7.1 with KOH at 37 °C; and 1 g. L-1 fatty acid free 
BSA)[180]. Duplicate tissue samples (2-3.5 mg) were transferred to the chambers of an 
O2K-Oxygraph high-resolution respirometer (Oroboros; Innsbruck Austria) 
containing 2 mL of MiR06 (MiR05 plus 280 IU.mL-1 catalase) and calibrated to air 
saturation. Individual chambers were oxygenated to approximately 485 nmol.mL-1 with 
pure O2 (BOC; Australia).  
SUBSTRATE-UNCOUPLER-INHIBITOR TITRATION PROTOCOL  
Malate (2 mM) was added to the chamber and the mass specific O2 flux (JO2; pmol.s-
1.mg-1 wet weight) stabilized for 5-10 minutes.  The tissue was then subjected to a 
substrate-uncoupler-inhibitor titration (SUIT) protocol that sequentially evaluates 
complex (C)I leak state (the addition of pyruvate, 5 mM and glutamate, 10 mM; state 2 
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respiration), oxidative phosphorylation with electron flux through CI, by titration (the 
addition of ADP, 0.25, 0.75, 2.5 and 5 mM; state 3 respiration), the integrity of the 
outer mitochondrial membrane (the addition of cytochrome C, 10 µM), maximal 
coupled respiration with electron flux through both CI+CII (the addition of succinate, 
10 mM; state 3 respiration), maximal capacity of the electron transport system (ETS) by 
uncoupling with a stepped titration (the addition of carbonyl cyanide p-
trifluoromethoxyphenylhydrazone (FCCP), 0.5 and 1 µM), uncoupled (u) oxidative 
phosphorylation with electron flux through CII (with the addition of the CI inhibitor 
rotenone, 0.5 µM) and, residual O2 consumption (ROX; with the addition of NaN3, 200 
mM). Chambers were maintained at 37 oC, while O2 saturation was maintained 
between 300 and 450 nmol.mL-1, via regular titrations of H2O2. Mass-specific O2 flux 
was determined using DATLAB (Oroboros, Innsbruck; Austria) from steady state JO2 
normalized to tissue wet weight and adjusted for instrumental background and ROX.  
In addition, flux control ratios (FCR; results normalized to the maximal capacity of the 
ETS) were calculated to determine mitochondrial function independent of 
mitochondrial density [180].  
MITOCHONDRIAL ENZYME ACTIVITIES 
Muscle homogenates (n=10 per group) were prepared over ice from snap-frozen soleus 
or EDL (10-20 mg for each) in buffer (KCl, 175 mM; EDTA, 2 mM, pH 7.4; 1:50 or 
1:100 dilution) then subjected to three freeze-thaw cycles. Citrate synthase (CS), β-
hydroxyacyl-CoA dehydrogenase (β-HAD) and total carnitine palmitoyltransferase 
(CPT) activities were determined using the methods of Srere [183], Bergmeyer [184] 
and Bieber [185] respectively, with the following modifications. Briefly, aliquots of 
homogenate were added to the appropriate wells of a 96-well microplate with a working 
solution with final concentrations of either Tris-HCl, 72.5 mM; Acetyl CoA, 0.45 mM; 
DTNB, 0.1 mM (for CS),  Tris-HCl, 50 mM; EDTA, 2 mM; NADH, 250 µM for (for β-
HAD) or Tris-HCl, 116 mM; EDTA, 1 mM; L-carnitine, 1.1 mM; DTNB, 100 µM (for 
CPT). After monitoring the wells for background activity, reactions were initiated via 
the addition of oxaloacetic acid, 0.5 mM (for CS), acetoacetyl-CoA, 100 µM (for β-
HAD) or palmitoyl-CoA, 1.9 mM (for CPT). Enzyme activities were determined by 
monitoring ∆absorbance at 412 nm (for CS and CPT) and 355 nm (for β-HAD) over 3 
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min at 25 ºC. Extinction coefficients of 13.6 µmol/cm2 (for CS and CPT) and 6.22 
µmol/cm2 (for β-HAD) were used to calculate rates of enzyme activity. Rates are 
expressed as µmol/min/g wet weight 
INTRAMYOCELLULAR TRIGLYCERIDE DETERMINATION 
Intramyocellular triglyceride (IMTG) concentration was determined according to the 
method described by Spriet et al. [186]. Briefly, freeze-dried soleus and EDL (n=8 per 
group for each muscle) was powdered and cleaned of all visible blood and connective 
tissue.  Total lipids in muscle fragments (5-10 mg dry muscle) were extracted in 
chloroform-methanol (13). The organic portion was then evaporated under a stream of 
N2 and reconstituted in chloroform. Silicic acid was then added to the organic portion 
and the phospholipids removed by centrifugation. The resultant supernatant was 
evaporated and saponified in ethanolic KOH and glycerol content was analyzed 
fluorometrically [187].  
NUCLEIC ACID EXTRACTION AND QUANTIFICATION 
DNA and RNA were each extracted from approximately 10-15 mg of snap-frozen 
soleus and EDL. RNA was extracted using Trizol reagent (Invitrogen, Mulgrave, 
Australia), whereas DNA was extracted using a commercially available kit (Qiagen, 
Doncaster, Australia). The quality and quantity of both extracts was determined using a 
NanoDrop 1000 spectrophotometer (Nanodrop Technologies, Wilmington, USA). For 
both DNA and RNA an aliquot was taken from each CON extract and pooled. 
Following quantification, the pooled sample was serially diluted in order to produce a 
standard curve for inclusion in each PCR run.  
REVERSE TRANSCRIPTION AND REAL-TIME PCR 
First-strand cDNA synthesis was performed for RNA extracts using Superscript VILO 
(Invitrogen, Mulgrave, Australia). Relative mRNA expression was determined using 
commercially available Taqman primer/probe sets (Applied Biosystems, Mulgrave, 
Australia) for PGC-1α (Ppargc1a; cat. no. Rn00580241_m1) and PPARδ (Ppard, cat. 
no. Rn00565707_m1). Glyceraldehyde-3-phosphate dehydrogenase (Gapdh; cat. no. 
Rn01775763_g1) was included as a housekeeping gene to normalize threshold cycle 
(CT) values. Mitochondrial DNA (MtDNA) copy number was determined as previously 
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described [188, 189], using Taqman primer/probes sets for mitochondrially-encoded 
nicotinamide adenine dinucleotide (reduced; NADH) dehydrogenase-1 (MT-ND1; cat. 
no. Rn03296764_s1) and nuclear-encoded Gapdh. Quantification was performed in 
duplicate using a 72-well Rotor-Gene 3000 Centrifugal Real-Time Cycler (Corbett 
Research, Mortlake, Australia). PCR conditions were as follows: 2 min at 50 ºC, 10 min 
at 95 ºC, followed by 40 cycles of 95 ºC for 15 s and 60 ºC for 60 s. Data was calculated 
using the ΔΔCt method [190].  
IMMUNOBLOTTING 
Approximately 50 mg of frozen soleus and EDL was homogenized in buffer (Tris HCl, 
50 mM, pH7.5; EDTA, 1 mM; EGTA, 1 mM; DTT, 1 mM; NaF, 50 mM; Na 
Pyrophosphate, 5 mM; glycerol, 10%; Triton X-100, 1%; trypsin inhibitor, 10 µg/mL; 
aprotinin, 2 µg/mL; benzamidine, 1 mM; phenylmethylsulfonyl fluoride, 1 mM; 1:8 
dilution), and centrifuged at 20,000 G for 30 min at 4 °C. Protein concentration of the 
supernatant was determined using the bicinchoninic method (Pierce, IL). Muscle 
lysates containing either 5, 10 or 20 µg protein were prepared in 4 x Laemmli buffer, 
subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), 
then transferred to polyvinylidene difluoride (PVDF) membranes. Membranes were 
blocked (5% non-fat dry milk) for 1 hr at room temperature, then incubated overnight 
at 4 °C with primary antibodies specific for: PPARδ (~49 KDa, Thermo Scientific, 
#PA1-823A), PPARα (~52 KDa, Abcam, #ab24509), PGC-1 (~100 KDa, Chemicon, 
#ab3242), CPT1-M (~80 KDa, Santa Cruz Biotechnology, #sc20670), uncoupling 
protein 3 (UCP3; ~35 KDa, Affinity BioReagents, #PA1-055), mitochondrial 
respiratory complexes I, II, III, IV (subunit I) and V (~18, ~25, ~45, ~37, ~52 KDa, 
respectively, MitoSciences, #MA604), Complex IV subunit II (~25 KDa, MitoSciences, 
#MS405), Complex IV subunit IV (~15 KDa, MitoSciences, #MS407), CS (~52 KDa, 
Abcam, #ab96600) and as a protein loading control, α-tubulin (~50 KDa, Sigma, St. 
Louis, MO). Protein was detected using enhanced chemiluminescence (Amersham 
Biosciences, Piscataway, NJ) and quantified by densitometry. 
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STATISTICAL ANALYSES 
All values are expressed as the group mean ± standard error of the mean (SE). An 
unpaired t-test was used to compare groups for all analyses except the GTT and the 
stepped titration of ADP, where a two-way analysis of varience (ANOVA) was used. 
Significance is reported where P<0.05. All statistical analyses were performed using 
Graph Pad Prism software.  
2.3    Results 
WESTERN DIETS ARE OBESOGENIC  
Rats fed the WD maintained a greater energy intake than CON throughout the study 
(Table 2.1; 335 ± 6 and 274 ± 4 kj/d respectively; P<0.0001). From 6 wk, WD rats were 
heavier than CON (P=0.01; 379.1 ± 7.1 and 356.6 ± 3.9 g, respectively) and remained 
heavier throughout the intervention (Fig. 2.1A).  
 
Table 2.1.  Daily energy intake and nutritional parameters  
 Control Western diet 
Daily energy intake, kJ 273.52 ± 3.94 335.41 ± 5.92* 
Protein (casein)   
          E% 21.00 17.00 
          g/d 3.39 ± 0.05 3.37 ± 0.06 
Carbohydrate   
          E% 63.00 43.00 
          Sucrose, g/d 1.69 ± 0.02 5.89 ± 0.10* 
          Starch, g/d 9.10 ± 0.13 2.66 ± 0.05* 
Lipid   
          E% 16.00 40.00 
          Total, g/d 1.19 ± 0.02 3.63 ± 0.06* 
          Saturated, g/d 0.08 ± 0.001 2.37 ± 0.04* 
          Unsaturated, g/d 1.10 ± 0.02 1.24 ± 0.02 
Values represent mean ± SE, as determined over 12 wk. E, energy. n=12 animals per group. 
*P<0.05  
 
 
 
As illustrated in Fig. 2.1B, epididymal fat pads were heavier in WD compared to CON 
(P=0.03; 8.1 ± 0.4 and 6.9 ± 0.3 g, respectively). IMTG’s were elevated 37% in WD 
compared to CON in the soleus (42.8 ± 5.1 and 31.2 ± 4.3 µmol/g dry wt respectively), 
although values did not attain statistical significance (P=0.10; Table 2.2). In the EDL, 
IMTG’s were not different between groups (P>0.05). 
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Figure 2.1. The WD  promotes (A) increased body mass and (B) epididymal fat pad 
mass when compared to the CON  diet over 12 wk. CON, control diet. WD, Western 
diet. Values represent mean ± SE. n=12 animals per group *P<0.05. 
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THE WESTERN DIET CAUSED HYPERINSULINAEMIA  
No differences were observed in fasting blood glucose concentrations. However fasting 
serum insulin was greater in WD compared to CON (P=0.007; Table 2.2). During the 
GTT, there was no diet effect or interaction, although there was a main effect for time 
in response to the glucose challenge (P<0.0001). The areas under the blood glucose 
curves for WD and CON were not different (results not shown). 
 
Table 2.2. Physiological parameters in blood and skeletal muscle  
 Control Western Diet 
Fasting blood glucose, mM 5.70 ± 0.24 5.10 ± 0.18 
Fasting serum insulin, ng/mL 1.70 ± 0.12 2.39 ± 0.20* 
Fasting serum cholesterol, mM 2.99 ± 0.17 3.53 ± 0.19 
Fasting serum triglycerides, mM 1.66 ± 0.13 3.09 ± 0.36* 
Fasting serum free fatty acids, mM 0.61 ± 0.02 0.73 ± 0.07 
Intramyocellular triglycerides, µM/g dry wt 
Soleus: 
EDL: 
 
31.17 ± 4.27 
5.93 ± 1.16 
 
42.78 ± 5.14 
5.97 ± 1.26 
Values represent mean ± SE, as determined after 12 wk. EDL, m. extensor digitorum longus .  
Soleus, m. soleus .  n=8-12 animals per group. *P<0.05  
 
THE WD INCREASED FASTING SERUM TRIGLYCERIDES 
Serum triglycerides were greater in WD compared to CON (P=0.001; Table 2.2). Total 
cholesterol and serum FFA’s were also greater in WD, however neither of these values 
attained statistical significance (18%, P=0.052 and 20%, P=0.12, respectively; Table 2.2).  
THE CAPACITY OF THE ETS WAS GREATER FOLLOWING CONSUMPTION OF A WESTERN DIET 
To evaluate the capacity of the ETS and thus determine maximal O2 flux through the 
mitochondria, O2 flux in the soleus was measured during a SUIT protocol with 
substrates for CI and CII (Fig. 2.2). State II respiration with electron leak through CI 
was greater in WD compared to CON (P<0.001; WD, 9.9 ± 0.6 pmol.s-1.mg wet wt-1 and 
CON, 5.8 ± 0.6 pmol.s-1.mg wet wt-1). A similar trend was observed for state III 
respiration with flux through CI, although this difference did not attain statistical 
significance (WD, 89.7 ± 8.9 pmol.s-1.mg wet wt-1 and CON, 70.6 ± 6.8 pmol.s-1.mg wet 
wt-1; P=0.11).  
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Figure 2.2. Under all SUIT conditions except CI OXPHOS, mass-specific O2 
consumption is greater in soleus from rats receiving the WD  compared to CON . 
CI, complex I. CII, complex II. CIIu, uncoupled flux through CII. CON, control diet. ETS, 
electron transfer system. OXPHOS, oxidative phosphorylation. SUIT, substrate-uncoupler-
inhibitor titration. WD, Western diet. Values represent mean ± SE. n=6 animals per group. 
*P<0.05  
 
 
 
However, greater sensitivity to ADP was observed (P<0.05, Fig. 2.3). State III 
respiration with flux through both CI and CII together (WD, 137.2 ± 11.8 pmol.s-1.mg 
wet wt-1 and CON, 101.7 ± 9.8 pmol.s-1.mg wet wt-1), and non-coupled respiration with 
flux through CII (WD, 73.9 ± 5.3 pmol.s-1.mg wet wt-1 and CON, 56.5 ± 4.5 pmol.s-1.mg 
wet wt-1) was greater in WD (P=0.04 and P=0.03, respectively). Similarly, 
uncoupled/maximal flux through the ETS was greater in WD compared to CON 
(P=0.02; 152.0 ± 11.3 and 110.8 ± 9.8 pmol.s-1.mg wet wt-1 respectively). In order to 
assess O2 flux independent of mitochondrial density, we calculated the FCR for each 
substrate combination (Table 2.3). There were no differences between dietary groups. 
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Figure 2.3 Soleus muscle from rats receiving the WD  displays greater sensitivity to a 
titration of ADP compared to CON . ADP, adenosine diphosphate. CON, control diet. 
Soleus, m. soleus. WD, Western diet. Values represent mean ± SE. n=6 animals per group. 
***P<0.05 Two-way ANOVA. *P<0.05 T-test 
 
Table 2.3. Flux control ratios 
 Control Western diet 
Complex I, Leak  0.06 ± 0.01 0.07 ± 0.01 
Complex I, OXPHOS (state III) 0.62 ± 0.02 0.62 ± 0.04 
Complex I and II, OXPHOS (state III) 0.92 ± 0.02 0.94 ± 0.02 
Complex II, uncoupled  0.53 ± 0.03 0.53 ± 0.04 
Flux control ratios are the respirometry data normalized to maximal O2 consumption in 
uncoupled states. OXPHOS, oxidative phosphorylation. Values represent mean ± SE. n=6 
animals per group.  
 
 
 
CONSUMPTION OF A WESTERN DIET INCREASES THE ACTIVITY OF MITOCHONDRIAL ENZYMES 
Both CS (WD, 23.5 ± 1.5 µM/min/g wet wt and CON, 19.4 ± 1.0 µM/min/g wet wt; 
P=0.03; Fig. 2.4A) and total CPT activity (WD, 0.8 ± 0.1 µM/min/g wet wt and CON, 
0.4 ± 0.1 µM/min/g wet wt; P=0.01; Fig. 2.4C) were higher in the soleus after WD 
compared to CON. There were no differences between dietary groups for β-HAD 
activity in the soleus (WD, 4.9 ± 0.2 µM/min/g wet wt and CON, 4.1 ± 0.3 µM/min/g 
wet wt; P=0.11, Fig. 2.4B). In the EDL, CS (WD, 10.1 ± 0.5 µM/min/g and CON, 8.3 ± 
0.5 µM/min/g; P=0.01; Fig. 2.4A), ß-HAD (WD, 2.6 ± 0.1 µM/min/g and CON, 2.2 ± 
0.2 µM/min/g; P=0.04; Fig. 2.4B) and CPT (WD, 0.13 ± 0.01 µM/min/g and CON 0.09 
± 0.01 µM/min/g; P=0.02; Fig. 2.4C) activities were all greater following the WD.  
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Figure 2.4 In the soleus, rats receiving the WD  had greater (A) citrate synthase and 
(C) CPT activity compared to CON , whereas in the EDL, rats receiving the WD had 
greater (A) citrate synthase, (B) β-HAD  and (C) CPT activities compared with CON. 
β-HAD, β-hydroxyacyl-CoA dehydrogenase. CON, control diet. CPT, carnitine 
palmitoyltransferase. EDL, m. extensor digitorum longus. Soleus, m. soleus. WD, Western diet. 
Values represent means ± SE. n= 10 animals per group. *P<0.05. 
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Figure 2.5 Relative mRNA expression was not different between WD  and CON  
for PPARδ or PGC-1α in either (A) soleus or (B) EDL. Also reported here are MtDNA 
copy number for both soleus and EDL. CON, control diet. EDL, m. extensor digitorum 
longus. MtDNA, mitochondrial DNA. PGC-1α, PPARγ co-activator-1α. PPARδ, peroxisome 
proliferator activated receptor-δ. Soleus, m. soleus. WD, Western diet. Values represent means 
± SE. n=7 animals per group.  
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Figure 2.6 (A) Representative immunoblots for the transcriptional regulators PPARδ, 
PPARα and PGC-1; their targets CPT1 and UCP3; and mitochondrial proteins C.S. 
and respiratory complexes I-V in the soleus muscle from both WD and CON animals. 
(B) Relative protein expression  as determined by densiometry for both WD  and 
CON  animals. AU, arbitrary units. CI, complex I. CII, complex II. CIII, complex III. CIVI, 
complex IV subunit I. CIVII, comlex IV subunit II. CIVIV, complex IV subunit IV. CV, complex 
V. CON, control diet. CPT1, carnitine palmitoyl transferase. C.S., citrate synthase. PGC-1, 
PPARγ coactivator-1. PPAR, peroxisome proliferator activated receptor-1α. Soleus, m. soleus. 
UCP3, uncoupling protein 3. WD, Western diet. Values are means ± SE; n= 8-10 animals per 
group. *P<0.05 
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Figure 2.7 (A) Representative immunoblots for the transcriptional regulators PPARδ, 
PPARα and PGC-1; their targets CPT1 and UCP3; and mitochondrial proteins C.S. 
and respiratory complexes I-V in the EDL muscle from both WD and CON animals. 
(B) Relative protein expression as determined by densiometry for both WD  and 
CON  animals. AU, arbitrary units. CI, complex I. CII, complex II. CIII, complex III. CIVI, 
complex IV subunit I. CIVII, comlex IV subunit II. CIVIV, complex IV subunit IV. CV, complex 
V. CON, control diet. CPT1, carnitine palmitoyl transferase. C.S., citrate synthase. EDL, m. 
extensor digitorum longus. PGC-1, PPARγ coactivator-1. PPAR, peroxisome proliferator 
activated receptor-1α. UCP3, uncoupling protein 3. WD, Western diet. Values are means ± SE; 
n= 8-10 animals per group. *P<0.05 
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2.4  Discussion 
The mitochondrion has long been implicated in the pathogenesis of obesity and 
metabolic dysfunction [27, 80]. However the extent of mitochondrial involvement and 
whether these changes are secondary to lifestyle factors (i.e., physical inactivity) are a 
matter of current debate. Previously it has been shown that a mitochondrial deficiency 
exists in obese humans [27] and rodents [84, 85]. However the results of recent studies 
suggest there is dissociation between mitochondrial dysfunction and the progression of 
obesity [109, 110, 112, 138]. Indeed, accumulating evidence indicates that HFD’s 
induce increases in the expression [109-112] and activity [106, 110] of key 
mitochondrial enzymes, and that this process is likely to be driven by an increase in 
circulating FFA’s [112]. The data presented in this chapter supports this hypothesis and 
demonstrates for the first time that skeletal muscle respiratory capacity is enhanced 
after 12 wk on an obesogenic (high-fat, high-sucrose) WD (Fig. 2.2). 
 High-resolution respirometry allows the direct monitoring of O2 consumption by 
the ETS in permeabilized muscle fibers [180],  and reflects the integrated activity of the 
TCA cycle and ETS, providing a dynamic measurement of the oxidative capacity of 
tissue ex vivo [180]. Twelve wk of a WD was shown to induce an increase in the activity 
of the ETS in skeletal muscle with high oxidative capacity (Fig. 2.2). When the data is 
normalized to allow interpretation of function independent of mitochondrial volume 
(Table 2.3), this increase is attenuated, suggesting that mitochondrial biogenesis, rather 
than increased activity, is likely to be responsible for the increase in respiratory 
capacity. This finding is supported by the increased expression and activity of the 
mitochondrial enzyme CS (Fig. 2.4A), an enzyme long used as a marker enzyme for 
mitochondrial content. Additional mitochondrial enzyme activity and protein 
measurements in the primarily glycolytic EDL muscle further support this notion (Fig. 
2.4-2.7). 
 Previously it has been shown in WD- [171] and HFD-fed rodents [109, 110, 112] 
that skeletal muscle has an increased capacity for fat oxidation after as little as four wk. 
In the current study, increased activity of total CPT (CPT1 and CPT2) was observed 
(Fig. 2.4C) and this is indicative of an increase in the delivery of long-chain FA’s into 
the mitochondria. While fat oxidation was not measured directly, HFD-induced 
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increases in the activity of CPT1 have previously been associated with greater rates of 
fat oxidation [110, 113]. Interestingly, no differences were observed in the activity of β-
HAD, the third enzyme of the β-oxidation pathway, implying that the rate of FA 
delivery to the mitochondria may be discordant with the capacity for β-oxidation in 
muscle with high oxidative capacity. It is important to note however, that this data is of 
maximal enzyme activity ex vivo and is not indicative of in vivo demand.  
 Although it is only possible to speculate whether or not this miss-match is likely 
to contribute to cellular lipid deposition (IMTG’s were elevated 37% in the soleus, 
P=0.10, but remained similar in the EDL where β-HAD activity was elevated; Table 
2.2), the notion that the β-oxidation and TCA cycle activities are disproportionate and 
contribute to lipid deposition in diet-induced obesity is not a new concept. Previously 
Hoehn et al. [191] demonstrated that simply driving metabolism toward increased fat 
oxidation is not sufficient to increase energy expenditure, while Koves et al. [104] 
suggest that incomplete FA oxidation and accumulation of lipid species occurs when 
the import of FA into the mitochondria exceeds metabolic demand. Moreover, human 
studies have shown that despite increases in IMTG storage, rates of FA oxidation may 
only be impaired in cases of extreme obesity where mobility is severely reduced [97, 
138]. This implies that impaired FA oxidation per se is unlikely to be responsible for the 
accumulation of lipid species during obesity but rather the reduction in physical 
activity. These findings suggest that chronic feeding of a WD increases the cellular 
machinery necessary to cope with increases in energy expenditure yet, without the 
appropriate energy demand substrates will accumulate in the tissue, eventually being 
stored. Pharmacological agonism of PPARδ has been shown to increase the expression 
of several oxidative proteins including UCP3 and CPT1 [192]. However, unless 
combined with an endurance training program, no functional improvements are seen, 
implying that there must be an appropriate stimulus for any functional enhancements 
to manifest. Therefore the increases in mitochondrial respiratory capacity observed in 
the current investigation could be considered a compensatory response in anticipation 
of the increase in substrate flux to the mitochondria.  
 A second aim of this investigation was to characterise potential mechanisms 
responsible for the increase in mitochondrial function. The PPAR’s are a family of 
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ligand-activated nuclear transcription factors that sense and respond to dietary lipids 
and their metabolites [193]. Of the three isoforms, PPARα and PPARδ are the two 
preferentially expressed in skeletal muscle, with PPARδ being the predominant isoform 
in this tissue [194].  Both PPARα and PPARδ play key roles in FA metabolism [115], 
acting with the transcriptional co-activator and “master regulator” of mitochondrial 
biogenesis, PGC-1α [195, 196] to induce increases in both nuclear and mitochondrial 
target genes for FA catabolism (Fig. 1.5 [171, 195]). Previous studies have identified 
PPARδ and PGC-1α as important mediators of diet-induced increases in mitochondrial 
function [197]. Furthermore, PPARδ is known to directly interact with CPT1 [195], 
while HFD’s or pharmaceutical PPARδ agonists increase UCP3 mRNA [171, 195] and 
protein expression [110, 198]. Unlike previous studies that have investigated the effect 
of a HFD on mitochondrial signalling, large increases in circulating FFA’s were not 
seen following the WD. However, total serum triglycerides were almost two-fold 
greater (Table 2.2). Moreover, marked differences in the gene and/or protein 
expression of PPARδ or PGC-1α could not be demonstrated (Fig. 2.5-2.7), the two 
signalling proteins that are thought to be responsible for HFD-induced alterations to 
mitochondrial function [110]. Despite this, the possibility that post-translational 
regulation of protein activity may be a potential mechanism by which mitochondrial 
function is enhanced cannot be discounted. Indeed it is well known that the acetylation 
status of PGC-1α is important in regulating its activity [199] while PPARδ itself may 
post translationally modify PGC-1α [200]. 
 Of note was that the expression of PPARδ’s down-stream target protein CPT1 
remained unchanged, despite an increase in total CPT activity (Fig. 2.6 and 2.7). 
Previous studies have reported increases in UCP3 mRNA following a WD [171], and in 
line with this UCP3 protein expression was observed to increase in the current study 
(Fig. 2.6 and 2.7). Taken together, increased CPT activity and UCP3 protein expression 
could be indicative of an increase in PPARδ activity [201], despite no increase in 
PPARδ gene or protein expression. While UCP3 remains without an established 
function [202, 203], increases in UCP3 expression due to PPAR stimulation implicate 
this protein in an array of metabolic processes that involve substrate handling. Further 
investigations will need to be undertaken over prolonged intervention periods to 
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determine if PPARδ activity is indeed altered by a WD. However it is also plausible that 
the reduced percentage of fat in a WD may have less agonist potential than that of a 
HFD and as such, other mechanisms may be responsible for the observed increase in 
CPT activity and UCP3 expression.  
 In conclusion, the results of the present investigation demonstrate that an increase 
in mitochondrial respiratory capacity occurs in response to WD-induced obesity. This 
is likely a compensatory mechanism to cope with excess energy availability in the 
absence of a simultaneous increase in energy demand. Such a scenario would be 
expected to contribute to intracellular lipid deposition and overall adiposity when 
sustained for prolonged periods without a concomitant increase in physical activity.  
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Chapter 3 
 
 
Divergent skeletal muscle respiratory capacities in rats 
artificially selected for high and low running ability: a role 
for NOR1? 
Adapted from E.J. Stephenson N.K. Stepto L.G. Koch S.L. Britton and J.A. Hawley (2012)  J  
Appl Physiol  Vol. 113 (9):1403-12 
 
3.1  Introduction 
The ability to deliver and utilize oxygen is an essential component of metabolic 
regulation, with an individual’s VO2max a good correlate of whole-body health status 
[38]. Aerobic power is determined by the interaction of intrinsic (i.e., genetic) and 
environmental (i.e., lifestyle) factors, with the heritability of endurance capacity 
estimated to be 40% or higher [153]. However, VO2max and its phenotypic expression 
(i.e., endurance running ability) can be rapidly modified by embarking on a vigorous 
exercise training program or, conversely, by adopting an inactive lifestyle. While such 
phenotypic plasticity can be harnessed to study the time-course of progression (or 
reversal) of a number of metabolic disease traits, the contribution of potential intrinsic 
mechanisms to such diseases becomes difficult to define because of the confounding 
impact of numerous environmental influences [38].  
 Through two-way artificial selection, Koch and Britton [160] have generated an 
animal model of low- or high- aerobic exercise capacity from a population of 
genetically heterogeneous rats. Divergent artificial selection for a complex trait (e.g., 
superior aerobic phenotype) produces a useful genetic model to study gene-exercise 
interactions because contrasting allelic variation is concentrated at the extremes from 
one generation to the next. In this model, 11 generations of two-way selection produced 
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rats that differed substantially in aerobic exercise capacity (374% difference between 
LCR and HCR, P<0.0001), whilst simultaneously presenting with markedly different 
metabolic and cardiovascular disease risk factors [161].  
 Because skeletal muscle mitochondrial respiration is a limiting factor for VO2max, 
and as skeletal muscle oxidative capacity correlates with whole-body insulin sensitivity 
[140], it has been proposed that differences in mitochondrial function in LCR-HCR 
animals are the major determinants of their divergent running capacities and metabolic 
phenotypes. In support of this assertion, HCR rats are better at utilizing O2, an adaptive 
variation likely to be present at the level of the skeletal muscle [153]. Results from a 
series of studies in this model [161, 162, 165-168, 204, 205] provide direct evidence that 
skeletal muscle from HCR rats has superior substrate handling ability (i.e., ‘metabolic 
flexibility’) and mitochondrial enzyme activities compared to LCR rats. However, there 
is some contention as to whether this is due to increases in the mitochondrial reticulum 
[165] or an enhanced capacity of some or all of the oxidative enzymes [167, 168, 206]. 
In addition Lessard et al. have shown that the differences in metabolic flexibility are 
linked to β-adrenergic signaling through the NR4A orphan nuclear receptor Neuron-
derived clone 77 (Nur77) [162, 204]. The NR4A family of orphan nuclear receptors 
Nur77, Nuclear receptor related protein 1 and Neuron-derived orphan receptor 1 
(NOR1) has recently emerged as a key player in the regulation of a number of 
important metabolic processes [162, 207-209]. All three have been linked to the 
regulation of skeletal muscle substrate handling and whole-body glucose homeostasis 
[162, 207-209], whereas NOR1 has been shown to be essential for oxidative metabolism 
[210] and may also be important in promoting several oxidative adaptations in the 
muscle [206]. 
 Since previous studies have been inconclusive as to whether skeletal muscle 
respiratory capacity is due to an increased number of mitochondria [165] or increased 
mitochondrial activity [166, 167], the aim of this study was to determine the ex vivo 
activity and protein expression of the key ETS respiratory complexes in muscle from 
LCR and HCR rats. It was hypothesized that skeletal muscle respiratory capacity would 
be greater in HCR rats compared to LCR rats, and that this difference would be due to a 
greater mitochondrial density in the muscle. Furthermore, a second hypothesis was that 
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the expression of NOR1 would be greater in the muscle of HCR rats compared to LCR 
rats. 
3.2    Materials and methods 
EXPERIMENTAL ANIMALS  
Rat models for LCR and HCR were derived from genetically heterogeneous N:NIH 
stock rats by artificial selection for treadmill running capacity as described previously 
by Koch and Britton [160]. Female offspring of either LCR (n=12, generation 27) or 
HCR (n=12, generation 27) rats were housed under a controlled 12:12 hr light/dark 
cycle at a constant temperature of 22 °C. Animals were provided ad libitum access to 
water and a standard chow diet. Breeding and phenotyping of parent rats was 
conducted at the University of Michigan (Ann Arbor, MI). Rats arrived at RMIT 
University at ~ 8 wk of age and were allowed to acclimate to the RMIT Animal Facility 
for 2 wk before commencement of any experimental procedures. This study was 
undertaken with approval from both the University of Michigan and RMIT University 
animal ethics committees. 
BLOOD ANALYSES  
After a 5 hr fast ~15 µL blood was collected via tail cut and glucose concentration was 
measured on a hand-held glucometer (Roche Diagnostics, Castle Hill, NSW, Australia). 
A separate aliquot of blood (~15-20 µL) was allowed to clot over ice and centrifuged to 
obtain serum. Serum was kept frozen at -20 °C for later analysis of fasting serum 
insulin concentrations using a commercially available ELISA (ALPCO Immunoassays, 
Salem, NH).  
GLUCOSE TOLERANCE TESTING  
The protocol for the GTT is outlined in Chapter 2. Briefly, fasted rats received a single 
glucose bolus (2 g/kg body mass) via intra-peritoneal injection, and blood glucose 
concentration was monitored at 30 min intervals throughout the subsequent 120 min. 
Additional aliquots of blood were collected at 30, 60 and 120 min post-injection for the 
later determination of serum insulin concentrations in response to the glucose 
challenge. 
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PHYSICAL ACTIVITY MONITORING 
Prior to monitoring, rats were familiarized with activity monitoring chambers 
comprising infrared beams in the X, Y and Z axes (MED Associates, inc. St Albans, VT) 
during three 10 min sessions in the week before testing. Spontaneous activity was 
monitored during both diurnal (1200 h) and nocturnal (0200 h) sessions. Horizontal, 
vertical and ambulatory locomotor activities were determined in 20 sec intervals over 2 
x 10 min sessions.  
TISSUE COLLECTION AND ANALYSES 
Tissue collection procedures were conducted after a 5 hr fast in 11 wk old rats, which 
were weighed and anaesthetized with sodium pentobarbital (60 mg/kg body mass) and 
hind limb muscles immediately excised. Similar experiments were performed on soleus 
and EDL portions from the same leg (for reasons outlined in Chapter 2). The left soleus 
was placed in ice-cold BIOPS and prepared for respirometry experiments according to 
the protocol outlined in Chapter 2. The contra-lateral soleus muscle was carefully 
dissected into longitudinal strips from tendon to tendon (15-20 mg per strip) and 
placed in pre-gassed Krebs-Henseleit (KHB) buffer for the measurement of basal and 
insulin-stimulated glucose uptake. The remaining hind limb muscles were freeze-
clamped in liquid N2 and stored at -80 °C for later analyses. Periovarian fat pads were 
removed and weighed as indicators of adiposity.  
GLUCOSE UPTAKE 
All reagents used were obtained from Sigma-Aldrich (Castle Hill, NSW, Australia) 
unless otherwise specified. Soleus muscle strips from the right leg were allowed to 
recover for 30 min in pre-oxygenated KHB (NaCl, 118.5 mM; NaHCO3, 25 mM; KCl, 
4.74 mM; MgSO4.7H2O, 1.19 mM; KH2PO4, 1.18 mM; CaCl2, 2.5 mM; pH 7.4) 
containing mannitol, 32 mM; pyruvate, 2 mM; glucose, 8 mM; and fatty-acid free BSA, 
0.1%. Vials were maintained at 30 °C in a shaking water bath throughout the 
experiment. Basal and insulin-stimulated glucose uptake was determined according to 
the method of Young et al. [211], with modifications [204, 212, 213]. Following the 
recovery incubation, muscle strips were incubated for an additional 30 min in 
continuously gassed modified KHB with or without insulin (60 nM; Humulin, Eli Lilly, 
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Indianapolis, IN). Muscle strips were next washed for 10 min in KHB modified with 
mannitol, 40 mM; pyruvate, 2 mM; fatty-acid free BSA, 0.1% and insulin, 60 nM, if it 
was present in the previous incubation. Following glucose wash-out, strips were 
transferred to vials containing oxygenated KHB containing fatty-acid free BSA, 0.1%; 
pyruvate, 2 mM; 2-[1,2-3H]-deoxyglucose, 1 mM (1 mCi/mL; Perkin Elmer); D-[1-14C]-
mannitol, 39 mM (0.1 µCi/mL; Perkin Elmer) and insulin, 60 nM, if it was present in 
the previous incubations. After 20 min, the reaction was stopped by washing muscle 
strips in KHB twice, blotting the tissue on filter paper, then freeze-clamping it with 
tongs pre-cooled in liquid N2. Muscle strips were weighed, homogenized in 10% 
trichloroacetic acid, and transferred to vials containing 5 mL of scintillation fluid 
(Ultima Gold XR, Perkin Elmer). Duplicate aliquots were counted in a liquid 
scintillation counter (Packard Tri-Carb, Perkin Elmer) set for simultaneous 3H and 14C 
counting. Rates of basal and insulin-stimulated skeletal muscle 2-[1,2-3H]-deoxyglucose 
transport were calculated according to the protocol  described by Lessard et al. [176]. 
HIGH-RESOLUTION RESPIROMETRY  
Approximately 10 mg of soleus (n=10 per group) was prepared for respirometry 
experiments using the methods outlined in Chapter 2. The remaining, non-
permeabilized muscle was frozen in liquid N2 for later analyses. 
SUBSTRATE-UNCOUPLER-INHIBITOR TITRATION  PROTOCOL 
Malate (2 mM) was added and JO2 (pmol.s-1.mg-1 wet weight) stabilized for 5-10 min. 
Subsequently, tissue samples were subjected to a SUIT protocol that sequentially 
evaluates the electron-transferring flavoprotein (ETF; fat oxidation) in leak state 
through the addition of octanoylcarnitine, 0.2mM (TOCRIS Bioscience; state 2 
respiration), oxidative phosphorylation with electron flux through the ETF, by titration  
of ADP (1 and 2.5 mM; state 3 respiration), oxidative phosphorylation with electron 
flux through the ETF and CI with the addition of glutamate (10 mM), oxidative 
phosphorylation with electron flux through the ETF, CI and CII with the addition of 
succinate (10 mM), maximal coupled oxidative phosphorylation with electron flux 
through the ETF, CI and CII with the addition of ADP (5 mM), the integrity of the 
outer mitochondrial membrane, with the addition of cytochrome C (10 µM), maximal 
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capacity of the ETS by uncoupling with a stepped titration of FCCP (0.5 and 1 µM), 
uncoupled respiration with electron flux through the ETF and CII with the addition of 
the CI inhibitor rotenone (0.5 µM), and ROX with the addition of antimycin A (2.5 
µM). Additionally, CIV activity was determined following the addition of the artificial 
electron donor N,N,N,N,N’,N’-tetramethyl-p-phenylenediamine dihydrochloride (0.5 
mM) in the presence of ascorbate (2 mM). The reaction was terminated by the addition 
of NaN3 (50 mM), after which the chambers were re-oxygenated for the determination 
of auto-oxidation. Mass specific O2 flux was determined using DATLAB (Oroboros, 
Innsbruck; Austria) from steady state JO2 normalized to tissue wet weight and adjusted 
for instrumental background, ROX and auto-oxidation.  In addition, FCR’s were 
calculated to determine mitochondrial function independent of mitochondrial density.
  
MITOCHONDRIAL ENZYME ACTIVITIES 
Muscle homogenates (n=10 per group) were prepared over ice from freeze-clamped 
soleus and EDL muscles (10-20 mg) according to the same protocols outlined in 
Chapter 2. CS and β-HAD activities were determined according to the modified 
methods of Srere (CS) [183] and Bergmeyer (β -HAD) [184]. These protocols are 
described in Chapter 2 [214]. 
NUCLEIC ACID EXTRACTION AND QUANTIFICATION 
DNA and RNA were each extracted according to the same methods outlined in 
Chapter 2. For each nucleic acid, an aliquot was taken from each sample (n=7 per 
group) and pooled. The pooled RNA or DNA sample was then quantified and serially 
diluted to produce standard curves for inclusion in each PCR run. 
REVERSE TRANSCRIPTION AND REAL-TIME PCR 
First-strand cDNA synthesis was performed for RNA extracts using Superscript VILO 
(Invitrogen). Relative mRNA expression was determined using commercially available 
Taqman primer/probe sets (Applied Biosystems, Mulgrave, Australia) for PGC-1α 
(Ppargc1a (PGC-1α); cat. no. Rn00580241_m1) and Fibronectin type III domain 
containing 5 (Fndc5; cat. no. Rn01519161_m1). Glyceraldehyde-3-phosphate 
dehydrogenase (Gapdh; cat. no. Rn01775763_g1) was included as a housekeeping gene 
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to normalize CT values.  Quantification was performed in duplicate using a 72-well 
Rotor-Gene 3000 Centrifugal Real-Time Cycler (Corbett Research, Mortlake, 
Australia). PCR conditions were as follows: 2 min at 50°C and 10 min at 95°C, followed 
by 40 cycles of 95°C for 15 s and 65°C for 60 s. Calculations were made using the ΔΔCT 
method [190] . 
MITOCHONDRIAL DNA COPY NUMBER DETERMINATION 
MtDNA copy number was determined in DNA extracts according to the protocol 
described in Chapter 2 [214], using Taqman primer/probe sets for mitochondrial-
encoded NADH dehydrogenase-1 (MT-ND1; cat. no. Rn03296764_s1) and nuclear-
encoded Gapdh. DNA samples were subjected to the same PCR conditions as described 
above. MtDNA copy number was calculated as described by Venegas & Halberg [189].  
IMMUNOBLOT ANALYSIS 
Approximately 50 mg of frozen soleus or EDL was homogenized in buffer according to 
the protocol described in Chapter 2 for immunoblot analysis [214]. Muscle lysates 
containing 10 µg protein from either EDL or soleus muscle were prepared in 4 x 
Laemlli buffer, subjected to SDS-PAGE, then transferred to PVDF membranes. 
Membranes were blocked (5% non-fat dry milk) for 1 hr at room temperature, then 
incubated overnight at 4 °C with primary antibodies specific for the following proteins: 
PGC-1 (~100 KDa, Chemicon, #ab3242), FNDC5 (~28 KDA, Abcam, #ab93373), 
Nur77 (~48 KDa, Santa Cruz Biotechnology #sc5569), NOR1 (~68 KDa, Abcam 
#92777), Glucose transport protein (GLUT4, ~45 KDa, Abcam #ab654), Fatty acid 
translocase/CD 36 (FAT/CD36; ~80KDa, Abcam #17044), Complexes I, II, III, IV 
(subunit 1) and V of the ETS (~18, ~25, ~45, ~37, ~52 KDa, respectively, MitoSciences, 
#MA604), Complex IV subunit II (~25 KDa, MitoSciences, #MS405), Complex IV 
subunit IV (~15 KDa, MitoSciences, #MS407), CS (~52 KDa, Abcam #ab96600) and 
UCP3 (~35 KDa, Affinity BioReagents, #PA1-055). α-Tubulin (~50 KDa, Sigma, St. 
Louis, MO) was used as a protein loading control. Protein expression was detected 
using enhanced chemiluminescence (Amersham Biosciences, Piscataway, NJ) and 
quantified by densitometry. 
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STATISTICAL ANALYSES 
All values are expressed as means ± SE. A two-way ANOVA was used to analyze data 
from the GTT. Physical activity and glucose uptake data were analyzed using a one-way 
ANOVA with a Student Newman-Keuls post-hoc test. An unpaired t-test was used to 
compare groups for all other analyses unless otherwise specified. Significance is 
reported where P<0.05. Statistical analyses were performed using Graph Pad Prism 
software.  
3.3    Results 
HCR AND LCR RATS HAVE DIVERGENT METABOLIC HEALTH PARAMETERS. 
The metabolic health characteristics of each rat phenotype are displayed in Table 3.1. 
Although there were no differences in the ages of the animals, LCR were 28% heavier 
than HCR (P<0.0001) and had 48% more periovarian fat (P=0.02). There were no 
differences in interscapular brown adipose masses. Fasting blood glucose 
concentrations were not different, but fasting serum insulin concentrations were 62% 
higher in LCR compared to HCR (P=0.02).  HCR were more glucose tolerant than LCR 
as determined by the area under the glucose curve during the GTT (LCR, 1267 ± 47.4 
and HCR, 1100 ± 27.8; P=0.01; Fig. 3.1A and B). Similarly, the insulin response to the 
GTT was 135% greater in LCR compared to HCR as determined by the area under the 
insulin curve during the GTT (LCR, 196.2 ± 15.8 and HCR, 83.6 ± 11.3; P=0.001; Fig. 
3.1C and D).  
 
Table 3.1. Body composition and metabolic parameters 
 LCR HCR 
Age, d 80.9 ± 0.6 81.0 ± 0.6 
Body mass, g 214.1 ± 3.7 167.7 ± 4.2* 
Periovarian fat pad mass, g 1.2 ± 0.1 0.8 ± 0.1* 
Interscapular brown adipose mass, mg 183.0 ± 13.7 185.1 ± 10.2 
Fasting blood glucose concentration, mM 6.5 ± 0.1 6.5 ± 0.2 
Fasting serum insulin concentration, ng/mL 0.62 ± 0.07 0.39 ± 0.01* 
LCR and HCR rats display divergent metabolic parameters. HCR, high capacity runner. LCR, 
low capacity runner. Values are means ±  SE.  n=8-12 per group.*P<0.05 
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Figure 3.1. GTT for LCR  and HCR  rats. (A) Blood glucose response over 120 
min. (B) Area under the blood glucose curve. (C) Serum insulin response over 120 
min. (D) Area under the serum insulin curve. AUC, area under the curve. GTT, glucose 
tolerance test. HCR, high capacity runner. LCR, low capacity runner. Values are means ± SE. 
n=8-10 per group. *P<0.05 
 
 
 
THE GLUCOSE UPTAKE RESPONSE TO INSULIN IS ENHANCED IN HCR RATS 
Rates of glucose uptake in the soleus are displayed in Fig. 3.2. There was no difference 
in the rate of basal glucose uptake between LCR and HCR (3.21 ± 0.35 and 3.57 ± 0.16 
µM/g/h, respectively). Insulin stimulation increased glucose uptake in both groups 
(LCR, 5.16 ± 0.21, P<0.0001 and HCR, 6.00 ± 0.23 µM/g/h, P<0.0001), although this 
increase was of a greater magnitude in HCR (14%; P=0.02).  
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Figure 3.2. Basal  and [60 nM insulin]-stimulated  glucose uptake in the soleus of 
LCR and HCR rats. HCR, high capacity runner. LCR, low capacity runner. Soleus, m. 
soleus. Values are means ± SE. n=11 per group. *P<0.05 different to basal value †P<0.05 
different to LCR value under the same conditions. 
 
 
 
HCR RATS ARE MORE ACTIVE THAN LCR RATS 
Physical activity data for each group is presented in Table 3.2. During the diurnal 
period, HCR completed a greater number of horizontal beam breaks (P=0.0004), spent 
more time ambulatory (P=0.02), less time stationary (P=0.02) and traveled a greater 
total distance (P=0.04) compared with LCR rats. During the nocturnal phase, HCR 
completed fewer horizontal beam breaks, had fewer stereotypic movements, and spent 
more time stationary than they did during the diurnal phase. For LCR rats, movement 
patterns were not different during diurnal or nocturnal testing periods. Compared with 
LCR rats during the nocturnal period, HCR spent more time ambulatory (P=0.007) and 
completed a greater number of horizontal beam breaks (P=0.07). Distance traveled or 
time spent stationary was not different between phenotypes during the nocturnal 
monitoring period. 
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Table 3.2. Physical activity levels of animals. 
 Diurnal period Nocturnal period 
 LCR HCR LCR HCR 
No movement, %  67.1 ± 0.7‡ 61.9 ± 1.9*† 70.9 ± 1.6 71.4 ± 2.7‡ 
Stereotypic movement, %  22.8 ± 0.6 22.3 ± 0.5† 20.4 ± 1.1‡ 17.8 ± 1.2*†‡ 
Ambulatory movement, %  7.5 ± 0.3‡ 10.0 ± 0.9* 7.4 ± 0.4 10.6 ± 0.6*† 
Horizontal beam breaks, count 54.8 ± 3.4‡ 133.6 ± 16.7*† 49.8 ± 6.5‡ 76.0 ± 12.4‡ 
Total distance traveled, cm 1280.0 ± 79.3‡ 1721.0 ± 187.9*† 1185.0 ± 79.4‡ 1336.0 ± 132.1‡ 
HCR, high capacity runner. LCR, low capacity runner. Values are means ± SE. n=8-12 per 
group. *P<0.05 different to LCR day. †P<0.05 different to LCR night. ‡P<0.05 different to 
HCR day.  
 
 
 
MITOCHONDRIAL RESPIRATORY CAPACITY IS GREATER IN HCR RATS COMPARED TO LCR RATS 
To evaluate the capacity of the ETS and thus determine maximal O2 flux through the 
mitochondria, we measured O2 flux during a SUIT protocol with substrates for the 
ETF, CI, CII and CIV (Fig. 3.3). State II respiration with electron leak through the ETF 
was not different between groups (LCR, 5.55 ± 0.42 and HCR, 6.61 ± 0.83 pmol.s-1.mg 
wet wt-1), however state III respiration with electron flux through the ETF was greater 
in HCR than LCR at 1 (17.6 ± 1.2 and 27.9 ± 1.7 pmol.s-1.mg wet wt-1 respectively) and 
2.5mM ADP (30.68 ± 1.97 and 19.54 ± 1.35 pmol.s-1.mg wet wt-1 respectively). State III 
respiration with electron flux through both the ETF and CI was greater in HCR 
compared to LCR (41.27 ± 2.44 and 26.77 ± 1.59 pmol.s-1.mg wet wt-1 respectively), and 
when flux through the ETF was taken into account, CI values for HCR remained 
elevated (HCR, 11.73 ± 2.14 and LCR, 7.62 ± 0.22 pmol.s-1.mg wet wt-1; P=0.09). State 
III respiration with electron flux through the ETF, CI and CII was greater in HCR 
compared to LCR at sub maximal (80.56 ± 2.79 and 65.29 ± 3.10 pmol.s-1.mg wet wt-1 
respectively) and maximal ADP saturation (95.52 ± 2.34 and 83.74 ± 2.34 pmol.s-1.mg 
wet wt-1 respectively). Uncoupled respiration with electron flux through the ETF and 
CII was greater in HCR compared to LCR (54.70 ± 2.19 and 46.72 ± 1.00 pmol.s-1.mg 
wet wt-1, respectively; P=0.007). Maximal uncoupled flux through the ETS (ETF, CI and 
CII) was greater in HCR compared to LCR (106.50 ± 3.54 and 87.86 ± 3.20 pmol.s-1.mg 
wet wt-1 respectively). CIV activity, as determined through the use of artificial electron 
donors, was not different between groups (LCR, 156.70 ± 6.7 and HCR, 169.7 ± 10.35 
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pmol.s-1.mg wet wt-1). In order to assess O2 flux independent of mitochondrial density, 
we calculated the FCR for each substrate combination. These are shown in Table 3.3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3. Mass-specific O2 consumption in the soleus of LCR  and HCR   rats. 
CIV, respiratory complex IV. D1, [1 mM] adenosine diphosphate (ADP). D2.5, [2.5 mM] ADP. 
D5, [5 mM] ADP. ETF, Electron Transferring Flavoprotein. ETS, Electron Transfer system. G, 
Glutamate. HCR, high capacity runner. LCR, low capacity runner. M, Malate. Oct, 
Octanoylcarnitine. Soleus, m. soleus. S, Succinate. Values are means ± SE. n=11 per group. 
*P<0.05 
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Table 3.3 .  Mitochondrial flux control ratios 
 LCR HCR 
ETF, Leak (State II) 0.07 ± 0.01 0.06 ± 0.01 
ETF, OXPHOS (State III) 0.23 ± 0.01 0.29 ± 0.02* 
ETF & CI, OXPHOS (State III) 0.32 ± 0.01 0.39 ± 0.2* 
ETF, CI & CII, OXPHOS (State III, Submax) 0.77 ± 0.02 0.76 ± 0.03 
ETF, CI & CII, OXPHOS (State III, Max) 0.96 ± 0.02 0.91 ± 0.03 
ETF & CII, Uncoupled (State IV) 0.57 ± 0.01 0.51 ± 0.01* 
CI, complex I.  CII, complex II.  ETF, electron transferring flavoprotein. HCR, high capacity 
runner. LCR, low capacity runner. OXPHOS, oxidative phosphorylation. Values are means ±  
SE. n=8-12 per group. *P<0.05. 
 
 
 
INCREASED O2 FLUX IN MUSCLE FROM HCR RATS IS ASSOCIATED WITH GREATER 
MITOCHONDRIAL ENZYME ACTIVITY AND INCREASED MTDNA COPY NUMBER 
CS activity was greater in HCR compared to LCR rats in both the soleus (HCR, 21.64 ± 
1.21 and LCR, 14.58 ± 1.23 µmol/min/g wet wt; P=0.009; Fig. 3.4A) and EDL muscles 
(HCR, 9.98 ± 0.62 and LCR, 7.06 ± 0.77 µmol/min/g wet wt; P=0.01; Fig. 3.4A). β-HAD 
activity was also greater in HCR compared to LCR in soleus (HCR, 5.62 ± 0.45 and 
LCR, 3.78 ± 0.31 µmol/min/g wet wt; P=0.003; Fig. 3.4B) and EDL (HCR, 1.29 ± 0.11 
and LCR, 0.75 ± 0.066 µmol/min/g wet wt; P=0.0004; Fig. 3.4B). In the EDL, MtDNA 
copy number was elevated in HCR compared to LCR (11810 ± 1640 and 7584 ± 891, 
respectively; P=0.049; Fig. 3.4C). MtDNA copy number was 44% greater in the soleus of 
HCR (HCR, 11930  ± 3235 and LCR, 6665 ± 1015; P=0.16; Fig. 3.4C). 
MUSCLE-SPECIFIC PROTEIN EXPRESSION OF PGC-1α AND FNDC5 
The relative expression of PGC-1α mRNA was not different between groups for either 
soleus or EDL muscle (data not shown). PGC-1α protein expression was not different 
in the soleus (Fig. 3.5), although a small but significant increase was observed in the 
EDL of HCR rats (9%; Fig. 3.6; P=0.03). Expression of the PGC-1α-dependent FNDC5 
gene was not different between groups in either muscle type (data not shown). 
Similarly, FNDC5 protein expression was not different in the soleus (Fig. 3.5). FNDC5 
protein expression was greater in the EDL of the HCR rats (17%; Fig. 3.6; P=0.0002). 
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Figure 3.4. Enzyme activities and relative MtDNA copy number in both soleus and 
EDL of LCR  and HCR  rats. (A) CS activity, n=10 per group. (B) β-HAD activity, 
n=10 per group. (C) MtDNA:nDNA, n=7 per group. β-HAD, β-hydroxyacyl-CoA 
dehydrogenase. CS, citrate synthase. EDL, m. extensor digitorum longus.  HCR, high capacity 
runner. LCR, low capacity runner. MtDNA, mitochondrial DNA. Values are means ± SE. 
*P<0.05 
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Figure 3.5. Protein content of soleus muscle as determined by immunoblotting. (A) 
Representative blots and (B) relative protein expression for LCR  and HCR  rats. 
AU, arbitrary units.  CI, complex I, CII, complex II. CIII, complex III. CIVI, complex IV 
subunit I. CIVII, complex IV subunit II. CIVIV, complex IV subunit IV. CV, complex V. CS, 
citrate synthase.  FAT/CD36, fatty acid translocase. FNDC5, Fibronectin domain containing 5. 
GLUT4, glucose transport protein 4. HCR, high capacity runner. LCR, low capacity runner. 
NOR1, Neuron-derived orphan receptor 1. Nur77, neuron-derived clone 77. PGC-1, 
peroxisome proliferator activated receptor-γ coactivator-1α. Soleus, m. soleus. UCP3, 
uncoupling protein 3. Values are means ± SE. n=8-12 per group. *P<0.05 
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Figure 3.6. Protein content of EDL muscle as determined by immunoblotting. (A) 
Representative blots and (B) relative protein expression for LCR  and HCR  rats. 
AU, arbitrary units.  CI, complex I, CII, complex II. CIII, complex III. CIVI, complex IV 
subunit I. CIVII, complex IV subunit II. CIVIV, complex IV subunit IV. CV, complex V. CS, 
citrate synthase.  EDL, m. extensor digitorum longus. FAT/CD36, fatty acid translocase. FNDC5, 
Fibronectin domain containing 5. GLUT4, glucose transport protein 4. HCR, high capacity 
runner. LCR, low capacity runner. NOR1, Neuron-derived orphan receptor 1. Nur77, neuron-
derived clone 77. PGC-1, peroxisome proliferator activated receptor-γ coactivator-1α. UCP3, 
uncoupling protein 3. Values are means ± SE. n=8-12 per group. *P<0.05 
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MITOCHONDRIAL PROTEIN EXPRESSION IS GREATER IN HCR  
In the soleus muscle, protein expression of all individual respiratory complexes was 
greater in HCR compared to LCR (Fig. 3.5; P<0.05), except for subunit I of CIV. 
Additionally, expression of CS was 14% greater in HCR compared to LCR (Fig. 3.5; 
P=0.03). In the EDL, expression of all respiratory complexes was greater in HCR 
compared to LCR (Fig. 3.6; P<0.05), except for subunit I of CIV, which was not 
different. CS protein expression was 38% greater in HCR (Fig. 3.6; P<0.0001). 
NOR1 EXPRESSION IS GREATER IN HCR RATS 
In both soleus and EDL muscles, protein expression of NOR1 was greater in HCR rats 
(soleus 21%, P=0.009; EDL 23%, P=0.016; Fig. 3.5 and 3.6). Expression of Nur77 
(soleus 40%, P=0.02; EDL 25%, P=0.01) and NR4A target proteins FAT/CD36 (soleus 
4%, P=0.04; EDL 9%, P=0.02) and UCP3 (soleus 32%, P=0.01; EDL 20%, P=0.0003) 
were also increased in both muscle types from HCR (Fig.3.5 and 3.6; both P<0.05).  
 
3.4  Discussion 
The motivation for developing the LCR/HCR model system originated after Koch and 
Britton noted the strong statistical association between low endurance exercise capacity 
and increased morbidity and mortality in humans.  From this, the aerobic hypothesis 
was formulated, proposing that aerobic energy metabolism is a central mechanistic 
determinant of the divide between disease and health.  As an unbiased test of this 
hypothesis divergent artificial selection for intrinsic low and high endurance running 
capacity was applied to rats.  As predicted by this hypothesis disease risks and reduced 
longevity segregated strongly with low aerobic capacity [215]. This chapter presents 
evidence which describes features that can explain the intrinsic aerobic exercise 
capacity differences between the LCR and HCR rats and, ostensibly, disease risks. 
 Alterations to mitochondrial function typically occur in parallel with disease 
progression, and although environmental influences undoubtedly play an important 
role in the development of metabolic diseases [216], there is a growing body of evidence 
to suggest that a substantial genetic component underlies many complex metabolic 
disorders [11, 12]. The current investigation demonstrates that skeletal muscle 
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respiratory capacity is greater in muscle from HCR compared with LCR rats (Fig. 3.3), 
and that this enhanced respiratory capacity is likely due to greater relative 
mitochondrial enzyme activities (particularly those with a role in fat oxidation (Fig. 3.3 
and 3.4)) coupled with increased mitochondrial number (Fig. 3.4-6). This increase in 
muscle oxidative capacity is associated with an increase in the protein expression of the 
nuclear receptor NOR1 (Fig. 3.5 and 3.6), which has previously been linked to the 
adaptive response of skeletal muscle in response to exercise training, [206, 217] and the 
expression of several proteins involved in glucose metabolism [162, 207-209]. These 
novel findings complement previous reports that have shown that there are a greater 
number of mitochondria present in the glycolytic muscle from HCR rats [165], and 
that muscle substrate handling is superior in these animals [162, 176, 204].  
 Low aerobic capacity, independent of physical activity levels, is a key predictor of 
early mortality [13, 14]. Along with a reduced lifespan [215] LCR rats express a number 
of characteristics common to metabolic disease phenotypes, such as increased body 
mass and adiposity (Table 3.1 [153, 166, 205, 218]), hyperinsulinaemia (Table 3.1 [161, 
205, 219]) and impaired glucose tolerance (Fig. 3.1 [165, 166, 205]). In contrast, HCR 
rats live 6-8 months longer [215] and present with superior metabolic health, 
characterized by resistance to weight gain [163, 166, 205] and an increased capacity for 
the uptake and oxidation of both glucose (Fig. 3.2 [165, 204]) and long-chain fatty acids 
[165, 166, 204, 205]. The differential expression of these characteristics appears to be 
linked to muscle oxidative capacity [205], although previous studies have been 
inconclusive with regard to the precise mechanisms involved. As noted, HCR rats have 
superior O2 handling capacity, an adaptive variation that resides at the level of the 
muscle [153]. Previous reports that indicate that there is a greater number of 
mitochondria in the muscle of HCR rats [161, 165] are confounded by other reports 
that do not support this observation [166, 168], and instead conclude that the 
difference in oxidative capacity is not due to mitochondrial size or number [166-168], 
but a difference in mitochondrial enzyme activity.  
 To address this, respirometry experiments were performed, monitoring O2 
consumption through the mitochondria of permeabilized soleus muscle of LCR and 
HCR rats in response to specific substrate combinations. In contrast to individual 
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enzyme activity assays, this dynamic measurement reflects the integrated activities of β-
oxidation, the TCA cycle and the ETS. During ADP-stimulated (state 3) respiration a 
greater O2 consumption with electron flux through the ETF, CI and CII was observed 
(Fig. 3.3). Additionally, maximal activity of the ETS was greater in muscle from HCR 
(Fig. 3.3). Previously, it has been shown that the oxidation of the long-chain FA 
palmitate is greater in in vitro soleus muscle incubations of HCR [204] and during 
hind-limb perfusion experiments [165]. Here it is confirmed that the capacity for total 
lipid oxidation is enhanced in the muscle of HCR, and that this is due to the increased 
activity of mitochondrial enzymes involved in the oxidation of fatty acids. Specifically, 
respiratory flux control ratios indicate that independent of mitochondrial volume, the 
relative contribution of the ETF to maximal flux is greater in HCR when the muscle is 
exposed to the medium-chain FA octanoylcarnitine (Table 3.3). Furthermore, β-HAD 
activity (the third enzyme of the β-oxidation pathway, Fig. 1.3A) was greater in muscle 
from HCR rats (Fig. 3.4B). In contrast, when data for the remaining substrate 
combinations were normalized to maximal uncoupled respiratory capacity, combined 
O2 flux was not different which suggests that the coupling of oxidative phosphorylation 
with CI and CII activity is similar for LCR and HCR (Table 3.3). This indicates that 
along with an increased capacity for fat oxidation per mitochondrion, an increase in the 
mitochondrial reticulum is also likely to contribute to the increased respiratory capacity 
of muscle from HCR rats.  
 Since respirometry and enzyme activity measurements are indirect determinants 
of mitochondrial content and must be supported by additional measurements, the 
MtDNA copy number (Fig. 3.4C), and the expression of a number of mitochondrial 
proteins (Fig. 3.5 and 3.6) in both soleus and EDL muscles are also reported. MtDNA 
copy number was found to be greater in both muscles under investigation, and 
moreover, the expression of a number of mitochondrial proteins was also increased in 
both muscle types, supporting the hypothesis of a greater mitochondrial volume in the 
muscle of HCR rats. Furthermore, the TCA cycle protein CS, which has long been 
regarded as a surrogate marker of mitochondrial volume, was expressed to a greater 
degree (Fig. 3.5 and 3.6) along with elevated maximal activities (Fig. 3.4A) in both 
soleus and EDL muscles of HCR rats. This difference in skeletal muscle is no doubt a 
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major contributing factor to the overall phenotype of these rats. Additionally, the 
greater capacity for lipid oxidation observed in HCR rats is likely to result in the 
sparing of glycogen during exercise, thereby contributing to their overall phenotype. 
Indeed, even in the untrained state, HCR rats exhibit muscle substrate storage profiles 
similar to that of endurance-trained athletes. Increased fuel availability as a result of 
greater intramuscular storage of glycogen and triglycerides [162, 165, 204], along with 
an increased capacity for lipid oxidation and overall enhanced rates of oxidative 
phosphorylation, would allow HCR rats to run longer distances than LCR rats. 
 Another finding of the present study is the elevated protein levels of FNDC5, 
which was confined to the glycolytic muscle of HCR rats (Fig. 3.6). This protein has 
recently been identified as PGC-1α-dependent membrane protein that is cleaved to 
become the putative myokine irisin [220]. Although it was not possible to measure 
circulating irisin concentrations from LCR and HCR rats, the reduced adiposity and 
superior glucose tolerance exhibited by HCR rats may, at least in part, be related to the 
increased expression of FNDC5 in the glycolytic muscle. Indeed, exercise training has 
been shown to increase the concentration of irisin in both mice and humans [220], so it 
is quite plausible that HCR have higher concentrations of circulating irisin than LCR 
rats. Furthermore, the “browning” effect seen in white adipose tissue following irisin 
administration [220] may not be restricted to this tissue, so the possibility that irisin 
elicits a similar effect on glycolytic skeletal muscle cannot be discounted. 
Characterization of the adipose tissue from LCR and HCR rats will determine whether 
differences in mitochondrial function are restricted to the muscle or if they are also 
present in other highly plastic tissues (Chapter 4).  
 Previously Nur77 and its downstream targets have been shown to be expressed to 
a lesser extent in LCR rats and have been linked to impaired β-adrenergic signaling in 
the skeletal muscle [162]. Another NR4A nuclear receptor, NOR1, shares high 
sequence homology with Nur77 and has been shown to be induced under many of the 
same conditions [207]. Pearen et al. [210] have demonstrated that NOR1 is essential for 
oxidative metabolism in cultured myotubes, and that muscle-specific NOR1-transgenic 
mice have a more oxidative skeletal muscle phenotype, a greater running capacity and 
better glucose tolerance compared to their wild-type litter mates [221]. The current 
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study provides evidence that HCR rats have greater NOR1 protein levels in both the 
soleus and EDL muscles (Fig. 3.5 and 3.6) and it is suggested that NOR1 may serve as a 
possible mechanism for increasing the cells oxidative machinery. In support of a 
possible NOR1-mediated response, no differences in PGC-1α mRNA expression were 
observed between phenotypes. Furthermore, little (in the EDL; Fig. 3.6) or no 
difference (in the soleus; Fig. 3.5) in PGC-1 protein levels was observed, suggesting that 
an alternative program may be responsible for the greater respiratory capacity seen the 
muscle of HCR rats. At present, little is known about the molecular mechanisms 
through which NOR1 is likely to drive changes in oxidative metabolism. Thus, more in-
depth analyses of the function of NOR1 and clarification of its primary targets will be 
essential in determining its precise role in the regulation of skeletal muscle metabolism. 
 Physical training increases skeletal muscle insulin sensitivity, oxidative capacity 
and induces a rapid increase in NOR1 transcription [206, 217, 222]. Although both 
LCR and HCR animals are kept under identical housing and feeding regimens that 
exclude formal exercise training, the possibility that habitual activity levels may play a 
role in the development of their distinct phenotypes cannot be discounted. Therefore 
the activity of the rats was monitored during both diurnal and nocturnal periods. It was 
found that HCR rats were consistently more active than LCR rats (Table 3.2). This 
observation is in agreement with others [163, 219, 223] who report differences in the 
habitual activity levels of LCR and HCR rats from earlier generations. Furthermore, 
Novak et al. have identified different activity levels in another strain of obesity-resistant 
rats [224], while others have identified a type of ‘inactivity physiology’ in humans [225, 
226]. Since there is a link between intrinsic exercise capacity and daily habitual activity 
in rodents, and a link between inactivity and poor metabolic health in humans [223, 
226-228], the extent to which spontaneous cage activity contributes to the distinct 
phenotypes of these rodent models is an important question that needs to be addressed. 
Although controlling for habitual activity is difficult, it is possible that the differences in 
physical activity are is partially responsible for the divergent metabolic phenotype 
displayed by these two rat strains, particularly as Lessard et al. have previously shown 
that exercise training LCR rats reverses many of negative metabolic health traits 
observed in these animals [204, 229]. 
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 In summary, the investigation described in this chapter uses an animal model in 
which artificial selection for high- and low-running capacity (in the total absence of 
exercise training) simultaneously controls for unknown environmental influences and 
allows the two phenotypes to act as controls for one another. In addition to their 
divergent running capacities, these rats display differences in a number of metabolic 
health traits and importantly, markedly different muscle oxidative capacities that 
underlie the major differences between phenotypes. Given that the nuclear receptor 
NOR1 has been shown to play a key role in metabolic regulation and is necessary for 
oxidative metabolism, it is proposed that the differential expression of NOR1 observed 
in HCR and LCR rats contributes to their distinct phenotypes and overall metabolic 
regulation. 
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Chapter 4 
 
 
Exercise training enhances white adipose tissue metabolism 
in rats selectively bred for low- or high- endurance running 
capacity 
Adapted from E.J.  Stephenson S.J.  Lessard D.A. Rivas M.J. Watt B.BIII. Yaspelkis L.G. Koch 
S.L. Britton and J.A. Hawley (2013) Am J Physiol Endocrinol Metab Vol. 305 (3):E429-38  
 
4.1  Introduction 
WAT mass is linked to metabolic health and plays a critical role in the maintenance of 
whole-body energy homeostasis [230, 231]. Increased WAT mass, especially in visceral 
storage depots, is associated with a greater risk of metabolic disease and mortality [232, 
233], while enlarged adipocyte size due to increased lipid content is linked to intrinsic 
cellular metabolic defects [234, 235]. Conversely, small adipocytes may play a protective 
role against the increased risk of metabolic disease [236] because, compared to larger 
adipocytes, these cells have enhanced rates of glucose transport [78, 237-239]. Although 
excessive lipid storage in visceral WAT depots is linked to metabolic abnormalities such 
as insulin resistance and impaired lipolysis [240, 241], the metabolic characteristics of 
WAT in differing metabolic phenotypes has not been well characterized.  
 Compared to other metabolically active tissues the oxidative capacity of WAT is 
relatively low [83], but essential cellular activities such as adipogenesis, lipogenesis, 
lipolysis and FA oxidation require large amounts of ATP [86, 232, 242]. Given that 
WAT metabolism is altered in obesity and insulin resistance [82, 242] and the 
metabolic activity of most cells is highly dependent on mitochondrial content, 
impairments in the regulation of the adipocyte mitochondrial network may lead to 
dysfunctional WAT metabolism [231]. Indeed, diminished mitochondrial gene 
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expression has been observed in WAT from insulin resistant humans [81, 82] and 
rodents [73, 86, 87].  
 As described in Chapter 3, animal models of high- and low- aerobic treadmill 
running capacity have been generated (in the absence of exercise training) through two-
way artificial selection [160]. Such selection has produced rats that simultaneously 
present with different metabolic and cardiovascular disease risk factors without the 
necessity for any environmental intervention [161]. It has been demonstrated that the 
metabolic characteristics of the skeletal muscle from these rats diverge substantially 
[165, 204, 243] and that exercise training ameliorates many of the adverse health 
features observed in the LCR rats [204]. Since exercise training is capable of reducing 
visceral WAT lipid content and adipocyte size [75, 78, 237, 239] while increasing the 
WAT expression of a number of mitochondrial proteins [72, 73], it is hypothesized that 
the oxidative profile of visceral WAT will be lower in untrained LCR compared to HCR 
rats, but that short-term exercise training will ameliorate this impairment. In line with 
this hypothesis, the aim of the current investigation is to determine if differences in 
intrinsic running capacity or training state would affect the expression and activity of a 
number of proteins with important roles in WAT metabolism.  
4.2    Materials and methods 
EXPERIMENTAL ANIMALS 
This study was undertaken with the combined approval of animal ethics committees 
from the University of Michigan (Ann Arbor, MI) and California State University 
(Northridge, CA). Rat models for LCR and HCR were derived from genetically 
heterogeneous N:NIH stock rats by artificial selection for treadmill running capacity as 
described in Chapter 3 [160]. Rats were housed in pairs in a temperature controlled 
environment which provided a reverse 12:12 h light-dark cycle. Throughout the study, 
rats were given ad libitum access to standard rodent chow and water. Prior to the 
commencement of any experimental procedures, rats were allowed to acclimate to 
laboratory conditions for 1 wk. 
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EXERCISE TRAINING PROTOCOL 
Age-matched pairs of ~20 wk old male LCR and HCR rats were randomly assigned to 
two groups: sedentary (LCR-SED, n=10 and HCR-SED, n=10) or exercise trained 
(LCR-EX, n=10 and HCR-EX, n=10). Rats assigned to undergo exercise training 
completed a 6-wk (four days/wk) incremental treadmill running protocol where all rats 
completed the same absolute cumulative running distance (~10 km) [204, 244]. 
Trained rats undertook their final exercise bout 48 h before the commencement of any 
experimental procedures. 
TISSUE COLLECTION AND ANALYSES 
Following a 5 h fast, blood samples were taken for the analysis of fasting blood glucose 
concentrations using a hand-held glucometer (Roche Diagnostics, Castle Hill, NSW, 
Australia). Serum was assessed for fasting insulin concentrations using a rat-specific 
ELISA (ALPCO Immunoassays, Salem, NH) and for non-esterified FA’s using a 
commercially available kit (WAKO Pure Chemical Industries, Osaka, Japan). Rats were 
weighed and anaesthetized using sodium pentobarbital (1 mL/kg body mass). Hind 
limb skeletal muscles and epididymal fat pads were surgically excised, weighed, freeze 
clamped in liquid nitrogen and stored at -80 °C for later analyses. Skeletal muscle 
analyses have been reported by Lessard et al. [204]. 
CITRATE SYNTHASE ACTIVITY 
Approximately 100 mg of epididymal adipose tissue (n=8-10 per group) was visibly 
cleared of blood vessels and connective tissue, then mechanically homogenized in 
buffer [175 mM KCl and 2 mM EDTA (pH 7.4), 1:2 dilution] and centrifuged at 20,000 
G for 15 min at 4 °C. The infranatant was collected and assayed for CS activity as 
according to the same protocol outlined in Chapter 2 [214]. Protein concentration of 
the infranatant was determined using the bicinchoninic method (Pierce, IL). Activity is 
expressed in nM/min/µg protein. 
IMMUNOBLOT ANALYSIS 
Approximately 250-300 mg of epididymal adipose tissue was visibly cleared of blood 
vessels and connective tissue and prepared according to the protocol outlined in 
Chapter 2 (1:2 dilution). Protein concentration of the infranatant was determined 
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using the bicinchoninic method (Pierce, IL). Adipose tissue lysates containing 10 µg 
protein were prepared in 4 x Laemmli buffer, subjected to SDS-PAGE, then transferred 
to PVDF membranes. A pooled lysate sample was prepared and included in each gel as 
an internal control for normalizing the data. Ponceau staining was used to confirm 
equal protein transfer. Membranes were then washed and blocked (5% non-fat dry milk 
or 5% BSA) for 1 hr at room temperature prior to incubation with the appropriate 
antibodies. Membranes were incubated overnight at 4 °C with primary antibodies 
specific for CS (~52 kDa; Abcam #ab96600), mitochondrial respiratory complexes I, II, 
III, IV (subunit 4; CIVIV) and V of the ETS (~18, ~25, ~45, ~15, ~52 kDa respectively; 
MitoSciences, #MA604 and #MS407), UCP1 (Santa Cruz Biotechnology #sc6529), 
PGC-1 (~100 kDa; Chemicon, #ab3242), hormone sensitive lipase (HSL; ~88 kDa; Cell 
Signaling, #4107), phospho-HSLS660 [245], Adipose Triglyceride Lipase (ATGL; ~54 
kDa; Cell Signaling, #2138), phospho-ATGLS406 (~54 kDa [246]), β3-adrenergic receptor 
(β3-AR, ~68 kDa; Santa Cruz Biotechnology #sc50436), perilipin 1 (PLIN1 ~68 kDa; 
Sigma P1873), comparative gene identification-58 (CGI-58; ~42 kDa; Santa Cruz 
Biotechnology), Fatty Acid Binding Protein 4 (FABP4; ~15 kDa; Abcam #ab37458), 
NUR77 (~48 kDa; Santa Cruz Biotechnology #sc5569), NOR1 (~68 kDa; Abcam 
#92777), GLUT4 (~45 kDa; Abcam #ab654), AMPKα (~62 kDa; Cell Signaling #2532), 
AMPK-phospho-Thr172 (~62 kDa; Cell Signaling #2535), Extracellular Regulated 
Kinase 1/2 (ERK1/2; ~46 and ~42 kDa; Cell Signaling #9102), phospho-ERK1/2T202/Y204 
(~46 and ~42 kDa; Cell Signaling #9101), p38 Mitotgen Activated Protein Kinase (p38 
MAPK; ~ 44 kDa;  Cell Signaling #9212), phospho-p38 MAPKT180/Y182 (~44 kDa; Cell 
Signaling #9211), c-JuN terminal Kinase 1/2 (JNK1/2; ~50 and ~46 kDa; Cell Signaling 
#9252) or phospho-JNK1/2T183/Y185 (~50 and ~46 kDa; Cell Signaling #9251). 
Membranes were also probed with anti-α-Tubulin (~50 kDa; Cell Signaling #2144) or 
β-Actin (~42 kDa; Sigma Aldrich) to confirm equal protein loading. After 1 h room-
temperature incubation in the appropriate secondary antibody, protein expression was 
detected using enhanced chemiluminescence (Amersham Biosciences, Piscataway, NJ) 
and quantified by densitometry. 
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STATISTICAL ANALYSIS 
All data is expressed as the group mean ± SE, unless otherwise specified. All data was 
analysed using a two-way ANOVA with running capacity and training state as fixed 
factors. Where main effects were considered significant, a Tukey test for multiple 
comparisons was conducted. Significance is reported where P<0.05. All statistical 
analyses were completed using GraphPad Prism software. 
 
4.3    Results 
PHYSIOLOGICAL PARAMETERS 
Data for body mass and fat pad mass have previously been reported by Lessard et al. 
[204] with new statistical analyses presented here. Adipose tissue protein content is 
reported as an indirect marker of changes in adipose tissue cellularity. Intrinsic running 
capacity and training status were main effects for body mass (Fig. 4.1A; P<0.0001 and 
P<0.0001, respectively), fat pad mass (Fig. 4.1B; P<0.0001 and P=0.0002, respectively) 
and total tissue protein (Fig. 4.1C; P=0.026 and P=0.024, respectively). In addition, an 
interaction between running capacity and training status was observed for body mass 
(P<0.0001) and fat pad mass (P=0.003). LCR were heavier than HCR with (33.4%, 
P<0.0001) or without (26.6%, P<0.0001) exercise training. LCR-SED was heavier than 
LCR-EX (31.1%, P<0.0001), whereas there was no difference between HCR-SED and 
HCR-EX. Epididymal fat pad mass was greater in LCR than HCR with (62.5%, 
P<0.0001) or without exercise training (50%, P<0.0001). LCR-SED had heavier fat pads 
than LCR-EX (34.4%, P<0.0001), whereas there was no difference between HCR-SED 
and HCR-EX. In line with this, total protein of WAT was lower in LCR-SED compared 
to HCR-SED (22.4%, P=0.052), whereas adipose protein was 33.4% greater in LCR-EX 
compared to LCR-SED (P=0.057). There were no differences in adipose protein 
between HCR-SED and HCR-EX, or LCR-EX and HCR-EX.  
 Intrinsic running capacity improved fasting blood glucose (main effect, P=0.0002) 
and serum FFA concentrations (main effect, P=0.02; Table 4.1), but not fasting serum 
insulin levels. Compared to HCR-SED, LCR-SED had 8% higher blood glucose 
(P=0.0008) and 37% higher NEFA concentrations (P=0.003). Exercise training was a 
main effect for fasting serum FFA’s (P<0.0001) and insulin concentrations (P<0.0001), 
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while there was a tendency for LCR-EX to have lower blood glucose concentrations 
than LCR-SED (8%; P=0.11). Exercise training had little effect on blood glucose 
concentrations in HCR animals. Both LCR-SED and HCR-SED had higher serum 
insulin concentrations when compared to LCR-EX (37%, P=0.0004) and HCR-EX 
(38%, P=0.0002), respectively. LCR-SED had 57% higher serum NEFA concentrations 
compared to LCR-EX (P<0.0001), whereas training had little effect on FFA 
concentrations in HCR animals.  
 
 
Table 4.1  Blood parameters 
 LCR-SED HCR-SED LCR-EX HCR-EX 
Glucose [mM]* 6.2 ± 0.1b 5.3 ± 0.1a 5.7 ± 0.2 5.3 ± 0.2 
Insulin [ng/mL] † 0.5 ± .004c,d 0.5 ± 0.02c,d 0.3 ± 0.06a,b 0.3 ± 0.07a,b 
NEFA [mM]* † 0.38 ± .03b,c 0.24 ± 0.02a 0.16 ± 0.03a 0.18 ± 0.02 
EX, exercise trained. HCR, high capacity runner. LCR, low capacity runner. NEFA, non-
esterefied fatty acids. SED, sedentary. Values are means ±  SE. n=7-10 per group. *P<0.05 
main effect for running capacity; †P<0.05, main effect for training status; aP<0.05, different 
to LCR-SED; bP<0.05, different to HCR-SED; cP<0.05, different to LCR-EX; dP<0.05, 
different to HCR-EX.  
 
 
CITRATE SYNTHASE ACTIVITY 
CS activity was increased with exercise training (Fig. 4.2A; main effect P=0.01) and 
tended to be increased in rats with high intrinsic running capacity (main effect, 
P=0.09). CS activity was 58% higher in epididymal fat pads from LCR-EX compared to 
LCR-SED (P=0.08).  
MITOCHONDRIAL PROTEIN CONTENT 
Under equal protein loading conditions (10 µg total protein), the contents of TCA cycle 
(CS), oxidative phosphorylation (ETS complexes I-V) and mitochondrial biogenesis 
(PGC-1α) proteins was similar between LCR and HCR rats independent of exercise 
training status (Fig. 4.2B). UCP1 was not detected in any sample (data not shown). 
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Figure 4.1 (A) Body mass, (B) Fat pad mass  and (C) WAT total protein  for LCR  
and HCR  rats with or without exercise training. EX, exercise trained. HCR, high 
capacity runner. LCR, low capacity runner. SED, sedentary. Values are means ± SE. n=7-10 per 
group. *P<0.05 main effect for running capacity. †P<0.05 main effect for training state. ‡P<0.05 
interaction between running capacity and training state. aP<0.05, different to LCR-SED; 
bP<0.05, different to HCR-SED; cP<0.05, different to LCR-EX; dP<0.05, different to HCR-EX.  
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Figure 4.2. (A) CS activity and (B) representative immunoblots of mitochondrial 
protein expression  in WAT from LCR  and HCR  rats with or without exercise 
training. CI, complex I. CII, complex II. CIII, complex III. CIVIV, complex IV subunit IV. CV, 
complex V. CS, citrate synthase. EX, exercise trained. HCR, high capacity runner. LCR, low 
capacity runner. PGC-1α, peroxisome proliferator activated receptor-γ co-activator-1α. SED, 
sedentary. WAT, white adipose tissue. Values are means ± SE. n=8-12 per group. †P<0.05 main 
effect for training state. aP<0.05, different to LCR-SED; dP<0.05, different to HCR-EX. 
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INTRACELLULAR REGULATORS OF LIPOLYSIS 
β3-AR expression was increased with exercise training (Fig. 4.3A; main effect P=0.03), 
whereas running capacity showed a tendency to increase this parameter (P=0.09). 
There was a significant interaction between running capacity and exercise training 
(P=0.006). The expression of the β3-AR was 17% greater in HCR-SED compared to 
LCR-SED (P=0.006) and 18% greater in LCR-EX compared to LCR-SED (P=0.004).The 
phosphorylation of ATGL at Ser406 and HSL at Ser660 was assessed as surrogate markers 
of their activity (3, 53). ATGL Ser406 phosphorylatation and total ATGL protein content 
were increased by both running capacity (P=0.02 and P=0.003, respectively) and 
exercise training status (Fig. 4.3B and C; P=0.0005 and P=0.03, respectively). Post-hoc 
analyses revealed a 25% increase in ATGL Ser406 phosphorylation in HCR-EX 
compared to HCR-SED (Fig. 3B; P=0.01). Total ATGL expression was 17% greater in 
HCR-EX compared to LCR-EX (Fig. 4.3C; P=0.04) and the ratio of ATGL Ser406 to total 
ATGL was not different. Total HSL protein remained similar for all groups, although 
there was a tendency for HSL Ser660 phosphorylation to be decreased in both LCR-EX 
and HCR-EX with training (main effect P=0.09). There was no difference in the ratio of 
HSL Ser660 phosphorylation to total HSL protein (data not shown). The content of 
PLIN1 (which controls lipolysis by regulating protein-protein interactions at the 
surface of lipid droplets, thereby facilitating access of lipases to their substrates) was 
increased by training (Fig. 4.3D; P=0.02) and an interaction was observed between 
training and running capacity (P=0.003). Post-hoc analyses revealed that PLIN1 
expression was 19% greater in LCR-SED compared to HCR-SED (P=0.03) and 25% 
greater in HCR-EX compared to HCR-SED (P=0.002). The protein content of CGI-58 
(which binds to and activates ATGL triglyceride lipase activity) was increased by 15% in 
HCR-SED compared to LCR-SED, and 15% greater in LCR-EX compared to LCR-SED, 
although neither of these values attained statistical significance (Fig. 4.3E; P=0.08 and 
P=0.1, respectively). There were main effects for both running capacity and exercise 
training for CGI-58 protein content (Fig. 4.3E; P=0.04 and P=0.03, respectively). No 
difference in FABP4 expression was observed between groups (data not shown). 
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Figure 4.3. Relative protein expression and 
representative immunoblots of the lipolytic 
proteins (A) β3-AR, (B) phosphor-ATGLS406, 
(C) total ATGL, (D) PLIN1 and (E) CGI-58 
in WAT from LCR  and HCR  rats with 
or without exercise training. ATGL, adipose 
triglyceride lipase. AU, arbitrary units. β3-AR, β3-
adrenergic receptor. CGI-58, comparative gene 
identification-58. EX, exercise trained. HCR, high 
capacity runner. LCR, low capacity runner. 
PLIN1, perilipin. SED, sedentary. WAT, white 
adipose tissue.  Values are means ± SE. n=8-12 
per group. *P<0.05 main effect for running 
capacity. †P<0.05 main effect for training state. 
aP<0.05, different to LCR-SED; bP<0.05, different 
to HCR-SED; cP<0.05, different to LCR-EX; 
dP<0.05, different to HCR-EX.  
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NOR1, NUR77 AND GLUT4 EXPRESSION 
A main effect of exercise training was observed for NOR1 expression (Fig. 4.4A; 
P<0.0001). Post-hoc analyses revealed that NOR1 expression was increased by 24% in 
LCR-SED compared to LCR-EX (P=0.008) and 21% in HCR-SED compared to HCR-
EX (P=0.01). Intrinsic running capacity did not influence the expression pattern of 
NOR1, while the expression of NUR77 was similar in LCR and HCR rats with or 
without exercise training (results not shown). The expression of GLUT4 was elevated 
with high intrinsic running capacity (Fig. 4.4B; P<0.0001) and with exercise training 
(P=0.007), with post-hoc analyses revealing that GLUT4 protein content was increased 
by 16% n HCR-EX compared to HCR-SED (P=0.01). Compared to LCR-EX, GLUT4 
protein content was 22% greater in HCR-EX (P=0.0007).!!
STRESS KINASE ACTIVATION 
Stress-activated kinase activation was investigated to determine their involvement in 
the adaptive response of WAT metabolism to exercise training. Total p38 MAPK 
expression was  reduced with training (Fig. 4.5A; P=0.03), while there was a tendency 
for phosporylation of p38 MAPK on the Thr180 and Tyr182 residues to be reduced by 
training (P=0.07). There was a main effect of exercise training on the ratio of phospho-
p38 MAPKT180/Y182 to total p38 MAPK (P=0.03). No differences were observed in total 
JNK1/2 expression, however training increased phospho-JNK1/2T183/Y185 (P=0.02) and 
the ratio of phospho-JNK1/2T183/Y185 to total JNK1/2 (Fig. 4.5B; P=0.002). No 
differences were observed in total ERK1/2 expression (Fig. 4.5C), although a significant 
main effect of running capacity was observed for phospho-ERK1/2T202/Y204 (P=0.03). 
There was also a tendency for the ratio of phospho-ERK1/2T202/Y204 to total ERK1/2 to be 
affected by running capacity (LCR>HCR; P=0.06). No differences were observed in 
total or phospho-AMPKT172 expression, or the ratio of phospho-AMPKT172 to total 
AMPK expression (data not shown). 
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Figure 4.4. Relative protein expression and representative immunoblots of (A) NOR1 
and (B) GLUT4 in WAT from LCR  and HCR  rats with or without exercise 
training. AU, arbitrary units. EX, exercise trained. GLUT4, glucose transport protein 4. HCR, 
high capacity runner. LCR, low capacity runner. NOR1, neuron-derived orphan receptor 1. 
SED, sedentary. WAT, white adipose tissue. Values are means ± SE. n=8-12 per group. *P<0.05 
main effect for running capacity. †P<0.05 main effect for training state. aP<0.05, different to 
LCR-SED; bP<0.05, different to HCR-SED; cP<0.05, different to LCR-EX; dP<0.05, different to 
HCR-EX.  
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Figure 4.5. Relative phosphorylation and representative immunoblots of (A) p38 
MAPK, (B) JNK1/2 and (C) ERK1/2 in WAT from LCR  and HCR  rats with or 
without exercise training. AU, arbitrary units. ERK1/2, extracellular regulated kinase 1/2. EX, 
exercise trained. HCR, high capacity runner. JNK1/2, c-JuN terminal kinase 1/2. LCR, low 
capacity runner. p38 MAPK, p38 mitogen-activated protein kinase. SED, sedentary. WAT, 
white adipose tissue. Values are means ± SE. n=8-12 per group. †P<0.05 main effect for training 
state. aP<0.05, different to LCR-SED; cP<0.05, different to LCR-EX; dP<0.05, different to HCR-
EX.  
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4.4  Discussion 
Using a rat model of divergent running capacity, this chapter describes novel findings 
that show 1) the mitochondrial protein content of visceral WAT is not related to 
intrinsic exercise capacity, 2) a short-term (6 wk) program of endurance exercise 
training does not modulate visceral WAT mitochondrial protein expression (despite 
training-induced increases in citrate synthase activity), 3), intrinsic running capacity 
and training status is associated with the differential WAT expression of several key 
lipolytic proteins, and 4) irrespective of intrinsic running capacity, exercise training 
induces alterations in the activity and expression of a number of proteins essential to 
the intracellular regulation of WAT lipid metabolism.  
 In humans, low aerobic capacity is a strong predictor of early mortality [13, 14]. 
This important clinical association suggests that the capacity for oxygen metabolism is 
the underlying determinant of the divide between complex disease and health (Aerobic 
Hypothesis; Koch & Britton, 2008 [247]). Artificial selection for aerobic capacity has 
been used as an unbiased test of this theory. Along with cardiovascular disease risk 
[161] and reduced lifespan [215], LCR rats express a number of characteristics common 
to metabolic disease phenotypes, such as increased body mass and adiposity [205, 243], 
hyperinsulinaemia [161, 205, 243] and impaired glucose tolerance [165, 205, 243]. In 
contrast, HCR rats live 6-8 months longer [215] and present with superior metabolic 
health, characterized by resistance to weight gain in the face of a high-fat diet [163, 205] 
and an increased capacity for the uptake and oxidation of glucose [165, 204, 243] and 
FA’s [165, 204, 205, 243]. While the differential expression of these key characteristics 
appears to be linked to the oxidative capacity of the skeletal muscle (see Chapter 3 for 
details [243]), less is known about the metabolic characteristics of the adipose tissue 
from these divergent aerobic phenotypes. 
 Chapter 3 presented evidence demonstrating that the skeletal muscle of LCR rats 
contains fewer mitochondria than HCR rats [165, 243]. Furthermore, impaired β-
adrenergic signaling and lipolysis has been observed in the muscle of LCR rats [162, 
204]. Given the divergent metabolic characteristics observed in LCR and HCR rats and 
the importance of WAT in regulating circulating concentrations of FA’s and glucose 
[230, 248, 249], this study sought to determine if differences similar to those seen in 
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muscle could also be identified in the WAT. Unlike previous investigations that report 
reduced expression of a selection of mitochondrial genes and proteins in the visceral 
WAT of insulin resistant rodents [86, 87] and humans with type 2 diabetes [82], 
differences in the expression of the key proteins involved in oxidative phosphorylation 
and the TCA cycle could not be detected in visceral WAT from LCR and HCR 
phenotypes (Fig. 4.2B). Although the possibility that differences in mitochondrial 
protein expression were masked due to equal amounts of protein being analyzed in 
each experiment cannot be ruled out (particularly since LCR-SED have less protein per 
gram of adipose tissue compared to the other three groups, Fig. 4.1C), the level of 
expression of all mitochondrial proteins measured was consistent for both sedentary 
and exercise trained cohorts, suggesting that the abundance of oxidative enzymes in 
visceral WAT may not be an important factor for determining running capacity and the 
associated phenotypes of the LCR-HCR rat model system.  
 Chronic β-adrenergic stimulation as a result of increased physical activity [72, 
250] or pharmacological activation [251] has been shown to enhance the oxidative 
capacity of WAT by up-regulating the expression of genes involved in oxidative 
phosphorylation and fat oxidation. Although the training program employed in this 
study was successful in ameliorating many of the metabolic differences observed in the 
skeletal muscle of LCR compared to HCR rats [204], including a reduction in body 
mass and adiposity (Fig. 4.1), it had little effect on oxidative enzyme expression in the 
WAT of either phenotype, an observation that is consistent with findings in human 
subcutaneous WAT [252]. Although mitochondrial protein content was not different, a 
marked training-induced increase in citrate synthase activity was observed in both LCR 
and HCR phenotypes (Fig 4.2A). While this might appear to be in contrast to the 
earlier findings (especially given that citrate synthase protein expression was 
unchanged), it is important to note that citrate is essential for replenishing the extra-
mitochondrial pool of acetyl-CoA, a substrate essential to de novo lipogenesis [253]. 
Furthermore, lipogenic pathways are energetically costly processes (Fig. 1.2). Therefore, 
although training may not have altered the amount of mitochondrial protein, changes 
in cellular energy needs in response to physiological demand are likely to have induced 
tighter allosteric control and a number of post–translational changes that increase the 
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maximal capacity of mitochondrial enzymes involved in the different energy producing 
pathways [254]. A limitation of this study is the absence of additional measures 
representing the coordinated activities of β-oxidation, the TCA cycle and oxidative 
phosphorylation.     
 Glucose incorporation into triglyceride (TG) is an essential component of lipid 
synthesis and intracellular glucose availability in adipocytes is dependent on plasma 
membrane glucose transport efficiency (a process that is directly associated with the 
intracellular pool of GLUT4 [78, 255, 256], training-induced increases in WAT GLUT4 
expression may be associated with an increased capacity for WAT TG synthesis. 
Indeed, adipose-specific GLUT4 over expression induces an increase in the capacity for 
TG synthesis via both re-esterification and de novo lipogenic pathways leading to an 
increase in total adipose mass in sedentary animals [255, 257]. Although it was not 
possible to measure lipogenic activity in the present study, both running capacity and 
training status are shown to affect GLUT4 content in visceral WAT (Fig. 4.4B), with 
LCR rats having reduced WAT GLUT4 content compared with HCR rats. Whether or 
not other adipose depots show similar changes remains to be determined. Either way, 
differences in adipose GLUT4 content in both sedentary and trained animals could 
have important implications on whole-body adiposity in these divergent rat phenotypes 
[230]. It is also worth noting that exercise training has been reported to increase 
subcutaneous WAT GLUT4 expression in type 2 diabetic humans [258]. Whether the 
same changes are observed in human visceral WAT is unclear, since subcutaneous and 
visceral adipose depots may have distinct responses to exercise [75]. Similarly, it is 
possible that the different visceral adipose depots may respond disparately to training. 
Thus, another limitation of this study is limiting the analyses to the epididymal WAT 
depot. 
 TG synthesis is tightly coupled with TG catabolism, therefore it is not surprising 
that exercise training induces an increase in the capacity for both basal and 
catecholamine-stimulated WAT lipolysis [259]. This is predominantly attributed to 
repeated transient elevations in circulating catecholamines acting via β-adrenergic 
signaling pathways [260]. The β3-AR plays an important role in regulating energy 
balance, particularly in WAT [261]. The expression of the β3-AR was reduced in LCR-
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SED compared to HCR-SED (Fig. 4.3A), which agrees with studies in both obese 
rodents [262, 263] and humans [264] that report impaired β-adrenergic signaling as an 
important factor in obesity development. Indeed, functional β-adrenergic signaling is 
essential for obesity resistance [265]. In line with this, exercise training ‘rescued’ the 
reduction in β3-AR in LCR-EX rats (Fig. 4.3A), while concomitantly reducing fat pad 
and total body mass (Fig. 4.1). Conversely, training did not effect β3-AR levels in HCR-
EX (Fig. 4.3A), nor did it effect fat pad or total body mass (Fig. 4.1). These findings are 
similar to previous observations of impaired β-adrenergic signaling in the skeletal 
muscle of LCR compared to HCR rats [162], an impairment that is also ameliorated 
with exercise training [204]. 
 β3-AR stimulation by catecholamines increases lipolysis by activating protein 
kinase A (PKA), which phosphorylates both ATGL [246] and HSL [266] to increase 
lipase activity. Furthermore, PKA phosphorylation of PLIN1 facilitates the dissociation 
of CGI-58 from PLIN1, thereby allowing CGI-58 to interact with ATGL to maximally 
activate lipolysis [267]. Given that the primary hypotheses of the current study were 
mitochondrial-focused, lipolysis could not be measured directly. Instead, the 
phosphorylation state of ATGL and HSL at key activating serine residues was 
determined, as well as the protein abundance of other key lipolytic proteins. ATGL 
Ser406 phosphorylation and total ATGL content were increased in HCR vs. LCR rats 
and by exercise training in both groups (Fig. 4.3B and C). Similarly, CGI-58 was 
increased in HCR vs. LCR rats and increased by exercise training in both groups (Fig. 
4.3E). Based on knowledge of protein function and results from knockout mice studies 
[268], the changes reported herein would predict increased lipolysis in high capacity 
runners and following exercise training. Such a response would match fatty acid 
availability with the increased fatty acid oxidation capacity/rates observed in HCR 
compared with LCR rats [162, 165, 243] and is consistent with an endurance trained 
individuals reliance on fatty acid as an energy source [33].  
 Previous investigations have reported links between β-adrenergic signaling, the 
expression of the orphan nuclear receptor NOR1 and whole-body lipid and 
carbohydrate metabolism [207]. Although its targets are largely unknown, NOR1 is 
purported to play an important role in regulating oxidative metabolism and glucose 
! 81!
transport in a number of tissues [207]. Notably, NOR1 is a cAMP-dependent target of 
PKA that is up-regulated upon HSL and ATGL inhibition [269, 270]. Chapter 3 
demonstrates that NOR1 expression is reduced in the skeletal muscle of LCR compared 
to HCR rats, a finding that suggests that the abundance of NOR1 may be linked to the 
oxidative capacity of the tissue [243]. In this chapter (Chapter 4) the difference in 
NOR1 expression was shown to be tissue-specific, as LCR-SED and HCR-SED 
displayed a similar abundance of NOR1 in WAT. This finding is incongruous with 
human studies that demonstrate that NOR1 is more highly expressed in the WAT of 
obese compared to healthy humans [271]. However, following weight loss the 
expression of NOR1 in human WAT is ‘normalized’ to levels similar to healthy control 
subjects [271]. Similarly, a reduction in NOR1 expression of a similar magnitude was 
observed for both LCR and HCR rats following exercise training (24% and 21% 
respectively, Fig. 4.4A). Taken collectively, this observation of reduced NOR1 
expression following exercise training in both LCR and HCR rats suggests a principal 
role for NOR1 in the metabolic regulation of WAT. 
 Given the role of β-adrenergic signaling in WAT metabolism and the finding that 
the expression of several proteins downstream of β-adrenergic stimulation are 
dependent on running capacity and/or training status (Fig. 4.5), the next logical step 
was to characterize the phosphorylation of several stress kinases that are purported to 
interact with β-adrenergic signaling pathways to influence intracellular metabolism 
[254, 272, 273]. Based on these experiments, it can now be reported that a short-term 
exercise training program induces distinct changes in the activity of the stress kinases 
p38 MAPK and JNK1/2 in visceral WAT (Fig. 4.5A and B). Both p38 MAPK and 
JNK1/2 are activated by FFA’s [274, 275] and both are increased in response to elevated 
lipolytic activity [276]. Importantly, the β-adrenergic activation of p38 MAPK has been 
shown to occur through cAMP-dependent mechanisms involving PKA [277] and both 
p38 MAPK and JNK1/2 phosphorylation are known to be elevated in visceral WAT 
during human obesity [278]. This chapter describes a modest reduction in the 
phosphorylation of p38 MAPK in visceral WAT following exercise training (Fig. 4.5A), 
a finding that is consistent with observations in human and rodent skeletal muscle, 
where training-induced attenuation of resting p38 MAPK activity is associated with the 
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adaptive response to exercise training [279, 280]. It is also worth noting that p38 
MAPK is a known activator of PGC-1α (and therefore mitochondrial biogenesis) [281, 
282] and as such, training-induced reductions in p38 MAPK activity may partially 
explain why changes in mitochondrial protein expression were not observed in the 
current study. In contrast to the findings for p38 MAPK, phosphorylation of JNK1/2 
was elevated as a result of exercise training (Fig. 4.5B). This is also consistent with 
findings in skeletal muscle [280], but inconsistent with reports that diet-induced 
elevations in JNK1/2 phosphorylation are attenuated by swim training in obese rats 
[283, 284]. Although the individual roles of JNK and p38 MAPK in adipocyte 
metabolism are no doubt complex, these findings indicate that in WAT, both kinases 
are exercise-responsive (in a manner similar to findings in skeletal muscle), thus 
implicating them in the array of signaling responses associated with changes in energy 
demand.   
 In summary, this chapter investigates the relationship between exercise capacity 
and WAT metabolism in regards to whole-body metabolic health. Novel data is 
presented, showing that the content of selected mitochondrial proteins in visceral WAT 
does not differ in relation to intrinsic exercise capacity or exercise training status and, 
as such, it can be posited that tighter allosteric control and/or post-translational 
regulation of oxidative enzymes may be important for coordinating aerobic energy 
metabolism in WAT. Running capacity and training state were also shown to regulate 
the expression and activity of a number of proteins down-stream of β-adrenergic 
signaling pathways, particularly those that are essential to WAT lipolysis. It is suggested 
that training-induced changes in the expression of the orphan nuclear receptor NOR1 
and the activities of the stress kinases p38 MAPK and JNK1/2 may be important factors 
for determining the expression and activity of metabolic proteins in WAT following 
exercise training. Further studies are necessary to provide mechanistic support for these 
purported relationships.  
 
!
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Chapter 5 
 
 
Perspective and significance 
 
The work undertaken for this thesis comprised a series of independent but related 
studies aimed at enhancing our understanding of the relationship between genetic 
factors and environmental stimuli in determining the capacity for aerobic energy 
production in skeletal muscle and white adipose tissue. Rodent models of divergent 
intrinsic running capacity (and, by association, metabolic health profile) and 
environmental interventions (i.e., diet and exercise) were employed in order to explore 
some of the mechanisms that determine the capacity for mitochondrial energy 
production in these two insulin-responsive tissues.  
   The main findings were the identification of several novel mechanisms by which 
mitochondrial adaptations to environmental stimuli can influence the capacity for 
energy substrate metabolism in skeletal muscle and white adipose tissue. It was shown 
that physical activity was a powerful environmental stimulus capable of improving or, 
in some instances, completely overriding metabolic pathways that have been genetically 
predisposed to metabolic inflexibility and disease-risk.  
 The first investigation (described in detail in Chapter 2) addressed the question of 
whether an obesogenic rodent diet (typical of a human Western diet, which is 
moderately high in fat but also high in carbohydrate) could induce changes in skeletal 
muscle respiratory capacity similar to that observed with rodent high-fat feeding 
(typically very high in fat but low in carbohydrate). The finding that mitochondrial 
respiratory capacity was indeed increased in response to Western diet feeding, and that 
it was likely due to an increase in mitochondrial content, raises the possibility that diet-
induced mitochondrial biogenesis is an adaptive response designed to help cope with 
the increased flux of energy substrates to metabolically active tissues. Indeed, as 
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contraction-induced mitochondrial biogenesis is triggered by disturbances in the 
metabolic state of the muscle (i.e., changes to the ATP:ADP ratio, elevated [Ca2+],  rate 
of NAD+ cycling, etc.), it seems reasonable to suggest that a persistent oversupply and 
flux of energy substrate to the muscle would also cause metabolic perturbations capable 
of inducing mitochondrial biogenesis. In support of this notion, Western diet-induced 
elevations in mitochondrial protein expression were more pronounced in the primarily 
glycolytic m. extensor digitorum longus, wherein an increase in mitochondrial 
machinery may be necessary to alleviate some of the stress endured by the primarily 
oxidative muscle groups in response to lipid overload. The finding that the 
intramyocellular triglyceride content was elevated in m. soleus but not m. extensor 
digitorum longus further supports this hypothesis. 
 Another important finding from this investigation was that, despite a significant 
increase in adiposity, rats consuming a Western diet did not show signs of impaired 
glucose tolerance. Furthermore, the fasting insulin levels of these rats were only 
moderately elevated (30%). These findings are indicative of early-stage insulin 
resistance and are more reflective of the pathogenesis of human insulin resistance than 
the rapid impairments typically seen after feeding rats an extreme high-fat diet (60-80% 
energy from fat versus ~40% in a typical Western diet). These disparate effects of diets 
differing in macronutrient composition on insulin action have important implications 
for future rodent studies investigating obesity and its comorbidities, in that progression 
of these pathologies occurs much more slowly in humans (and in rodents fed a Western 
diet) and therefore may be associated with a number of functional adaptations prior to 
the presentation of overt metabolic disease. Given that diet-induced mitochondrial 
biogenesis may be one (transient) adaptation, a time-course of disease progression in 
rats fed a Western diet would help to clarify the relationship between obesity, insulin 
resistance and skeletal muscle mitochondrial function. Understanding when and where 
these purported functional adaptations take place could allow for early intervention 
strategies aimed at slowing (or even reversing) cardio-metabolic disease progression. 
 Although environmental factors (such as diet and level of habitual physical 
activity) are important contributors to metabolic health, evidence also points to a 
strong genetic underpinning to many metabolic diseases. Therefore, the aim of the 
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second investigation (Chapter 3) was to identify whether or not skeletal muscle 
mitochondrial function and/or density was related to intrinsic running capacity (and 
subsequently, metabolic disease risk), and to characterize some of the potential 
mechanisms underlying these differences. The first major finding from this study was 
that skeletal muscle from rats with inherent high running capacity (and superior 
metabolic health; HCR) has an increased mitochondrial content and, in addition, an 
elevated capacity for lipid oxidation compared to muscle from rats with intrinsically 
low running capacity (LCR). This finding is consistent with the observation that 
endurance trained individuals have a greater reliance on lipid-based fuels as an energy 
source, and explains, in part, how intrinsically determined skeletal muscle metabolism 
contributes to the phenotype of running capacity and its correlated traits. However, this 
interpretation is not without its limitations. Importantly, despite originating from the 
same genetically heterogeneous background and being exposed to identical 
environmental conditions, LCR rats are less active than their HCR counterparts. Given 
that habitual physical activity is a powerful environmental influence on skeletal muscle 
metabolism, the disparity in spontaneous activity between these two divergent 
phenotypes makes it difficult to ascertain whether or not part (or all) of the differences 
in muscle respiratory capacity can be attributed to differing physical activity levels or, if 
differing levels of habitual activity are an indirect consequence of low (or high) inherent 
skeletal muscle oxidative capacity. The degree to which habitual physical activity 
contributes to skeletal muscle mitochondrial content and lipid metabolism in this 
rodent model system is an important question to be addressed in future studies.  
 The second major finding of this investigation (Chapter 3) was that the orphan 
nuclear receptor NOR1 was more highly expressed in the muscle of HCR rats 
compared to LCR rats. Previous studies have implicated this receptor in a plethora of 
metabolic processes, most notably for its role in promoting oxidative adaptations in 
skeletal muscle in both rodents and humans. At the center of this paradigm is an 
apparent relationship between β-adrenergic signaling, PKA- and p38 MAPK- 
dependent NOR1 activation and the oxidative capacity of skeletal muscle (particularly 
rates of lipid oxidation). Indeed knock-down of NOR1 in myotubes suppresses the 
expression of peroxisome proliferator activated receptor-γ coactivator-1α (PGC-1α) 
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and partitions energy metabolism toward O2-independant processes. Taken together, 
these findings implicate NOR1 as playing a major role in determining skeletal muscle 
mitochondrial content. However, the functional role and primary targets of NOR1 
must be first be characterized in order to determine the precise mechanisms involved. 
Tissue culture and animal studies that take a gain/loss of function approach will go a 
long way to providing such information.  
 Recent advances in our understanding of white adipose tissue metabolism have 
demonstrated that it is more than the inert lipid storage facility it was once thought to 
be. White adipose tissue plays a central role in regulating whole-body lipid metabolism, 
with the co-ordination of the rates of lipolysis and lipogenesis/fatty acid re-
esterification being a crucial factor for substrate metabolism in other peripheral tissues 
(such as skeletal muscle). As these are all energetically costly processes, impaired 
mitochondrial function in white adipose tissue has been posited to play a role in the 
pathogenesis of obesity and insulin resistance. Thus, the primary aim of the third 
investigation (Chapter 4) was to characterize the expression and activity of 
mitochondrial proteins important to the tricarboxylic acid cycle and oxidative 
phosphorylation in white adipose tissue from the LCR and HCR rat phenotypes. 
Additionally, since exercise training has recently been shown to alter important aspects 
of white adipose tissue energy metabolism (such as improved insulin action and 
elevated expression of PGC-1α and uncoupling protein 1), the effect of a short-term 
treadmill running protocol on white adipose tissue from LCR and HCR rats was also 
investigated.  
 The first important finding from this study was that the abundance of selected 
mitochondrial proteins under investigation was not different between LCR and HCR 
rats, nor did they change in response to exercise training, despite training-induced 
increases in oxidative enzyme activity (i.e., citrate synthase). This raises the possibility 
that post-translational changes and/or tighter allosteric control are of greater 
importance to white adipose tissue metabolism than mitochondrial enzyme content per 
se. In skeletal muscle, training-induced mitochondrial biogenesis is dependent on both 
exercise intensity and volume. However, less is known about the effects of different 
exercise protocols on mitochondrial biogenesis in white adipose tissue. Given that 
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previous studies have reported training-induced increases in the white adipose tissue 
content of selected mitochondrial enzymes (respiratory complexes II, IV and 
cytochrome C), the possibility that a more intense training protocol to the one 
employed in this study could induce increased mitochondrial enzyme content cannot 
be discounted. Nevertheless, the improvements in whole-body metabolism that were 
observed in both LCR and HCR rats following training indicate that the mitochondrial 
content of visceral white adipose tissue is not likely to be as important as other points of 
metabolic control (i.e., the activity of lipolytic and lipogenic proteins). Indeed, the 
findings presented in Chapter 4 demonstrate that the visceral white adipose tissue of 
LCR and HCR rats is exercise-responsive in a way that alters its capacity for lipid 
metabolism. In line with this notion, the observation of training-induced increases in 
the abundance and activating phosphorylation of lipolytic proteins, as well as 
differences between LCR and HCR rats, is consistent with an endurance trained 
individuals greater reliance on fatty acids as an energy source, as previously noted. Such 
a finding is also consistent with observations from the muscle of LCR and HCR rats 
after the same training protocol. Thus, in untrained HCR rats, a greater capacity for 
lipolysis in both white adipose tissue and skeletal muscle, as well as an increased 
capacity for lipid oxidation in muscle, are likely to be important factors underlying the 
distinct phenotypes. 
 The mechanisms behind training-induced changes in white adipose tissue 
metabolism are not well defined. However, the results from this investigation (Chapter 
4) demonstrate that exercise training down-regulates the expression of NOR1 and the 
activating phosphorylation of p38 MAPK. Given that both NOR1 and p38 MAPK are 
cAMP-dependent targets of PKA, and that exercise training resulted in an increase in 
expression of several important lipolytic proteins, this implicates the β-adrenergic 
signaling cascade in the adaptive response of white adipose tissue to exercise training. 
The precise mechanisms that control the actions and/or interactions of each of the 
exercise-responsive proteins are complex. As such, this is an exciting new area of 
research to pursue. Mechanistic studies using tissue culture, ex vivo incubations and 
transgenic models will aid our understanding of the actions of these proteins while 
contributing to our overall understanding of whole-body metabolism.   
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 In conclusion, the findings presented in this thesis suggest that although there is a 
genetic predisposition towards obesity and its comorbidities, this may, in part, be 
mediated by a predisposition toward physically inactive behaviors. Whether differences 
in habitual activity are a cause or a consequence of differing capacities for skeletal 
muscle and/or white adipose tissue metabolism is a question that remains unanswered. 
Regardless, the results from the studies undertaken for this thesis demonstrate that diet 
and exercise are powerful environmental stimuli capable of altering metabolic pathways 
that have otherwise been (genetically) programmed toward metabolic health or disease-
risk.  
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Stephenson EJ, Camera DM, Jenkins TA, Kosari S, Lee JS,
Hawley JA, Stepto NK. Skeletal muscle respiratory capacity is
enhanced in rats consuming an obesogenic Western diet. Am J Physiol
Endocrinol Metab 302: E1541–E1549, 2012. First published April 10,
2012; doi:10.1152/ajpendo.00590.2011.—Obesity-induced lipid over-
supply promotes skeletal muscle mitochondrial biogenesis. Previous
investigations have utilized extreme high-fat diets (HFD) to induce
such mitochondrial perturbations despite their disparity from human
obesogenic diets. Here, we evaluate the effects of Western diet
(WD)-induced obesity on skeletal muscle mitochondrial function.
Long-Evans rats were given ad libitum access to either a WD [40%
energy (E) from fat, 17% protein, and 43% carbohydrate (30%
sucrose); n ! 12] or a control diet (CON; 16% of E from fat, 21%
protein, and 63% carbohydrate; n ! 12) for 12 wk. Rats fed the WD
consumed 23% more E than CON (P ! 0.0001), which was associ-
ated with greater increases in body mass (23%, P ! 0.0002) and
adiposity (17%, P! 0.03). There were no differences in fasting blood
glucose concentration or glucose tolerance between diets, although
fasting insulin was increased by 40% (P ! 0.007). Fasting serum
triglycerides were also elevated in WD (86%, P ! 0.001). The
maximal capacity of the electron transfer system was greater follow-
ing WD (37%, P ! 0.02), as were the maximal activities of several
mitochondrial enzymes (citrate synthase, "-hydroxyacyl-CoA dehy-
drogenase, carnitine palmitoyltransferase). Protein expression of ci-
trate synthase, UCP3, and individual respiratory complexes was
greater after WD (P # 0.05) despite no differences in the expression
of peroxisome proliferator-activated receptor (PPAR)$, PPAR%, or
PPAR& coactivator-1 mRNA or protein abundance. We conclude that
the respiratory capacity of skeletal muscle is enhanced in response to
the excess energy supplied by a WD. This is likely due to an increase
in mitochondrial density, which at least in the short term, and in the
absence of increased energy demand, may protect the tissue from
lipid-induced impairments in glycemic control.
diet-induced obesity; skeletal muscle mitochondria; mitochondrial
biogenesis; peroxisome proliferator-activated receptor-& coactivator-
1$; peroxisome proliferator-activated receptor-%
THE MACRONUTRIENT COMPOSITION OF THE DIET is an important
factor in the pathogenesis of obesity (12, 23), and when
combined with a sedentary lifestyle, a human obesogenic diet
[characterized by the overconsumption of dietary fat and sim-
ple sugars (12, 43)] results in an energy imbalance and subse-
quent increase in the flux of energy substrates to metabolically
active tissues (12). When substrate delivery exceeds a tissue’s
needs, substrates accumulate and are eventually stored (9, 56).
Skeletal muscle is a major site for both fatty acid (FA) and
glucose disposal (28, 46). In obesity, inappropriate lipid depo-
sition in nonadipose tissues (such as skeletal muscle) and a
concomitant reduction in the ability of cells to completely
oxidize lipids has been described frequently (3, 31, 44). Given
that the mitochondria are entirely responsible for FA "-oxida-
tion, it is not surprising that mitochondrial functional defects
and deficiencies have been observed in the skeletal muscle of
obese rodents (7, 37, 48) and humans (30, 42). These findings
have led to the notion that lipid-induced abnormalities in
mitochondrial metabolism are a causative factor in the patho-
genesis of obesity and its comorbidities (1, 11, 30, 31, 39, 41,
48, 53).
The issue of whether mitochondrial “deficiency and/or dys-
function” contributes to the obesity sequelae has been ques-
tioned in light of recent reports of high-fat diet (HFD)-induced
increases in mitochondrial enzyme activities and protein ex-
pression (13, 21, 25, 51, 52). Indeed, such diets cause an
increase in circulating free fatty acids (FFA) (19–21, 53),
which, acting as ligands to peroxisome proliferator-activated
receptors (PPARs) (18), are thought to increase mitochondrial
biogenesis via the PPAR&-coactivator-1$ (PGC-1$) pathway
(18, 21, 26, 45). The results of these studies, as well as
previous work from our laboratory (15), suggest that certain
aspects of mitochondrial function (i.e., "-oxidation and oxida-
tive phosphorylation) may be upregulated following a HFD.
High-fat fed rodents rapidly gain weight while concomi-
tantly developing insulin resistance (32, 33, 57). As such, this
model is used frequently to investigate the underlying mecha-
nisms of obesity and its associated conditions. Investigations
are often undertaken based on the assumption that these pa-
thologies develop similarly in rodents as they do in humans.
However, the typical human obesogenic diet, i.e., a Western
diet (WD), is moderately high in fat ['40–45% of total energy
(E)] yet still comprises a substantial proportion of E from
carbohydrate (particularly simple sugars) and protein (43). In
contrast, a typical rodent HFD usually contains extreme levels
of fat (!80% of total available E) and very low carbohydrate
(9, 43). Given the role diet composition plays in the mecha-
nistic progression of obesity and insulin resistance, the dispar-
ity between the macronutrient breakdown of a rodent HFD and
a typical human obesogenic diet is an important factor to
consider when interpreting results (9, 56). Whereas diets high
in fat and diets high in sugar may result in similar outcomes,
such as rapid weight gain (9, 56), increased circulating lipids
(9, 56), and insulin resistance (9), the mechanisms underlying
these changes are likely to be markedly different (9).
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In the current investigation, we fed rats a commercially
available diet that closely mimics a human WD (a diet both
high in fat and in sucrose) and measured the mitochondrial
respiratory capacity of skeletal muscle using high-resolution
respirometry. We hypothesized that 12 wk of a WD would
increase the respiratory capacity of skeletal muscle mitochon-
dria via the upregulation of PPAR% and PGC-1$.
METHODS
Animals. Eight-week-old male Long-Evans rats (n ! 24) were
obtained from Monash Animal Services (Monash, Australia) and
housed under a controlled 12:12-h light-dark cycle at a constant
temperature of 22°C. Animals had ad libitum access to food and water
and were allowed to acclimate to the Royal Melbourne Institute of
Technology (RMIT) Animal Facility for 1 wk prior to commencement
of the study. All procedures were approved by the RMIT Animal
Ethics Committee.
Experimental groups. Following the acclimation period rats were
randomly assigned to one of two 12-wk dietary interventions: a control
diet (CON; n! 12, 16% of E from fat, 21% from protein, and 63% from
carbohydrate, 16.1 kJ/g; Specialty Feeds, Glen Forrest, Western Austra-
lia, Australia) or a commercially available WD (n! 12; 40% E from fat,
17% from protein, and 43% from carbohydrate, 19.4 kJ/g; Specialty
Feeds). The macronutrient breakdown of each diet is presented in Table 1.
Body mass and food intake were monitored twice weekly.
Intraperitoneal glucose tolerance tests. After 11 wk, all rats were
subjected to a glucose challenge to assess glucose clearance. Follow-
ing an overnight fast (14 h), '15 (l of blood was collected via tail
cut, and glucose concentration was measured on a hand-held glucom-
eter (Roche Diagnostics, Castle Hill, New South Wales, Australia).
Rats then received a single glucose bolus (2 g/kg body wt) via
intraperitoneal injection, and blood glucose concentration was moni-
tored at 30-min intervals over 120 min postinjection.
Tissue collection and analyses. After 12 wk, animals were decap-
itated and hindlimb muscles immediately excised. The left soleus
('87% type I and '13% type IIA fibers) was placed in ice-cold
muscle preservation medium [BIOPS; 50 mM K)-MES, 20 mM
taurine, 0.5 mM dithiothreitol, 6.56 mM MgCl2, 5.77 mM ATP, 15
mM phosphocreatine, and 20 mM imidazole, pH 7.1, adjusted with 5
N KOH at 0°C; Ca-EGTA buffer (10 mM; 2.77 mM CaK2EGTA )
7.23 mM K2EGTA, 0.1 (M free calcium)] (38, 47, 54), whereas the
contralateral soleus and extensor digitorum longus (EDL; '2% type
I, '42% type IIA, and '56% type IIB fibers) muscles were snap-
frozen in liquid N2 for later analyses. Epidydimal fat pads were
removed and weighed as indicators of adiposity. All reagents used
were obtained from Sigma-Aldrich (Castle Hill, New South Wales,
Australia) unless otherwise specified.
High-resolution respirometry. High-resolution respirometry pro-
vides a direct measurement of mitochondrial respiratory capacity ex
vivo from which we can obtain information about specific compo-
nents in a working system (38). Soleus (n ! 6/dietary treatment) was
separated mechanically over ice using fine forceps (38) and then
chemically permeablized with saponin (50 (g/ml in BIOPS) for 30
min. This was followed by a 10-min wash period in mitochondrial
respiratory medium (MiR05; 110 mM sucrose, 60 mM K-lactobion-
ate, 0.5 mM EGTA, 3 mM MgCl2, 20 mM taurine, 10 mM KH2PO4,
20 mM HEPES, adjusted to pH 7.1 with KOH at 37°C, and 1 g/l fatty
acid-free BSA; ACROS Organics) (38). Duplicate tissue samples
(2–3.5 mg) were transferred to the chambers of an O2K-Oxygraph
high-resolution respirometer (Oroboros, Innsbruck, Austria) contain-
ing 2 ml of MiR06 (MiR05 ) 280 IU/ml catalase) and calibrated to
air saturation. Individual chambers were oxygenated to'485 nmol/ml
with pure O2 (BOC Australia).
Substrate uncoupler inhibitor titration protocol. Malate (2 mM)
was added to the chamber and the mass specific oxygen flux (JO2;
pmol·s*1·mg*1 wet wt) stabilized for 5–10 min. The tissue was then
subjected to a substrate uncoupler inhibitor titration (SUIT) protocol
that sequentially evaluates complex (C)I leak state (the addition of 5
mM pyruvate and 10 mM glutamate; state 2 respiration), oxidative
phosphorylation with electron flux through CI by titration (the addi-
tion of 0.25, 0.75, 2.5, and 5 mM ADP; state 3 respiration), the
integrity of the outer mitochondrial membrane (the addition of 10 (M
cytochrome c), maximal coupled respiration with electron flux
through both CI and CII (the addition of 10 mM succinate; state 3
respiration), maximal capacity of the electron transport system (ETS)
by uncoupling with a stepped titration (the addition of 0.5 and 1 (M
carbonyl cyanide p-trifluoromethoxyphenylhydrazone), uncoupled
oxidative phosphorylation with electron flux through CII (with the
addition of 0.5 (M of the CI inhibitor rotenone), and residual O2
consumption (ROX; with the addition of NaN3, 200 mM). Chambers
were maintained at 37°C, and O2 saturation was maintained between
300 and 450 nmol/ml via regular titrations of H2O2. Mass-specific O2
flux was determined using DatLab (Oroboros) from steady-state JO2
normalized to tissue wet weight and adjusted for instrumental back-
ground and ROX. In addition, flux control ratios (results normalized
to the maximal capacity of the ETS) were calculated to determine
mitochondrial function independent of mitochondrial density (38).
Mitochondrial enzyme activities. Muscle homogenates (n! 10/group)
were prepared over ice from snap-frozen soleus or EDL (10–20 mg for
each) in buffer (175 mM KCl and 2 mM EDTA, pH 7.4, 1:50 or 1:100
dilution) and then subjected to three freeze-thaw cycles. Citrate synthase
(CS), "-hydroxyacyl-CoA dehydrogenase ("-HAD), and total carnitine
palmitoyltransferase (CPT) activities were determined using the methods
of Srere (49), Bergmeyer (5), and Bieber et al. (6), respectively, with the
following modifications. Briefly, aliquots of homogenate were added to
the appropriate wells of a 96-well microplate with a working solution,
with final concentrations of either 72.5 mM Tris·HCl, 0.45 mM acetyl-
CoA, 0.1 mM DTNB (for CS), 50 mM Tris·HCl, 2 mM EDTA, 250 (M
NADH (for "-HAD), and 116 mM Tris·HCl or 1 mM EDTA, 1.1 mM
L-carnitine, and 100 (M DTNB (for CPT). After the wells were moni-
tored for background activity, reactions were initiated via the addition of
0.5 mM oxaloacetic acid (for CS) and 100 (M acetoacetyl-CoA (for
"-HAD) or 1.9 mM palmitoyl-CoA (for CPT). Enzyme activities were
determined by monitoring +absorbance at 412 (for CS and CPT) and 355
nm (for "-HAD) for 3 min at 25°C. Extinction coefficients of 13.6 (for
CS and CPT) and 6.22 (mol/cm2 (for "-HAD) were used to calculate
rates of enzyme activity. Rates are expressed as (mol·min*1·g*1 wet wt.
Intramyocellular triglyceride determination. Intramyocellular triglycer-
ide (IMTG) concentration was determined as described previously
(48). Briefly, freeze-dried soleus and EDL (n ! 8/group for each
muscle) were powdered and cleaned of all visible blood and connec-
tive tissue. Total lipids in muscle fragments (5–10 mg of dry muscle)
Table 1. Daily energy intake and nutritional parameters
for control rats and rats receiving the WD
Control WD
Daily energy intake, kJ 273.52 , 3.94 335.41 , 5.92*
Protein (casein)
E% 21.00 17.00
g/day 3.39 , 0.05 3.37 , 0.06
Carbohydrate
E% 63.00 43.00
Sucrose, g/day 1.69 , 0.02 5.89 , 0.10*
Starch, g/day 9.10 , 0.13 2.66 , 0.05*
Lipid
E% 16.00 40.00
Total, g/day 1.19 , 0.02 3.63 , 0.06*
Saturated, g/day 0.08 , 0.001 2.37 , 0.04*
Unsaturated, g/day 1.10 , 0.02 1.24 , 0.02
Values represent means , SE, as determined over 12 wk; n ! 12 animals/
group. WD, Western diet; E%, energy percent. *P # 0.05.
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were extracted in chloroform-methanol (13). The organic portion was
then evaporated under a stream of N2 and reconstituted in chloroform.
Silicic acid was then added to the organic portion, and the phospho-
lipids were removed by centrifugation. The resultant supernatant was
evaporated and saponified in ethanolic KOH, and glycerol content was
analyzed fluorometrically.
Nucleic acid extraction and quantification. DNA and RNA were
each extracted from '10–15 mg of snap-frozen soleus and EDL.
RNA was extracted using Trizol reagent (Invitrogen, Mulgrave, Aus-
tralia), whereas DNA was extracted using a commercially available
kit (Qiagen, Doncaster, Australia). The quality and quantity of both
extracts was determined using a NanoDrop 1000 spectrophotometer
(Nanodrop Technologies). For both DNA and RNA an aliquot was
taken from each CON extract and pooled. Following quantification,
the pooled sample was serially diluted to produce a standard curve for
inclusion in each PCR run.
Reverse transcription and real-time PCR. First-strand cDNA synthesis
was performed for RNA extracts using Superscript VILO (Invitrogen).
Relative mRNA expression was determined using commercially avail-
able Taqman primer/probe sets (Applied Biosystems, Mulgrave, Austra-
lia) for PGC-1$ (Ppargc1a; cat. no. Rn00580241_m1) and PPAR%
(Ppard; cat. no. Rn00565707_m1). Glyceraldehyde-3-phosphate dehy-
drogenase (Gapdh; cat. no. Rn01775763_g1) was included as a house-
keeping gene to normalize threshold cycle (CT) values. Mitochondrial
DNA (mtDNA) copy number was determined as described previously
(55, 58), using Taqman primer/probes sets for mitochondrially encoded
NADH dehydrogenase-1 (MT-ND1; cat. no. Rn03296764_s1) and nu-
clear-encoded Gapdh. Quantification was performed in duplicate using a
72-well Rotor-Gene 3000 Centrifugal Real-Time Cycler (Corbett Re-
search, Mortlake, Australia). PCR conditions were as follows: 2 min at
50°C and and 10 min at 95°C, followed by 40 cycles of 95°C for 15 s and
60°C for 60 s. Data were calculated using the ++CT method.
Immunoblotting. Approximately 50 mg of frozen soleus and EDL
was homogenized in buffer (50 mM Tris·HCl, pH 7.5, 1 mM EDTA,
1 mM EGTA, 1 mM DTT, 50 mM NaF, 5 mM Na pyrophosphate,
10% glycerol, 1% Triton X-100, 10 (g/ml trypsin inhibitor, 2 (g/ml
aprotinin, 1 mM benzamidine, and 1 mM phenylmethylsulfonyl flu-
oride; 1:8 dilution) and centrifuged at 20,000 g for 30 min at 4°C.
Protein concentration of the supernatant was determined using the
bicinchoninic method (Pierce). Muscle lysates containing either 5 or
20 (g of protein were prepared in 4- Laemmli buffer, subjected to
SDS-PAGE, and then transferred to polyvinylidene difluoride mem-
branes. Membranes were blocked (5% nonfat dry milk) for 1 h at
room temperature and then incubated overnight at 4°C with primary
antibodies specific for signaling proteins [PPAR% (no. PA1–823A;
Thermo Scientific), PPAR$ (no. ab24509; Abcam), and PGC-1 (no.
ab3242; Chemicon) and their targets CPT I-M (no. sc20670; Santa
Cruz Biotechnology) and UCP3 (no. PA1-055; Affinity BioRe-
agents)], for mitochondrial proteins [complexes I, II, III, IV (subunit
I), and V of the electron transfer system (no. MA604; MitoSciences),
complex IV (subunit II, no. MS405; MitoSciences), complex IV
(subunit IV, no. MS407; MitoSciences), CS (no. ab96600; Abcam)],
and as a protein loading control ($-tubulin; Sigma, St. Louis, MO).
Protein was detected using enhanced chemiluminescence (Amersham
Biosciences, Piscataway, NJ) and quantified by densitometry.
Statistical analyses. All values expressed are means , SE. An
unpaired t-test was used to compare groups for all analyses except the
intraperitoneal glucose tolerance test and the stepped titration of ADP,
where a two-way analysis of variance was used. All statistical anal-
yses were performed using Graph Pad Prism software. Significance is
reported where P # 0.05.
RESULTS
WDs are obesogenic. Rats fed the WD maintained a greater
energy intake than CON throughout the study (335 , 6 and 274 ,
4 kj/day, respectively, P # 0.0001; Table 1). From 6 wk, WD
rats were heavier than CON (379.1 , 7.1 and 356.6 , 3.9 g,
respectively, P ! 0.01) and remained heavier throughout the
intervention (Fig. 1A). As illustrated in Fig. 1B, epididymal fat
pads were heavier in WD compared with CON (8.1 , 0.4 and
6.9 , 0.3 g, respectively, P ! 0.03). IMTGs were elevated 37%
in WD compared with CON in the soleus (42.8, 5.1 and 31.2,
4.3 (mol/g dry wt, respectively), although values did not attain
statistical significance (P ! 0.10; Table 2). In the EDL, IMTGs
were not different between groups (P . 0.05).
Fig. 1. The Western diet promotes increased body mass (A) and epididymal fat
pad mass (B) compared with the control diet over 12 wk. Values represent
means , SE; n ! 12 animals/group. *P # 0.05.
Table 2. Physiological parameters in blood and skeletal
muscle of fasted animals
Control WD
Fasting blood glucose, mM 5.70 , 0.24 5.10 , 0.18
Fasting serum insulin, ng/ml 1.70 , 0.12 2.39 , 0.20*
Fasting serum cholesterol, mM 2.99 , 0.17 3.53 , 0.19
Fasting serum triglycerides, mM 1.66 , 0.13 3.09 , 0.36*
Fasting serum free fatty acids, mM 0.61 , 0.02 0.73 , 0.07
Intramyocellular triglycerides, (M/g dry wt
Soleus 31.17 , 4.27 42.78 , 5.14
EDL 5.93 , 1.16 5.97 , 1.26
Values represent means , SE, as determined after 12 wk; n ! 8–12
animals/group. EDL, extensor digitorum longus. *P # 0.05.
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WD caused hyperinsulinaemia but did not alter fasting
blood glucose concentrations or the response to a glucose
challenge. No differences were observed in fasting blood
glucose concentrations. However, fasting serum insulin was
greater in WD compared with CON (P ! 0.007; Table 2).
During the intraperitoneal glucose tolerance test there was no
diet effect or interaction, although there was a main effect for
time in response to the glucose challenge (P # 0.0001). The
areas under the blood glucose curves for WD and CON were
not different (results not shown).
WD increased fasting serum triglycerides. Serum triglycer-
ides were greater in WD compared with CON (P ! 0.001;
Table 2). Total cholesterol and serum FFAs were also greater
in WD; however, neither of these values attained statistical
significance (18%, P ! 0.052, and 20%, P ! 0.12, respec-
tively; Table 2).
In oxidative muscle the capacity of the ETS was greater
following consumption of a WD. To evaluate the capacity of the
ETS and thus determine maximal O2 flux through the mito-
chondria, we measured O2 flux in the soleus during a SUIT
protocol with substrates for CI and CII (Fig. 2A). State II
respiration with electron leak through CI was greater in WD
compared with CON (WD 9.9 , 0.6 pmol·s*1·mg wet wt*1
and CON 5.8 , 0.6 pmol·s*1·mg wet wt*1, P # 0.001). A
similar trend was observed for state III respiration with flux
through CI, although this difference did not attain statistical
significance (WD 89.7 , 8.9 pmol·s*1·mg wet wt*1 and CON
70.6 , 6.8 pmol·s*1·mg wet wt*1, P ! 0.11). However,
greater sensitivity to ADP was observed (P # 0.05; Fig. 2B).
State III respiration with flux through both CI and CII together
(WD 137.2 , 11.8 pmol·s*1·mg wet wt*1 and CON 101.7 ,
9.8 pmol·s*1·mg wet wt*1) and noncoupled respiration with
flux through CII (WD 73.9 , 5.3 pmol·s*1·mg wet wt*1 and
CON 56.5 , 4.5 pmol·s*1·mg wet wt*1) were greater in WD
(P ! 0.04 and P ! 0.03, respectively). Similarly, uncoupled/
maximal flux through the ETS was greater in WD compared
with CON (152.0 , 11.3 pmol·s*1·mg wet wt*1 and 110.8 ,
9.8 pmol·s*1·mg wet wt*1, respectively, P ! 0.02).
To assess O2 flux independently of mitochondrial density,
we calculated the flux control ratios for each substrate combi-
nation (Table 3). There were no differences between dietary
groups.
Consumption of a WD increases maximal activity of mito-
chondrial enzymes. Both CS (WD 23.5, 1.5 (M·min*1·g wet
wt*1 and CON 19.4 , 1.0 (M·min*1·g wet wt*1, P ! 0.03;
Fig. 3A) and total CPT activity (WD 0.8 , 0.1 (M·min*1·g
wet wt*1 and CON 0.4 , 0.1 (M·min*1·g wet wt*1, P !
0.01; Fig. 3C) were higher in the soleus after WD compared
with CON. There were no differences between dietary groups
for "-HAD activity in the soleus (WD 4.9 , 0.2 (M·min*1·g
wet wt*1 and CON 4.1 , 0.3 (M·min*1·g wet wt*1, P !
0.11; Fig. 3B). In the EDL, CS (WD 10.1, 0.5 (M·min*1·g*1
and CON 8.3 , 0.5 (M·min*1·g*1, P ! 0.01; Fig. 3A),
"-HAD (WD 2.6 , 0.1 (M·min*1·g*1and CON 2.2 , 0.2
(M·min*1·g*1, P! 0.04; Fig. 3B), and CPT (WD 0.13, 0.01
(M·min*1·g*1 and CON 0.09 , 0.01 (M·min*1·g*1, P !
0.02; Fig. 3C) activities were all greater following the WD.
Enhanced respiratory capacity was not associated with
changes in PPAR" or PGC-1 expression in the soleus. No
differences were observed in the gene expression of PPAR% or
PGC-1$ in either soleus or EDL muscles (Fig. 4). There were
also no differences in the protein expression of PGC-1,
PPAR%, or CPT I between dietary treatments for the soleus.
Small but significant increases were observed in the protein
expression of UCP3 in both soleus (3%, P ! 0.04; Fig. 5) and
EDL muscle (6%, P ! 0.002, Fig. 6). In the EDL, PGC-1
Fig. 2. A: under all substrate uncoupler inhibitor titration conditions except
complex (C)I oxidative phosphorylation (OXPHOS), mass-specific O2 con-
sumption is greater in the soleus from rats receiving the Western diet. B: soleus
muscle from rats receiving the WD displays greater sensitivity to a titration of
ADP compared with control rats. Values represent means , SE; n ! 6
animals/group. *P # 0.05; ***P # 0.05, 2-way ANOVA. ETS, electron
transport system; u, uncoupled.
Table 3. Flux control ratios
Control WD
Complex I, leak 0.06 , 0.01 0.07 , 0.01
Complex I, OXPHOS (state III) 0.62 , 0.02 0.62 , 0.04
Complex I and II, OXPHOS (state III) 0.92 , 0.02 0.94 , 0.02
Complex II, uncoupled 0.53 , 0.03 0.53 , 0.04
Values represent means , SE; n ! 6 animals/group. OXPHOS, oxidative
phosphorylation. Flux control ratios are the respirometry data normalized to
maximal O2 consumption in uncoupled states (electron transport system).
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protein expression was 4% greater following the WD (P !
0.005; Fig. 6), and there was a trend toward increased expres-
sion of PPAR%; however, this did not attain statistical signif-
icance (P ! 0.07; Fig. 6).
A WD induces muscle-specific changes to mitochondrial
protein expression. In the soleus, protein expression of CS was
increased in WD (27%, P! 0.03; Fig. 5); however, expression
of individual electron transfer system complexes was similar
between WD and CON for all complexes except for CI, which
was greater in WD than in CON (11%, P# 0.05; Fig. 5). There
was also a strong trend toward increased mtDNA copy number
following the WD (70%, P ! 0.07; Fig. 4A), although this did
not attain statistical significance. In the EDL (Fig. 6), CS
protein expression was greater in WD for CS (45%, P ! 0.02),
CI (14%, P ! 0.04), CII (16%, P ! 0.009), CIII (18%, P !
0.04), and CV (13%, P ! 0.02), whereas there was a trend
toward increased CIVIV expression (10%, P! 0.08). Similarly
to the soleus, there was a trend toward increased mtDNA copy
number with the WD (42%, P ! 0.08; Fig. 4B), although this
did not attain statistical significance.
DISCUSSION
The mitochondrion has long been implicated in the patho-
genesis of obesity and metabolic dysfunction (30, 34). How-
ever, the extent of mitochondrial involvement and whether
these changes are secondary to lifestyle factors (i.e., physical
inactivity) are a matter of current debate. Previously, it has
been shown that a mitochondrial deficiency exists in obese
humans (30) and rodents (11, 48). However, the results of
recent studies suggest that there is dissociation between mito-
chondrial dysfunction and the progression of obesity (4, 19, 21,
51). Indeed, accumulating evidence indicates that HFDs induce
increases in the expression (13, 19, 21, 51) and activity (1, 51)
Fig. 4. Relative mRNA expression was not different between Western diet and
controls for peroxisome proliferator-activated receptor-% (PPAR%) or PPAR&
coactivator-1$ (PGC-1$) in either soleus (A) or EDL (B). mitochondrial DNA
(mtDNA) copy no. in both soleus and EDL. Values represent means , SE;
n ! 7 animals/group.
Fig. 3. In the soleus, rats receiving the Western diet had greater citrate synthase
(A) and carnitine palmitoyltransferase (CPT; C) activity, whereas in the
extensor digitorum longus (EDL), rats receiving the Western diet had greater
citrate synthase, "-hydroxyacyl-CoA dehydrogenase ("-HAD; B), and CPT
activities compared with control rats. Values represent means , SE; n ! 10
animals/group. *P # 0.05.
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of key mitochondrial enzymes and that this process is likely to
be driven by an increase in circulating FFAs (21). Our data
support this hypothesis and demonstrate for the first time that
skeletal muscle respiratory capacity is enhanced after 12 wk on
an obesogenic (high-fat, high-sucrose) WD.
We employed a method of high-resolution respirometry that
allows the direct monitoring of O2 consumption by the ETS in
permeabilized muscle fibers (38) and reflects the integrated
activity of the tricarboxylic acid cycle and electron transfer
system, providing a dynamic measurement of the oxidative
capacity of tissue ex vivo (38). We show that 12 wk of a WD
induces an increase in the activity of the ETS in skeletal muscle
with a high oxidative capacity. When the data was normalized
to allow interpretation of function independent of mitochon-
drial volume, this increase was attenuated, suggesting that
mitochondrial biogenesis, rather than increased activity, is
likely to be responsible for the increase in respiratory capacity.
This finding is supported by the increased expression and
activity of the mitochondrial enzyme CS, an enzyme long used
as a marker enzyme for mitochondrial content. Additional
mitochondrial enzyme activity and protein measurements in
the EDL muscle (composed mainly of primarily glycolytic
fibers) further support this notion.
Previously, it has been shown in WD- (56) and HFD-fed
rodents (19, 21, 51) that skeletal muscle has an increased
capacity for fat oxidation after as little as 4 wk. In the current
study, we observed increased activity of total CPT (CPT I and
CPT II), which was indicative of an increase in the delivery of
long-chain fatty acids into the mitochondria. Although we did
not measure fat oxidation directly, HFD-induced increases in
the activity of CPT I have previously been associated with
greater rates of fat oxidation (10, 51). Interestingly, in the
soleus we did not observe any differences in the activity of
"-HAD, the third enzyme of the "-oxidation pathway, imply-
Fig. 5. A: representative Western blots for tran-
scriptional coactivators PPAR%, PPAR$, and
PGC-1, their targets CPT I and uncoupling
protein 3 (UCP3), and mitochondrial proteins
in the soleus muscle. B: relative protein expres-
sion as determined by densitometry. Values
represent means , SE; n ! 8–10 animals/
group. *P # 0.05. CS, citrate synthase.
Fig. 6. A: representative Western blots for tran-
scriptional coactivators PPAR%, PPAR$, and
PGC-1, their targets CPT I and UCP3, and
mitochondrial proteins in the EDL muscle.
B: relative protein expression as determined
by densitometry. Values represent means ,
SE; n ! 8 –10 animals/group. *P # 0.05.
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ing that the rate of fatty acid delivery to the mitochondria may
be discordant with the capacity for "-oxidation in muscle with
high oxidative capacity. However, it is important to note that
these data are of maximal enzyme activity ex vivo and are not
indicative of in vivo demand.
Although we can only speculate whether or not this mis-
match is likely to contribute to cellular lipid deposition
(IMTGs were elevated 37% in the soleus but remained similar
in the EDL, where "-HAD activity was elevated), the notion
that the "-oxidation and tricarboxylic acid cycle activities are
disproportionate and contribute to lipid deposition in diet-
induced obesity is not a new concept. Previously, Hoehn et al.
(24) demonstrated that simply driving metabolism toward
increased fat oxidation is not sufficient to increase energy
expenditure, whereas Koves et al. (31) suggested that incom-
plete fatty acid oxidation and accumulation of lipid species
occur when the import of fatty acid into the mitochondria
exceeds metabolic demand. Moreover, human studies have
shown that, despite increases in IMTG storage, rates of fatty
acid oxidation may be impaired only in cases of extreme
obesity, where mobility is reduced severely (4, 27). This
implies that impaired fatty acid oxidation per se is unlikely to
be responsible for the accumulation of lipid species during
obesity but rather the reduction in physical activity. Our
findings suggest that chronic feeding of a WD increases the
cellular machinery necessary to cope with increases in energy
expenditure, and yet without the appropriate energy demand
substrates will accumulate in the tissue, eventually being
stored. Pharmacological agonism of PPAR% has been shown
previously to increase the expression of several oxidative
proteins, including UCP3 and CPT I (36). However, unless
combined with an endurance training program, no functional
improvements are seen, implying that there must be an appro-
priate stimulus for any functional enhancements to manifest.
We propose that the increases in mitochondrial respiratory
capacity observed in the current investigation are a compensa-
tory response in anticipation of a potential increase in substrate
flux to the mitochondria.
A second aim of this investigation was to characterize poten-
tial mechanisms responsible for the increase in mitochondrial
function. The PPARs are a family of ligand-activated nuclear
transcription factors that sense and respond to dietary lipids
and their metabolites (16). Of the three isoforms, PPAR$ and
PPAR% are the two expressed preferentially in skeletal muscle,
with PPAR% being the predominant isoform in this tissue (8).
Both PPAR$ and PPAR% play key roles in fatty acid metab-
olism (18), acting with the transcriptional coactivator and
“master regulator” of mitochondrial biogenesis, PGC-1$ (40,
50), to induce increases in both nuclear and mitochondrial
target genes for fatty acid catabolism (50, 56). Previous studies
have identified PPAR% and PGC-1$ as important mediators of
diet-induced increases in mitochondrial function (29). Further-
more, PPAR% is known to interact directly with CPT I (50),
whereas HFDs or pharmaceutical PPAR% agonists increase
UCP3 mRNA (50, 56) and protein expression (22, 51). Unlike
previous studies that have investigated the effect of a HFD on
mitochondrial signaling, we did not find a large increase in
circulating FFAs following the WD. However, total serum
triglycerides were almost twofold greater. Moreover, we were
unable to demonstrate marked differences in the gene and/or
protein expression of PPAR% or PGC-1$, the two signaling
proteins that are thought to be responsible for HFD-induced
alterations to mitochondrial function (51). Despite this, we
cannot discount the possibility that posttranslational regulation
of protein activity may be a potential mechanism by which
mitochondrial function is enhanced. Indeed, it is well known
that the acetylation status of PGC-1$ is important in regulating
its activity (14), whereas PPAR% itself may posttranslationally
modify PGC-1$ (15).
Of note was that the expression of PPAR%’s downstream
target protein CPT I remained unchanged despite an increase in
total CPT activity. Previous studies have reported increases in
UCP3 mRNA following a WD (56), and in line with this we
show increases in UCP3 protein expression. Taken together,
increased CPT activity and UCP3 protein expression could be
indicative of an increase in PPAR% activity (17) despite no
increase in PPAR% gene or protein expression. Although UCP3
remains without an established function (2, 35), increases in
UCP3 expression due to PPAR stimulation implicate this
protein in an array of metabolic processes that involve sub-
strate handling. Further investigations will need to be under-
taken over prolonged intervention periods to determine
whether PPAR% activity is indeed altered by a WD. However,
it is also plausible that the reduced percentage of fat in a WD
may have less agonist potential than that of a HFD, and as
such, other mechanisms may be responsible for the observed
increase in CPT activity and UCP3 expression.
In conclusion, the results of the present investigation dem-
onstrate that an increase in mitochondrial respiratory capacity
occurs in response to WD-induced obesity. This is likely a
compensatory mechanism to cope with excess energy avail-
ability in the absence of a simultaneous increase in energy
demand. Such a scenario would be expected to contribute to
intracellular lipid deposition and overall adiposity when sus-
tained for prolonged periods. Further investigations are re-
quired to identify the precise mechanisms that lead to this
adaptation.
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Divergent skeletal muscle respiratory capacities in rats artificially
selected for high and low running ability: a role for Nor1? J Appl
Physiol 113: 1403–1412, 2012. First published August 30, 2012;
doi:10.1152/japplphysiol.00788.2012.—Inactivity-related diseases are
becoming a huge burden on Western society. While there is a major
environmental contribution to metabolic health, the intrinsic proper-
ties that predispose or protect against particular health traits are harder
to define. We used rat models of inborn high running capacity (HCR)
and low running capacity (LCR) to determine inherent differences in
mitochondrial volume and function, hypothesizing that HCR rats
would have greater skeletal muscle respiratory capacity due to an
increase in mitochondrial number. Additionally, we sought to deter-
mine if there was a link between the expression of the orphan nuclear
receptor neuron-derived orphan receptor (Nor)1, a regulator of oxi-
dative metabolism, and inherent skeletal muscle respiratory capacity.
LCR rats were 28% heavier (P ! 0.0001), and fasting serum insulin
concentrations were 62% greater than in HCR rats (P " 0.02). In
contrast, HCR rats had better glucose tolerance and reduced adiposity.
In the primarily oxidative soleus muscle, maximal respiratory capacity
was 21% greater in HCR rats (P " 0.001), for which the relative
contribution of fat oxidation was 20% higher than in LCR rats (P "
0.02). This was associated with increased citrate synthase (CS; 33%,
P " 0.009) and #-hydroxyacyl-CoA (#-HAD; 33%, P " 0.0003)
activities. In the primarily glycolytic extensor digitum longus muscle,
CS activity was 29% greater (P" 0.01) and #-HAD activity was 41%
(P " 0.0004) greater in HCR rats compared with LCR rats. Mito-
chondrial DNA copy numbers were also elevated in the extensor
digitum longus muscles of HCR rats (35%, P " 0.049) and in soleus
muscles (44%, P " 0.16). Additionally, HCR rats had increased
protein expression of individual mitochondrial respiratory complexes,
CS, and uncoupling protein 3 in both muscle types (all P ! 0.05). In
both muscles, Nor1 protein was greater in HCR rats compared with
LCR rats (P ! 0.05). We propose that the differential expression of
Nor1 may contribute to the differences in metabolic regulation be-
tween LCR and HCR phenotypes.
intrinsic running capacity; mitochondria; skeletal muscle; metabo-
lism; neuron-derived orphan receptor 1
THE ABILITY to deliver and utilize O2 is an essential component
of metabolic regulation, with an individual’s maximal aerobic
power [maximal O2 consumption (V˙ O2 max)] a good correlate
of whole body health status (13). Aerobic power is determined
by the interaction of intrinsic (i.e., genetic) and environmental
(i.e., lifestyle) factors, with the heritability of endurance ca-
pacity estimated to be 40% or higher (10). However, V˙ O2 max
and its phenotypic expression (i.e., endurance running ability)
can be rapidly modified by embarking on a vigorous exercise
training program or, conversely, by adopting an inactive life-
style. While such phenotypic plasticity can be harnessed to
study the time course of progression (or reversal) of a number
of metabolic disease traits, the contribution of potential intrin-
sic mechanisms to such diseases becomes difficult to define
because of the confounding impact of numerous environmental
influences (13).
Through two-way artificial selection, we have generated an
animal model of low or high aerobic exercise capacity [low
(LCR) or high running capacity (HCR), respectively] from a
population of genetically heterogeneous rats. Divergent artifi-
cial selection for a complex trait (e.g., superior aerobic pheno-
type) produces a useful genetic model to study gene-exercise
interactions because contrasting allelic variation is concen-
trated at the extremes from one generation to the next. In this
model, 11 generations of two-way selection produced rats that
differ substantially in aerobic exercise capacity (374% differ-
ence between LCR and HCR rats, P ! 0.0001) while simul-
taneously presenting with markedly different metabolic and
cardiovascular disease risk factors (48).
Because skeletal muscle mitochondrial respiration is a lim-
iting factor for V˙ O2 max, and because skeletal muscle oxidative
capacity correlates with whole body insulin sensitivity (4), it
has been proposed that differences in mitochondrial function in
LCR-HCR animals are the major determinants of their diver-
gent running capacities and metabolic phenotypes. In support
of this contention, HCR rats are better at using O2, an adaptive
variation likely to be present at the level of the skeletal muscle
(10). Results from a series of studies from our laboratory (16,
17, 35) and others (24, 25, 41, 45, 48) have provided direct
evidence that skeletal muscle from HCR rats has superior
substrate handling ability (i.e., “metabolic flexibility”) and
mitochondrial enzyme activities compared with LCR rats.
However, there is some contention as to whether this is due to
increases in the mitochondrial reticulum (35) or an enhanced
capacity of some or all of the oxidative enzymes (24, 41, 45).
Additionally, we have shown that the differences in metabolic
flexibility are linked to #-adrenergic signaling through the
nuclear receptor (NR)4A orphan NR neuron-derived clone
(Nur)77 (16, 17). The NR4A family of orphan NRs [Nur77,
Nurr1, and neuron-derived orphan receptor (Nor)1] has re-
cently emerged as a key player in the regulation of a number of
important metabolic processes (4, 16, 31, 33). All three have
been linked to the regulation of skeletal muscle substrate
Address for reprint requests and other correspondence: J. Hawley, Health
Innovations Research Institute, School of Medical Sciences, RMIT Univ., PO Box
71, Bundoora, Victoria 3083, Australia (e-mail: john.hawley@rmit.edu.au).
J Appl Physiol 113: 1403–1412, 2012.
First published August 30, 2012; doi:10.1152/japplphysiol.00788.2012.
8750-7587/12 Copyright © 2012 the American Physiological Societyhttp://www.jappl.org 1403
 at R
M
IT Library - B
undoora on M
arch 19, 2013
http://jap.physiology.org/
D
ow
nloaded from
 
handling and whole body glucose homeostasis (4, 16, 31, 33),
and Nor1 has been shown to be essential for oxidative metab-
olism (32) and may also be important in promoting several
oxidative adaptations in the muscle (21).
Since previous studies have been inconclusive as to whether
skeletal muscle respiratory capacity is due to an increased
number of mitochondria (35) or increased mitochondrial ac-
tivity (24, 41), we aimed to determine the ex vivo activity and
protein expression of the key electron transfer system (ETS)
respiratory complexes in muscle from LCR and HCR rats. We
hypothesized that skeletal muscle respiratory capacity would
be greater in HCR rats compared with LCR rats and that this
difference would be due to a greater mitochondrial density in
the muscle. Furthermore, we hypothesized that the expression
of Nor1 would be greater in the muscle of HCR rats compared
with LCR rats.
METHODS
Experimental animals. Rat models for LCR and HCR were derived
from genetically heterogeneous N:NIH stock rats by artificial selec-
tion for treadmill running capacity, as previously described (12).
Female offspring of either LCR rats (N " 12, generation 27) or HCR
rats (N " 12, generation 27) were housed under a controlled 12:12-h
light-dark cycle at a constant temperature of 22°C. Animals were
provided ad libitum access to water and a standard chow diet.
Breeding and phenotyping of parent rats was conducted at the Uni-
versity of Michigan (Ann Arbor, MI). Rats arrived at RMIT Univer-
sity at $8 wk of age and were allowed to acclimate to the RMIT
Animal Facility for 2 wk before the commencement of any experi-
mental procedures. This study was undertaken with approval from
both the University of Michigan and RMIT University Animal Ethics
Committees.
Fasting blood and insulin measurements. After a 5-h fast, $15-%l
aliquot of blood was collected via a tail cut, and the glucose concen-
tration was measured on a hand-held glucometer (Roche Diagnostics,
Castle Hill, NSW, Australia). A separate aliquot of blood ($15–20
%l) was allowed to clot over ice and centrifuged to obtain serum.
Serum was kept frozen at &20°C for later analysis of fasting serum
insulin concentrations using a commercially available ELISA (no.
80-INSRT-E01, ALPCO Immunoassays,).
Intraperitoneal glucose tolerance testing. After the fasting blood
collection, rats received a single glucose bolus (2 g/kg body wt) via
intraperitoneal injection, and blood glucose concentrations were mon-
itored at 30-min intervals throughout the subsequent 120 min. Addi-
tional aliquots of blood were collected at 30, 60, and 120 min
postinjection for the later determination of serum insulin concentra-
tions in response to the glucose challenge.
Physical activity monitoring. Before being monitored, rats were
familiarized with activity monitoring chambers comprising infrared
beams in the x-, y-, and z-axes (MED Associates, St. Albans, VT)
during three 10-min sessions in the week before testing. Spontaneous
activity was monitored during both diurnal (1200 hours) and nocturnal
(0200 hours) sessions. Horizontal, vertical, and ambulatory locomotor
activities were determined in 20-s intervals over 2' 10-min sessions.
Tissue collection and analyses. Tissue collection procedures were
conducted after a 5-h fast in 11-wk-old rats, which were weighed and
anesthetized with pentobarbital sodium (60 mg/kg body wt), and
hindlimb muscles were immediately excised. To limit any possible
differences that might occur as a result of differing cage activity, the
soleus and extensor digitorum longus (EDL) muscles were chosen for
study. The soleus ($87% type I fibers and $12% type IIA fibers) is
predominantly a postural muscle and therefore has a high daily
activity level, whereas many of the fibers in the EDL muscle ($2%
type I fibers, $42% type IIA fibers, and $56% type IIB fibers) are
recruited only during rapid, high-intensity tasks (1). Similar experi-
ments were performed on soleus and EDL portions from the same leg.
The left soleus muscle was placed in ice-cold muscle preservation
media [BIOPS; 50 mM K(-MES, 20 mM taurine, 0.5 mM DTT, 6.56
mM MgCl2, 5.77 mM ATP, 15 mM phosphocreatine, and 20 mM
imidazole (pH 7.1 adjusted with 5 N KOH at 0°C); Ca2(-EGTA
buffer (10 mM; 2.77 mM CaK2EGTA ( 7.23 mM K2EGTA, 0.1 %M
free calcium)] for respirometry experiments (34, 36, 42), whereas the
contralateral soleus muscle was carefully dissected into longitudinal
strips from tendon to tendon (15–20 mg/strip) and placed in pregassed
Krebs-Henseleit buffer (KHB) for measurements of basal and insulin-
stimulated glucose uptake. The remaining hindlimb muscles were
freeze clamped in liquid N2 and stored at &80°C for later analyses.
Periovarian fat pads were removed and weighed as indicators of
adiposity.
Glucose uptake. All reagents used were obtained from Sigma-
Aldrich (Castle Hill, NSW, Australia) unless otherwise specified.
Soleus muscle strips from the right leg were allowed to recover for
30 min in preoxygenated KHB [118.5 mM NaCl, 25 mM NaHCO3,
4.74 mM KCl, 1.19 mM MgSO4·7H2O, 1.18 mM KH2PO4, and 2.5
mM CaCl2 (pH 7.4)] containing 32 mM mannitol, 2 mM pyruvate, 8
mM glucose, and 0.1% fatty-acid free BSA. Vials were maintained at
30°C in a shaking water bath throughout the experiment. Basal and
insulin-stimulated glucose uptake were determined according to the
method of Young et al. (49) with modifications (8, 17, 44). After the
recovery incubation, muscle strips were incubated for an additional 30
min in continuously gassed modified KHB with or without insulin (60
nM, Humulin, Eli Lilly, Indianapolis, IN). Muscle strips were next
washed for 10 min in KHB modified with 40 mM mannitol, 2 mM
pyruvate, 0.1% fatty-acid free BSA, and 60 nM insulin, if it was
present in the previous incubation. After glucose washout, strips were
transferred to vials containing oxygenated KHB containing 0.1%
fatty-acid free BSA, 2 mM pyruvate, 1 mM 2-[1,2-3H]deoxyglucose
(1 mCi/ml, Perkin-Elmer), 39 mM D-[1-14C]-mannitol (0.1 %Ci/ml,
Perkin-Elmer), and 60 nM insulin, if it was present in the previous
incubations. After 20 min, the reaction was stopped by washing the
muscle strips in KHB twice, blotting the tissue on filter paper, and
then freeze clamping it with tongs precooled in liquid N2. Muscle
strips were weighed, digested in 10% tricarboxylic acid (TCA), and
transferred to vials containing 5 ml scintillation fluid (Ultima Gold
XR, Perkin-Elmer). Duplicate aliquots were counted in a liquid
scintillation counter (Packard Tri-Carb, Perkin-Elmer) set for simul-
taneous 3H and 14C counting. Rates of basal and insulin-stimulated
skeletal muscle 2-[1,2-3H]deoxyglucose transport were calculated as
previously described (15).
High-resolution respirometry. Approximately 10 mg of the soleus
(n " 10 soleus muscles/group) were mechanically separated over ice
using fine forceps (34) and then chemically permeablized with sapo-
nin (50 %g/ml in BIOPS) for 30 min. This was followed by a 10-min
wash period in mitochondrial respiratory media [MIR05; 110 mM
sucrose, 60 mM K-lactobionate (ACROS Organics), 0.5 mM EGTA,
3 mM MgCl2, 20 mM taurine, 10 mM KH2PO4, 20 mM HEPES
(adjusted to pH 7.1 with KOH at 37°C), and 1 g/l fatty acid-free BSA]
(36). Duplicate tissue samples (2–3.5 mg) were transferred to the
chambers of an O2K-Oxygraph high-resolution respirometer (Oro-
boros, Innsbruck, Austria) containing 2 ml MIR06 (MIR05 plus 280
IU/ml catalase) and calibrated to air saturation. Individual chambers
were oxygenated to $485 nmol/ml with pure O2 (BOC Australia).
Chambers were maintained at a temperature of 37°C, and O2 satura-
tion was kept between 450 and 300 nmol/ml with regular titrations of
H2O2. The remaining, nonpermeabilized muscle was frozen for later
analyses.
Substrate-uncoupler-inhibitor titration protocol. Malate (2 mM)
was added, and the mass-specific O2 flux (in pmol·s&1·mg wet wt&1)
was stabilized for 5–10 min. Subsequently, tissue samples were
subjected to a substrate-uncoupler-inhibition titration (SUIT) proto-
col, which sequentially evaluates an electron-transferring flavoprotein
(ETF; fat oxidation) in leak state through the addition of octanoylcar-
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nitine (0.2 mM, TOCRIS Bioscience; state 2 respiration), oxidative
phosphorylation (OXPHOS) with electron flux through the ETF by
titration of ADP (1 and 2.5 mM; state 3 respiration), OXPHOS with
electron flux through the ETF and complex I (CI) with the addition of
glutamate (10 mM), OXPHOS with electron flux through the ETF, CI,
and complex II (CII) with the addition of succinate (10 mM), maximal
coupled OXPHOS with electron flux through the ETF, CI, and CII
with the addition of ADP (5 mM), the integrity of the outer mito-
chondrial membrane with the addition of cytochrome c (10 %M), the
maximal capacity of the ETS by uncoupling with a stepped titration of
FCCP (0.5 and 1 %M), uncoupled respiration with electron flux
through the ETF and CII with the addition of the CI inhibitor rotenone
(0.5 %M), and residual O2 consumption with the addition of antimycin
A (2.5 %M). Additionally, complex IV (CIV) activity was determined
after the addition of the artificial electron donor N,N,N,N,N=,N=-
tetramethyl-p-phenylenediamine dihydrochloride (0.5 mM) in the
presence of ascorbate (2 mM). The reaction was terminated by the
addition of NaN3 (50 mM), after which the chambers were reoxygen-
ated for the determination of auto-oxidation. Mass-specific O2 flux
was determined using DATLAB (Oroboros) from steady-state O2 flux
normalized to tissue wet weight and adjusted for instrumental back-
ground, residual O2 consumption, and auto-oxidation. In addition, flux
control ratios (results normalized to the maximal capacity of the ETS)
were calculated to determine mitochondrial function independent of
mitochondrial density.
Mitochondrial enzyme activities. Muscle homogenates (n " 10
homogenates/group) were prepared over ice from freeze-clamped
soleus and EDL muscles (10–20 mg) in buffer [175 mM KCl and 2
mM EDTA (pH 7.4), 1:50 or 1:100 dilution]. Homogenates were then
subjected to three freeze-thaw cycles. Citrate synthase (CS) and
#-hydroxyacyl-CoA dehydrogenase (#-HAD) activities were deter-
mined according to the methods of Srere (CS) (37) and Bergmeyer
(#-HAD) (2) with modifications as previously described (38).
Nucleic acid extraction and quantification. DNA and RNA were
each extracted from$10–30 mg of frozen soleus and EDL. RNA was
extracted using TRIzol reagent (Invitrogen, Mulgrave, Australia), and
DNA was extracted using a commercially available kit (Qiagen,
Doncaster, Australia). A NanoDrop 1000 spectrophotometer (Nano-
drop Technologies) was used to determine the quality and quantity of
both extracts. For each nucleic acid, an aliquot was taken from each
sample (n " 7 samples/group) and pooled. The pooled RNA or DNA
sample was then quantified and serially diluted to produce standard
curves for inclusion in each PCR run.
Reverse transcription and real-time PCR. First-strand cDNA syn-
thesis was performed for RNA extracts using Superscript VILO
(Invitrogen). Relative mRNA expression was determined using com-
mercially available Taqman primer/probe sets (Applied Biosystems,
Mulgrave, Australia) for peroxisome proliferator-activated receptor-)
coactivator (PGC)-1* (cat. no. Rn00580241_m1) and fibronectin type
III domain-containing 5 (FNDC5; cat. no. Rn01519161_m1).
GAPDH (cat. no. Rn01775763_g1) was included as a housekeeping
gene to normalize threshold cycle (CT) values. Quantification was
performed in duplicate using a 72-well Rotor-Gene 3000 Centrifugal
Real-Time Cycler (Corbett Research, Mortlake, Australia). PCR con-
ditions were as follows: 2 min at 50°C and 10 min at 95°C followed
by 40 cycles of 95°C for 15 s and 65°C for 60 s. Calculations were
made using the ++CT method (20).
Mitochondrial DNA copy number determination. Mitochondrial
(mt)DNA copy numbers were determined in DNA extracts as previ-
ously described (38) using Taqman primer/probe sets for mitochon-
drial-encoded NADH dehydrogenase-1 (cat. no. Rn03296764_s1) and
nuclear-encoded GAPDH. DNA samples were subjected to the same
PCR conditions as described above. mtDNA copy numbers were
calculated as described by Venegas and Halberg (43).
Immunoblot analysis. Approximately 50 mg of frozen soleus or
EDL was homogenized in buffer [50 mM Tris·HCl (pH 7.5), 1 mM
EDTA, 1 mM EGTA, 1 mM DTT, 50 mM NaF, 5 mM Na pyrophos-
phate, 10% glycerol, 1% Triton X-100, 10 %g/ml trypsin inhibitor, 2
%g/ml aprotinin, 1 mM benzamidine, and 1 mM PMSF; 1:8 dilution]
and centrifuged at 20,000 g for 30 min at 4°C. The protein concen-
tration of the supernatant was determined using the bicinchoninic acid
method (Pierce). Muscle lysates containing 10 %g protein were
prepared in 4' Laemmli buffer, subjected to SDS-PAGE, and then
transferred to polyvinylidene difluoride membranes. Membranes were
blocked (5% nonfat dry milk) for 1 h at room temperature and then
incubated overnight at 4°C with primary antibodies specific for the
following proteins: PGC-1 ($100 kDa, no. ab3242, Chemicon),
FNDC5 ($28 kDa, no. ab93373, Abcam,), Nur77 ($48 kDa, no.
sc5569, Santa Cruz Biotechnology), Nor1 ($68 kDa, no. 92777,
Abcam), glucose transporter 4 ($47 kDa, no. ab654, Abcam), fatty
acid translocase/CD36 ($80 kDa, no. 17044, Abcam), CI ($18 kDa),
CII ($25 kDa), complex III (CIII; $45 kDa), CIV subunit I ($37
kDa), and complex V (CV; $52 kDa) of the ETS (no. MA604,
MitoSciences), CIV subunit II ($25 kDa, no. MS405, MitoSciences),
CIV subunit IV ($15 kDa, no. MS407, MitoSciences), CS ($52 kDa,
no. ab96600, Abcam), and uncoupling protein 3 (UCP3;$35 kDa, no.
PA1-055, Affinity BioReagents). *-Tubulin ($50 kDa, Sigma) was
used as a protein loading control. Protein expression was detected
using enhanced chemiluminescence (Amersham Biosciences, Piscat-
away, NJ) and quantified by densitometry.
Statistical analyses. All values are expressed as means , SEM.
Two-way ANOVA was used to analyze data from the intraperitoneal
glucose tolerance test (IP-GTT). Physical activity and glucose uptake
data were analyzed using one-way ANOVA with a Student-Newman-
Keuls post hoc test. An unpaired t-test was used to compare groups for
all other analyses unless otherwise specified. Statistical analyses were
performed using Graph Pad Prism software. Significance is reported
where P ! 0.05.
RESULTS
HCR and LCR rats have divergent metabolic health parameters.
The metabolic health characteristics of each rat phenotype are
shown in Table 1. Although there were no differences in the
ages of the animals, LCR rats were 28% heavier than HCR rats
(P ! 0.0001) and had 48% more periovarian fat (P " 0.02).
There were no differences in interscapular brown adipose
masses. Fasting blood glucose concentrations were not differ-
ent, but fasting serum insulin concentrations were 62% higher
in LCR rats compared with HCR rats (P " 0.02). HCR rats
were more glucose tolerant than LCR rats, as determined by the
area under the glucose curve during the IP-GTT (LCR rats:
1,267 , 47.4 and HCR rats: 1,100 , 27.8, P " 0.01; Fig. 1, A
and B). Similarly, the insulin response to the IP-GTT was
135% greater in LCR rats compared with HCR rats, as deter-
mined by the area under the insulin curve during the IP-GTT
(LCR rats: 196.2 , 15.8 and HCR rats: 83.6 , 11.3, P "
0.001; Fig. 1, C and D).
Table 1. Body composition and metabolic parameters
LCR Rats HCR Rats
Age, days 80.9 , 0.6 81.0 , 0.6
Body weight, g 214.1 , 3.7 167.7 , 4.2*
Periovarian fat pad mass, g 1.2 , 0.1 0.8 , 0.1*
Interscapular brown adipose mass, mg 183.0 , 13.7 185.1 , 10.2
Fasting blood glucose concentration, mM 6.5 , 0.1 6.5 , 0.2
Fasting serum insulin concentration, ng/ml 0.62 , 0.07 0.39 , 0.01*
Values are means , SE; N " 8–12 rats/group. LCR rats, rats with low
running capacity; HCR rats, rats with high running capacity. *P ! 0.05.
1405Intrinsic Running Capacity and Mitochondrial Respiration • Stephenson EJ et al.
J Appl Physiol • doi:10.1152/japplphysiol.00788.2012 • www.jappl.org
 at R
M
IT Library - B
undoora on M
arch 19, 2013
http://jap.physiology.org/
D
ow
nloaded from
 
The glucose uptake response to insulin is enhanced in HCR
rats. Rates of glucose uptake in the soleus are shown in Fig. 2.
There were no differences in the rate of basal glucose uptake
between LCR and HCR rats (3.21 , 0.35 and 3.57 , 0.16
%M·g&1·h&1, respectively). Insulin stimulation increased glucose
uptake in both groups (LCR rats: 5.16, 0.21 %M·g&1·min&1, P !
0.0001, and HCR rats: 6.00 , 0.23 %M·g&1·min&1, P !
0.0001), and this increase was of a greater magnitude in HCR
rats (14%, P " 0.02).
HCR rats are more active than LCR rats. Physical activity
data for each group are shown in Table 2. During the diurnal
period, HCR rats completed a greater number of horizontal
beam breaks (P " 0.0004), spent more time ambulatory (P "
0.02) and less time stationary (P" 0.02), and traveled a greater
total distance (P " 0.04) compared with LCR rats. During the
nocturnal phase, HCR rats completed fewer horizontal beam
breaks, had fewer stereotypic movements, and spent more time
stationary than they did during the diurnal phase. For LCR rats,
movement patterns were not different during diurnal or noc-
turnal testing periods. Compared with LCR rats during the
nocturnal period, HCR rats spent more time ambulatory (P "
0.007) and completed a greater number of horizontal beam
breaks (P " 0.07). Distance traveled or time spent stationary
was not different between phenotypes during the nocturnal
monitoring period.
Mitochondrial respiratory capacity is greater in HCR rats
compared with LCR rats. To evaluate the capacity of the ETS
and thus determine maximal O2 flux through the mitochondria,
we measured O2 flux during a SUIT protocol with substrates
for the ETF, CI, CII, and CIV (Fig. 3). State 2 respiration with
electron leak through the ETF was not different between
groups (LCR rats: 5.55 , 0.42 pmol·s&1·mg wet wt&1 and
HCR rats: 6.61 , 0.83 pmol·s&1·mg wet wt&1); however, state
3 respiration (OXPHOS) with electron flux through the ETF
was greater in HCR rats than in LCR rats at 1 mM ADP
(17.6 , 1.2 and 27.9 , 1.7 pmol·s&1·mg wet wt&1, respec-
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Fig. 1. Glucose tolerance test. A: blood glucose responses over 120 min. B: areas under the blood glucose curve (Glucose AUC). C: serum insulin responses over
120 min. D: areas under the serum insulin curve (Insulin AUC). HCR rats, rats with high running capacity; LCR rats, rats with low running capacity. Values
are means , SE; N " 8–10. *P ! 0.05.
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Fig. 2. Basal and insulin-stimulated glucose uptake in the soleus muscles of
LCR and HCR rats. Values are means , SE; N " 11. *P ! 0.05, different
from the basal value; †P ! 0.05 different from the LCR value under the same
conditions.
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tively) and 2.5 mM ADP (30.68 , 1.97 and 19.54 , 1.35
pmol·s&1·mg wet wt&1, respectively). State 3 respiration with
electron flux through both the ETF and CI was greater in HCR
rats compared with LCR rats (41.27 , 2.44 and 26.77 , 1.59
pmol·s&1·mg wet wt&1, respectively), and when flux through
the ETF was taken into account, CI values for HCR rats
remained elevated (HCR rats: 11.73 , 2.14 pmol·s&1·mg wet
wt&1 and LCR rats: 7.62 , 0.22 pmol·s&1·mg wet wt&1, P "
0.09). State 3 respiration with electron flux through the ETF,
CI, and CII was greater in HCR rats compared with LCR rats
at submaximal (80.56 , 2.79 and 65.29 , 3.10 pmol·s&1·mg
wet wt&1, respectively) and maximal (95.52 , 2.34 and
83.74 , 2.34 pmol·s&1·mg wet wt&1, respectively) ADP sat-
uration. Uncoupled OXPHOS with electron flux through the
ETF and CII was greater in HCR rats compared with LCR rats
(54.70 , 2.19 and 46.72 , 1.00 pmol·s&1·mg wet wt&1,
respectively, P " 0.007). Maximal uncoupled flux through the
ETS (ETF, CI, and CII) was greater in HCR rats compared
with LCR rats (106.50 , 3.54 and 87.86 , 3.20 pmol·s&1·mg
wet wt&1, respectively). CIV activity, as determined through
the use of artificial electron donors, was not different between
groups (LCR rats: 156.70 , 6.7 pmol·s&1·mg wet wt&1 and
HCR rats: 169.7 , 10.35 pmol·s&1·mg wet wt&1). To assess
O2 flux independent of mitochondrial density, we calculated
the flux control ratio for each substrate combination. These are
shown in Table 3.
Increased O2 flux in muscle from HCR rats is associated
with greater mitochondrial enzyme activity and increased
mtDNA copy numbers. CS activity was greater in HCR rats
compared with LCR rats in both the soleus (HCR rats: 21.64,
1.21 %mol·min&1·g wet wt&1 and LCR rats: 14.58 , 1.23
%mol·min&1·g wet wt&1, P " 0.009; Fig. 4A) and EDL (HCR
rats: 9.98 , 0.62 %mol·min&1·g wet wt&1 and LCR rats: 7.06 ,
0.77 %mol·min&1·g wet wt&1, P " 0.01; Fig. 4A) muscles.
#-HAD activity was also greater in HCR rats compared with LCR
rats in the soleus (HCR rats: 5.62, 0.45 %mol·min&1·g wet wt&1
and LCR rats: 3.78 , 0.31 %mol·min&1·g wet wt&1, P " 0.003;
Fig. 4B) and EDL (HCR rats: 1.29 , 0.11 %mol·min&1·g wet
wt&1 and LCR rats: 0.75 , 0.066 %mol·min&1·g wet wt&1, P "
0.0004; Fig. 4B) muscles. In the EDL, mtDNA copy numbers
were elevated in HCR rats compared with LCR rats (11,810 ,
1,640 and 7,584 , 891, respectively, P " 0.049; Fig. 4C). The
mtDNA copy number was 44% greater in the soleus of HCR rats
(HCR rats: 11,930 , 3,235 and LCR rats: 6,665 , 1,015, P "
0.16; Fig. 4C).
Muscle-specific protein expression of PGC-1! and FNDC5.
The relative expression of PGC-1* mRNA was not different
between groups for either soleus or EDL muscles (data not
shown). PGC-1* protein expression was not different in the
soleus (Fig. 5), although a small but significant increase was
observed in the EDL of HCR rats (9%, P " 0.03; Fig. 6).
Expression of the PGC-1*-dependent FNDC5 gene was not
different between groups in either muscle type (data not
shown). Similarly, FNDC5 protein expression was not differ-
Table 2. Physical activity levels of animals
Day Night
LCR rats HCR rats LCR rats HCR rats
No movement, % 67.1 , 0.7‡ 61.9 , 1.9*† 70.9 , 1.6 71.4 , 2.7‡
Stereotypic movement, % 22.8 , 0.6 22.3 , 0.5† 20.4 , 1.1‡ 17.8 , 1.2*†‡
Ambulatory movement, % 7.5 , 0.3‡ 10.0 , 0.9* 7.4 , 0.4 10.6 , 0.6*†
Horizontal beam breaks, counts 54.8 , 3.4‡ 133.6 , 16.7*† 49.8 , 6.5‡ 76.0 , 12.4‡
Total distance traveled, cm 1280.0 , 79.3‡ 1721.0 , 187.9*† 1185.0 , 79.4‡ 1336.0 , 132.1‡
Values are means , SE; N " 8–12 rats/group. *P ! 0.05, different from LCR rats during the day; †P ! 0.05, different from LCR rats during the night; ‡P !
0.05, different from HCR rats during the day.
Fig. 3. Mass-specific O2 consumption in the soleus muscles of LCR and HCR
rats. Oct, octanoylcarnitine; M, malate; D1, 1 mM ADP; D22.5, 2.5 mM ADP;
ETF, electron-transferring flavoprotein; G, glutamate; S, succinate, D5, 5 mM
ADP; ETS, electron transfer system (uncoupled respiration); CIV, respiratory
complex IV (cytochrome c oxidase). Values are means , SE; N " 11. *P !
0.05.
Table 3. Mitochondrial flux control ratios
LCR Rats HCR Rats
ETF and leak (state 2) 0.07 , 0.01 0.06 , 0.01
ETF and OXPHOS (state 3) 0.23 , 0.01 0.29 , 0.02*
ETF, CI, and OXPHOS (state 3) 0.32 , 0.01 0.39 , 0.2*
ETF, CI, CII, and OXPHOS (state 3,
submaximal) 0.77 , 0.02 0.76 , 0.03
ETF, CI, CII, and OXPHOS (state 3,
maximal) 0.96 , 0.02 0.91 , 0.03
ETF and CII (uncoupled, state 4) 0.57 , 0.01 0.51 , 0.01*
Values are means , SE; N " 8–12 rats/group. ETF, electron-transferring
flavoprotein; OXPHOS, oxidative phosphorylation; CI, complex I; CII, com-
plex II. *P ! 0.05.
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ent in the soleus (Fig. 5). FNDC5 protein expression was
greater in the EDL of HCR rats (17%, P " 0.0002; Fig. 6).
Nor1 expression is greater in HCR rats. In both the soleus
and EDL muscles, protein expression of the orphan NR Nor1
was greater in HCR rats (soleus: 21%, P " 0.009, and EDL:
23%, P " 0.016; Figs. 5 and 6). Expression of Nur77 (soleus:
40%, P " 0.02, and EDL: 25%, P " 0.01) and NR4A target
proteins fatty acid translocase/CD36 (soleus: 4%, P " 0.04,
and EDL: 9%, P " 0.02) and UCP3 (soleus: 32%, P " 0.01,
and EDL: 20%, P" 0.0003) was also increased in both muscle
types from HCR rats (P ! 0.05; Figs. 5 and 6).
Mitochondrial protein expression is greater in HCR rats. In
the soleus muscle, expression of all individual ETS complex
proteins was greater in HCR rats compared with LCR rats (P!
0.05; Fig. 5) except for CIV subunit I. Additionally, expression
of CS was 14% greater in HCR rats compared with LCR rats
(P " 0.03; Fig. 5). In the EDL muscle, expression of all
individual ETS complexes was greater in HCR rats compared
with LCR rats (P ! 0.05; Fig. 6) except for CIV subunit I,
which was not different. CS protein expression was 38%
greater in HCR rats (P ! 0.0001; Fig. 6).
DISCUSSION
The motivation for developing the LCR/HCR model system
originated from noting the strong statistical association be-
tween low endurance exercise capacity and increased morbid-
ity and mortality in humans (4). From this, we formulated the
general hypothesis that aerobic energy metabolism is a central
mechanistic determinant of the divide between disease and
health, which we termed the “aerobic hypothesis.” As an
unbiased test of this hypothesis, we applied divergent artificial
selection for intrinsic LCR and HCR. As predicted by this
hypothesis, disease risks and reduced longevity segregated
strongly with low aerobic capacity (14). Here, we provide
specification for features that can explain the intrinsic aerobic
exercise capacity differences between the LCR and HCR and,
ostensibly, disease risks.
Alterations to mitochondrial function typically occur in
parallel with disease progression, and although environmental
influences undoubtedly play an important role in the develop-
ment of metabolic diseases (6), there is a growing body of
evidence to suggest that a substantial genetic component un-
derlies many complex metabolic disorders (22, 29). Here, we
present data showing that skeletal muscle respiratory capacity
is greater in oxidative muscle from HCR rats compared with
LCR rats (Fig. 3) and that this enhanced respiratory capacity is
likely due to greater relative mitochondrial enzyme activities
[particularly those with a role in fat oxidation (Figs. 3 and 4)]
coupled with increased mitochondrial number (Figs. 4–6).
This increase in muscle oxidative capacity is associated with an
increase in the protein expression of the NR Nor1 (Figs. 5 and
6), which has previously been linked to the adaptive response
of skeletal muscle in response to exercise training, (21, 50) and
the expression of several proteins involved in glucose metab-
olism (4, 16, 31, 33). These novel findings complement our
previous reports in which we have shown that there are a
greater number of mitochondria present in the glycolytic mus-
cle from HCR rats (35) and that muscle substrate handling is
superior in these animals (15–17).
Low aerobic capacity, independent of physical activity lev-
els, is a key predictor of early mortality (23, 47). Along with a
reduced lifespan (14), LCR rats express a number of charac-
teristics common to metabolic disease phenotypes, such as
increased body weight and adiposity (Table 1) (10, 24, 25, 39),
hyperinsulinemia (Table 1) (25, 40, 48), and impaired glucose
tolerance (Fig. 1) (24, 25, 35). In contrast, HCR rats live 6–8
mo longer (14) and present with superior metabolic health, as
characterized by resistance to weight gain (24–26) and an
increased capacity for the uptake and oxidation of both glucose
(Fig. 2) (17, 35) and long-chain fatty acids (17, 24, 25, 35). The
differential expression of these characteristics appears to be
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Fig. 4. Enzyme activities and relative mitochondrial (mt)DNA copy numbers
in both the soleus and EDL muscles of LCR and HCR rats. A: citrate synthase
(CS) activity (N " 10). B: #-hydroxyacyl-CoA (#-HAD) activity (N " 10).
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linked to muscle oxidative capacity (25), although previous
studies have been inconclusive with regard to the precise
mechanisms involved. As noted, HCR rats have superior O2
handling capacity, an adaptive variation that resides at the level
of the muscle (10). We (35, 48) have previously reported a
greater number of mitochondria in the muscle of HCR rats,
although results from previous studies have not supported this
observation (24, 45) and have concluded that the difference in
oxidative capacity is not due to mitochondrial size or number
(24, 41, 45) but to a difference in mitochondrial enzyme
activity.
To address this issue, we performed respirometry experi-
ments, monitoring O2 consumption through the mitochondria
of permeabilized soleus muscles from LCR and HCR rats in
response to specific substrate combinations. In contrast to
individual enzyme activity assays, this is a dynamic measure-
ment that reflects the integrated activities of #-oxidation, the
TCA, cycle and the ETS. During ADP-stimulated (state 3)
respiration, we observed greater O2 consumption with electron
flux through the ETF, CI, and CII. Additionally, maximal
activity of the ETS was greater in muscles from HCR rats.
Previously, we have shown that the oxidation of the long-chain
fatty acid palmitate is greater in in vitro soleus muscle incu-
bations from HCR rats (17) and during hindlimb perfusion
experiments (35). Here, we confirmed that the capacity for total
lipid oxidation is enhanced in the muscle of HCR rats and that
this is due to the increased activity of mitochondrial enzymes
involved in the oxidation of fatty acids. Specifically, respira-
tory flux control ratios indicated that independent of mitochon-
drial volume, the relative contribution of the ETF to maximal
flux was greater in HCR rats when the muscle was exposed to
the medium-chain fatty acid octanoylcarnitine (Table 3). Fur-
thermore, #-HAD activity (the third enzyme of the #-oxidation
pathway) was greater in muscles from HCR rats (Fig. 4B). In
contrast, when data for the remaining substrate combinations
were normalized to maximal uncoupled respiratory capacity,
combined O2 flux was not different, which suggests that the
coupling of OXPHOS and CI and CII activity are similar for
LCR and HCR rats. This indicates that along with an increased
capacity for fat oxidation per mitochondrion, an increase in the
mitochondrial reticulum is also likely to contribute to the
increased respiratory capacity of muscles from HCR rats. Since
respirometry and enzyme activity measurements are indirect
determinants of mitochondrial content that must be supported
by additional measurements, we also measured mtDNA copy
numbers (Fig. 4C) and the expression of a number of mito-
chondrial proteins (Figs. 5 and 6) in both soleus and EDL
muscles. We found that the mtDNA copy number was greater
in both muscles under investigation and, moreover, that the
expression of a number of mitochondrial proteins was in-
creased in both muscle types, supporting our hypothesis of a
greater mitochondrial volume in the muscle of HCR rats.
Furthermore, the TCA cycle protein CS, which has long been
regarded as a surrogate marker of mitochondrial volume, was
expressed to a greater degree (Figs. 5 and 6) along with
elevated maximal activities (Fig. 4A) in both the soleus and
EDL muscles of HCR rats. This difference in skeletal muscle
respiratory capacity is no doubt a major contributing factor to
A BLCR HCR
Soleus
Fig. 5. Protein content of the soleus muscle from LCR and HCR rats as determined by Western blot analysis. PGC-1, peroxisome proliferator-activated receptor-)
coactivator-1; Nur77, neuron-derived clone 77; Nor1, neuron-derived orphan receptor 1; FNDC5, fibronectin type III domain-containing 5; GLUT4, glucose
transporter 4; FAT/CD36, fatty acid translocase/CD36; UCP3, uncoupling protein 3; CI, complex I; CII, complex II; CIII, complex III; CIVI, CIV subunit I;
CIVII, CIV subunit II; CIVIV, CIV subunit IV; CV, complex V. Values are means , SE; N " 8–12. *P ! 0.05.
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the overall phenotype of these rats. The greater capacity for
lipid oxidation observed in HCR rats is likely to result in the
sparing of glycogen during exercise. Indeed, even in the
untrained state, HCR rats exhibit muscle substrate storage
profiles similar to that of endurance-trained athletes. Increased
fuel availability as a result of greater intramuscular storage of
glycogen and triglycerides (16, 17, 35), along with an in-
creased capacity for lipid oxidation and overall enhanced rates
of OXPHOS, would allow HCR rats to run longer distances
than LCR rats.
Another finding of the present study is the elevated protein
levels of FNDC5, which was confined to the glycolytic muscle
of HCR rats. This protein has recently been identified as a
PGC-1*-dependent membrane protein that is cleaved to be-
come the putative myokine irisin (3). Although we were unable
to measure circulating irisin concentrations, the reduced adi-
posity and superior glucose tolerance exhibited by HCR rats
may, at least in part, be related to the increased expression of
FNDC5 in the glycolytic muscle. Indeed, exercise training has
been shown to increase the concentration of irisin in both mice
and humans (3), so it is quite plausible that HCR rats have
higher concentrations of circulating irisin than LCR rats. Fur-
thermore, the “browning” effect seen in white adipose tissue
after irisin administration (3) may not be restricted to this
tissue, and we cannot discount the possibility that irisin elicits
a similar effect on glycolytic skeletal muscle. Characterization
of the adipose tissue from LCR and HCR rats will determine
whether differences in mitochondrial function are restricted to
the muscle or if they are also present in other highly plastic
tissues.
Previously, we (16) have shown that the orphan NR Nur77
and its downstream targets are expressed to a lesser extent in
LCR rats and that this is linked to impaired #-adrenergic
signaling in the skeletal muscle. Another NR4A NR, Nor1,
shares a high sequence homology with Nur77 and has been
shown to be induced under many of the same conditions (31).
Pearen et al. (32) demonstrated that Nor1 is essential for
oxidative metabolism in cultured myotubes and that muscle-
specific Nor1 transgenic mice have a more oxidative skeletal
muscle phenotype, a greater running capacity, and better glu-
cose tolerance compared with their wild-type littermates (30).
Here, we provide evidence showing that HCR rats have greater
Nor1 protein levels in both the soleus and EDL muscles (Figs.
5 and 6) and suggest that Nor1 may serve as a possible
mechanism for increasing the cell’s oxidative machinery. In
support of a possible Nor1-mediated response, we found no
differences in PGC-1* mRNA expression between pheno-
types. Furthermore, little (in the EDL; Fig. 6) or no difference
(in the soleus; Fig. 5) in PGC-1 protein levels was observed,
suggesting that an alternative program is responsible for the
greater respiratory capacity seen in the muscle of HCR rats. At
present, little is known about the molecular mechanisms
through which Nor1 is likely to drive changes in oxidative
metabolism. Thus, more indepth analyses of the function of
Nor1 and clarification of its primary targets will be essential in
determining its precise role in the regulation of skeletal muscle
metabolism.
Physical training increases skeletal muscle insulin sensitivity
and oxidative capacity and induces a rapid increase in Nor1
transcription (21, 46, 50). Although both LCR and HCR
animals were kept under identical housing and feeding regi-
mens that excluded formal exercise training, we cannot dis-
count the possibility that habitual activity levels may play a
role in the development of their distinct phenotypes. Therefore,
A
LCR HCR
B
EDL
Fig. 6. Protein content of the EDL muscle from LCR and HCR rats as determined by Western blot analysis. Values are means , SE; N " 8–12. *P ! 0.05.
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we monitored the activity of the rats during both diurnal and
nocturnal periods and found that HCR rats were consistently
more active than LCR rats (Table 2). This observation is in
agreement with others (26, 27, 40) who report differences in
the habitual activity levels of LCR and HCR rats from earlier
generations. Furthermore, Novak et al. (28) identified different
activity levels in another strain of obesity-resistant rats,
whereas others (7, 19) identified a type of “inactivity physiol-
ogy” in humans. Since there is a link between intrinsic exercise
capacity and daily habitual activity in rodents, and a link
between inactivity and poor metabolic health in humans (7, 11,
18, 27), the extent to which spontaneous cage activity contrib-
utes to the distinct phenotypes of these rodent models is an
important question that needs to be addressed. Although con-
trolling for habitual activity is difficult, we propose that it is
partially responsible for the divergent metabolic phenotype
displayed by these two rat strains, as we (9, 17) have previ-
ously shown that exercise training of LCR rats reverses many
of negative metabolic health traits observed in these animals.
In summary, we used an animal model in which artificial
selection for HCR and LCR (in the total absence of exercise
training) simultaneously controls for unknown environmental
influences and allows the two phenotypes to act as controls for
one another. In addition to their divergent running capacities,
these rats displayed differences in a number of metabolic
health traits and, importantly, markedly different muscle oxi-
dative capacities that underlie the major differences between
phenotypes. Given that the NR Nor1 has been shown to play a
key role in metabolic regulation and is necessary for oxidative
metabolism, we propose that the differential expression of
Nor1 observed in HCR and LCR rats may contribute to their
distinct phenotypes and overall metabolic regulation. “Gain/
loss of function” experiments will be required to confirm this
hypothesis.
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First published June 11, 2013; doi:10.1152/ajpendo.00544.2012.—Impaired
visceral white adipose tissue (WAT) metabolism has been implicated
in the pathogenesis of several lifestyle-related disease states, with
diminished expression of several WAT mitochondrial genes reported
in both insulin-resistant humans and rodents. We have used rat models
selectively bred for low- (LCR) or high-intrinsic running capacity
(HCR) that present simultaneously with divergent metabolic pheno-
types to test the hypothesis that oxidative enzyme expression is
reduced in epididymal WAT from LCR animals. Based on this
assumption, we further hypothesized that short-term exercise training
(6 wk of treadmill running) would ameliorate this deficit. Approxi-
mately 22-wk-old rats (generation 22) were studied. In untrained rats,
the abundance of mitochondrial respiratory complexes I–V, citrate
synthase (CS), and PGC-1 was similar for both phenotypes, al-
though CS activity was greater than 50% in HCR (P ! 0.09).
Exercise training increased CS activity in both phenotypes but did
not alter mitochondrial protein content. Training increased the
expression and phosphorylation of proteins with roles in "-adren-
ergic signaling, including "3-adrenergic receptor (#16% LCR;
P $ 0.05), NOR1 ($24% LCR, 21% HCR; P $ 0.05), phospho-
ATGL (#25% HCR; P $ 0.05), perilipin (#25% HCR; P $ 0.05),
CGI-58 (#15% LCR; P $ 0.05), and GLUT4 (#16% HCR; P $
0.0001). A training effect was also observed for phospho-p38
MAPK ($12% LCR, $20% HCR; P $ 0.05) and phospho-JNK
(#29% LCR, $20% HCR; P $ 0.05). We conclude that in the
LCR-HCR model system, mitochondrial protein expression in
WAT is not affected by intrinsic running capacity or exercise
training. However, training does induce alterations in the activity
and expression of several proteins that are essential to the intra-
cellular regulation of WAT metabolism.
white adipose tissue; exercise; metabolism; mitochondria; lipolysis
WHITE ADIPOSE TISSUE (WAT) mass is linked to metabolic health
and plays a critical role in the maintenance of whole body
energy homeostasis (1, 15). Increased WAT mass, especially in
visceral storage depots, is associated with a greater risk of
metabolic disease and mortality (6, 55), whereas enlarged
adipocyte cell size due to increased lipid content is linked to
intrinsic cellular metabolic defects (43, 74). Conversely, small
adipocytes may play a protective role against the increased risk
of metabolic disease (57) because compared with larger adi-
pocytes these cells have enhanced rates of glucose transport
(19, 22, 23, 34). Although excessive lipid storage in visceral
WAT depots is linked to metabolic abnormalities such as
insulin resistance and impaired lipolysis (4, 65), the metabolic
characteristics of WAT in differing metabolic phenotypes have
not been well characterized.
Compared with other metabolically active tissues, the oxi-
dative capacity of WAT is relatively low (17), but essential
cellular activities such as adipogenesis, lipogenesis, lipolysis,
and fatty acid (FA) oxidation require large amounts of ATP (6,
16, 58). Given that WAT metabolism is altered in obesity and
insulin resistance (16, 70) and the metabolic activity of most
cells is highly dependent on mitochondrial content, impair-
ments in the regulation of the adipocyte mitochondrial network
may lead to dysfunctional WAT metabolism (15). Indeed,
diminished mitochondrial gene expression has been observed
in WAT from insulin-resistant humans (14, 70) and rodents
(37, 58, 63).
Through two-way artificial selection, we have generated
animal models of high [high-intrinsic running capacity (HCR)]
and low aerobic treadmill running capacity [low-intrinsic run-
ning capacity (LCR)] in the absence of exercise training (31).
Such selection has produced rats that simultaneously present
with different metabolic and cardiovascular disease risk factors
without the necessity for any environmental intervention (75).
Previously, we have shown that the metabolic characteristics of
the skeletal muscle from these rats diverge substantially (39,
56, 61) and that exercise training ameliorates many of the
adverse health features observed in the LCR rats (39). Since
exercise training is capable of reducing visceral WAT lipid
content and adipocyte cell size (18, 19, 22, 34) while increas-
ing the WAT expression of a number of mitochondrial proteins
(60, 62), we hypothesized that the oxidative profile of visceral
WAT would be lower in untrained LCR compared with HCR
rats but that short-term exercise training would ameliorate this
impairment. In line with this hypothesis, we aimed to deter-
mine whether differences in intrinsic running capacity or train-
ing state would affect the expression and activity of a number
of proteins with important roles in WAT metabolism.
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MATERIALS AND METHODS
Animal model. This study was undertaken with the combined
approval of the animal ethics committees from both the University of
Michigan (Ann Arbor, MI) and California State University
(Northridge, CA). Rat models for LCR and HCR were derived from
genetically heterogeneous N:NIH stock (National Institutes of Health)
rats by artificial selection for treadmill running capacity, as described
previously (31). Rats were housed in pairs in a temperature-controlled
environment that provided a reverse 12:12-h light-dark cycle.
Throughout the study, rats were given ad libitum access to standard
rodent chow and water. Prior to the commencement of any experi-
mental procedures, rats were allowed to acclimate to laboratory
conditions for 1 wk.
Experimental design. Age-matched pairs of%20-wk-old male LCR
and HCR rats were randomly assigned to two groups: sedentary
[LCR-SED (n ! 10) and HCR-SED (n ! 10)] or exercise trained
[LCR-EX (n ! 10) and HCR-EX (n ! 10)]. Rats assigned to undergo
exercise training completed a 6-wk (4 days/wk) incremental treadmill
running protocol where all rats completed the same absolute cumu-
lative running distance (%10 km) (32, 39). Trained rats undertook
their final exercise bout 48 h before the commencement of any
experimental procedures.
Tissue collection and blood analyses. Following a 5-h fast, blood
samples were taken for the analysis of fasting blood glucose concen-
trations using a hand-held glucometer (Roche Diagnostics, Castle
Hill, New South Wales, Australia). Serum was assessed for fasting
insulin concentrations using a rat-specific ELISA (ALPCO diagnos-
tics, Salem, NH) and for nonesterified FAs (NEFA) using a commer-
cially available kit (WAKO Pure Diagnostics, Osaka, Japan). Rats
were weighed and anesthetized using pentobarbital sodium (1 ml/kg
body mass). Hindlimb skeletal muscles and epididymal fat pads were
surgically excised, weighed, freeze-clamped in liquid nitrogen, and
stored at &80°C for later analyses. Muscle data has been reported
previously (39).
Citrate synthase activity. Approximately 100 mg of epididymal
adipose tissue was visibly cleared of blood vessels and connective
tissue and then mechanically homogenized in buffer [175 mM KCl
and 2 mM EDTA (pH 7.4), 1:2 dilution] and centrifuged at 20,000 g
for 15 min at 4°C. The infranatant was collected and assayed for
citrate synthase activity, as described previously (61). Protein con-
centration of the infranatant was determined using the bicinchoninic
method (Pierce). Activity is expressed in nM·min&1·'g protein&1.
Immunoblotting. Approximately 250–300 mg of epididymal adi-
pose tissue was visibly cleared of blood vessels and connective tissue
and then mechanically homogenized in buffer (50 mM Tris·HCl, pH
7.5, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 50 mM NaF, 5 mM Na
pyrophosphate, 10% glycerol, 1% Triton X-100, 10 'g/ml trypsin
inhibitor, 2 'g/ml aprotinin, 1 mM benzamidine, 1 mM phenylmeth-
ylsulfonyl fluoride, 1:8 dilution) and centrifuged at 20,000 g for 30
min at 4°C. Protein concentration of the infranatant was determined
using the bicinchoninic method (Pierce). Adipose tissue lysates con-
taining 10 'g of protein were prepared in 4( Laemmli buffer,
subjected to SDS-PAGE, and then transferred to polyvinylidene
difluoride membranes. A pooled lysate sample was prepared and
included in each gel as an internal control for normalizing the data.
Ponceau staining was used to confirm equal protein transfer. Mem-
branes were then washed and blocked (5% nonfat dry milk or 5%
BSA) for 1 h at room temperature prior to incubation with the
appropriate antibodies. Membranes were incubated overnight at 4°C
with primary antibodies specific for citrate synthase (CS; %52 kDa;
Abcam, no. ab96600), mitochondrial respiratory complexes I, II, III,
IV (subunit 4; COX-IV), and V of the electron transport chain (%18,
%25, %45, %15, and %52 kDa respectively; MitoSciences, nos.
MA604 and MS407), uncoupling protein 1 (UCP1; Santa Cruz Bio-
technology, no. sc6529), peroxisome proliferator-activated receptor-)
coactivator-1 (PGC-1; %100 kDa; Chemicon, no. ab3242), hormone-
sensitive lipase (HSL; %88 kDa; Cell Signaling Technology, no.
4107), phospho-HSLS660 (71), adipose triglyceride lipase (ATGL;
%54 kDa; Cell Signaling Technology, no. 2138), phospho-ATGLS406
[%54 kDa (53)], "3-adrenergic receptor ("3-AR; %68 kDa; Santa
Cruz Biotechnology, no. sc50436), perilipin 1 (PLIN1; %68 kDa;
Sigma, P1873), comparative gene identification-58 (CGI-58; %42
kDa), FA-binding protein 4 (FABP4; %15 kDa; Abcam, no.
ab37458), neuron-derived clone 77 (NUR77; %48 kDa; Santa Cruz
Biotechnology, no. sc5569), neuron-derived orphan receptor 1
(NOR1; %68 kDa; Abcam, no .92777), GLUT4 (%45 kDa; Abcam,
no. ab654), AMP-activated protein kinase (AMPK)* (%62 kDa; Cell
Signaling Technology, no. 2532), AMPK phospho-Thr172 (%62 kDa;
Cell Signaling Technology, no. 2535), extracellular regulated kinase
1/2 (ERK1/2; %46 and %42 kDa; Cell Signaling Technology, no.
9102), phospho-ERK1/2T202/Y204 (%46 and %42 kDa; Cell Signaling
Technology, no. 9101), p38 mitotgen-activated protein kinase (p38
MAPK; %44 kDa; Cell Signaling Technology, no. 9212), phospho-
p38 MAPKT180/Y182 (%44 kDa; Cell Signaling Technology, no.
9211), c-Jun NH2-terminal ninase 1/2 (JNK1/2; %50 and %46 kDa;
Cell Signaling Technology, no. 9252), or phospho-JNK1/2T183/Y185
(%50 and %46 kDa; Cell Signaling Technology, no. 9251). Mem-
branes were also probed with anti-*-tubulin (%50 kDa; Cell Signaling
Technology, no. 2144) or "-actin (%42 kDa; Sigma-Aldrich) to
confirm equal protein loading. After 1-h room temperature incubation
in the appropriate secondary antibody, protein expression was de-
tected using enhanced chemiluminescence (Amersham Biosciences,
Piscataway, NJ) and quantified by densitometry.
Statistical analyses. All data are expressed as group means + SE,
unless specified otherwise. All data were analyzed using a two-way
ANOVA, with running capacity and training state as fixed factors.
Where main effects were considered significant, a Tukey test for
multiple comparisons was conducted. Significance is reported where
P $ 0.05. All statistical analyses were completed using GraphPad
Prism software.
RESULTS
Physiological parameters. Data for body mass (BM) and fat
pad mass have been reported previously (39), with new statistical
analyses presented here. Adipose tissue protein content is reported
as an indirect marker of changes in adipocyte cellularity. Intrinsic
running capacity and training status were main effects for BM
(P$ 0.0001 and P$ 0.0001, respectively; Fig. 1A), fat pad mass
(P $ 0.0001 and P ! 0.0002, respectively; Fig. 1B), and total
tissue protein (P ! 0.026 and P ! 0.024, respectively; Fig.
1C). In addition, an interaction between running capacity and
training status was observed for BM (P $ 0.0001) and fat pad
mass (P ! 0.003). LCR rats were heavier than HCR rats with
(33.4%, P $ 0.0001) or without (26.6%, P $ 0.0001) exercise
training. The LCR-SED group was heavier than the LCR-EX
group (31.1%, P $ 0.0001), whereas there was no difference
between HCR-SED and HCR-EX. Epididymal fat pad mass
was greater in LCR than HCR rats with (62.5%, P $ 0.0001)
or without exercise training (50%, P$ 0.0001). LCR-SED rats
had heavier fat pads than LCR-EX rats (34.4%, P $ 0.0001),
whereas there was no difference between HCR-SED and
HCR-EX rats. In line with this, total protein of WAT was lower
in LCR-SED compared with HCR-SED rats (22.4%, P !
0.052), whereas adipose protein was 33.4% greater in LCR-EX
compared with LCR-SED rats (P ! 0.057). There were no
differences in adipose protein between HCR-SED and
HCR-EX or LCR-EX and HCR-EX rats.
Intrinsic running capacity improved fasting blood glucose
(main effect, P ! 0.0002) and serum NEFA concentrations
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(main effect, P ! 0.02; Table 1), but not fasting serum insulin
levels. Compared with HCR-SED, LCR-SED rats had 8%
higher blood glucose (P ! 0.0008) and 37% higher NEFA
concentrations (P ! 0.003). Exercise training was a main
effect for fasting serum NEFAs (P $ 0.0001) and insulin
concentrations (P$ 0.0001), whereas there was a tendency for
LCR-EX rats to have lower blood glucose concentrations than
LCR-SED rats (8%; P ! 0.11). Exercise training had little
effect on blood glucose concentrations in HCR animals. Both
LCR-SED and HCR-SED rats had higher serum insulin con-
centrations compared with LCR-EX (37%, P ! 0.0004) and
HCR-EX rats (38%, P ! 0.0002), respectively. LCR-SED rats
had 57% higher serum NEFA concentrations compared with
LCR-EX rats (P $ 0.0001), whereas training had little effect
on NEFA concentrations in HCR animals.
CS activity. CS activity was increased with exercise training
(main effect, P ! 0.01; Fig. 2A) and tended to be increased in
rats with HCR (main effect, P ! 0.09). CS activity was 58%
higher in epididymal fat pads from LCR-EX compared with
LCR-SED rats (P ! 0.08).
Mitochondrial protein content. Under equal protein loading
conditions (10 'g of total protein), the contents of tricarboxylic
acid cycle (CS), oxidative phosphorylation (electron transfer
complexes I–V), and mitochondrial biogenesis (PGC-1) pro-
teins were similar between LCR and HCR rats independent of
exercise training status (Fig. 2B). UCP1 was not detected in
any sample (data not shown).
Intracellular regulators of lipolysis. "3-AR expression was
increased with exercise training (main effect, P ! 0.03; Fig. 3A),
whereas running capacity showed a tendency to increase this
parameter (P ! 0.09). There was a significant interaction
between running capacity and exercise training (P ! 0.006).
The expression of the "3-AR was 17% greater in HCR-SED
compared with LCR-SED rats (P ! 0.006) and 18% greater in
LCR-EX compared with LCR-SED rats (P ! 0.004).The
phosphorylation of ATGL at Ser406 and HSL at Ser660 was
assessed as surrogate markers of their activity (3, 53). ATGL
Ser406 phosphorylatation and total ATGL protein content were
increased by both running capacity (P ! 0.02 and P ! 0.003,
respectively) and exercise training status (P ! 0.0005 and P !
0.03, respectively; Fig. 3, B and C). Post hoc analyses revealed
a 25% increase in ATGL Ser406 phosphorylation in HCR-EX
compared with HCR-SED rats (P ! 0.01; Fig. 3B). Total
ATGL expression was 17% greater in HCR-EX compared with
LCR-EX rats (P! 0.04; Fig. 3C) and the ratio of ATGL Ser406
to total ATGL was not different. Total HSL protein remained
similar for all groups, although there was a tendency for HSL
Ser660 phosphorylation to be decreased in both LCR-EX and
HCR-EX rats with training (main effect, P ! 0.09). There was
no difference in the ratio of HSL Ser660 phosphorylation to
total HSL protein (data not shown). The content of PLIN1
(which controls lipolysis by regulating protein-protein interac-
tions at the surface of lipid droplets, thereby facilitating access
of lipases to their substrates) was increased by training (P !
0.02; Fig. 3D), and an interaction was observed between
training and running capacity (P ! 0.003). Post hoc analyses
revealed that PLIN1 expression was 19% greater in LCR-SED
Table 1. Blood parameters
LCR-SED HCR-SED LCR-EX HCR-EX
Glucose, mM* 6.2 + 0.1b 5.3 + 0.1a 5.7 + 0.2 5.3 + 0.2
Insulin, ng/ml† 0.5 + 0.004c,d 0.5 + 0.02c,d 0.3 + 0.06a,b 0.3 + 0.07a,b
NEFA, mM*† 0.38 + 0.03b,c 0.24 + 0.02a 0.16 + 0.03a 0.18 + 0.02
Values are means + SE; n ! 7–10 rats/group. LCR, low-capacity running
rats; HCR, high-capacity running rats; SED, sedentary; EX, exercise trained;
NEFA, nonesterefied fatty acids. *P $ 0.05, main effect for running capacity;
†P $ 0.05, main effect for training status; aP $ 0.05, different from LCR-
SED; bP $ 0.05, different from HCR-SED; cP $ 0.05, different from
LCR-EX; dP $ 0.05, different from HCR-EX.
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Fig. 1. Body mass (A), epididymal fat pad mass (B), and white adipose tissue
(WAT) total protein (C) for low- (LCR; open bars) and high-capacity running
rats (HCR; filled bars) with or without exercise training. Values are means +
SE; n! 8–10/group. Significance is reported where P$ 0.05. *Main effect for
running capacity; †main effect for training; ‡interaction between running ca-
pacity and training; adifferent from LCR-sedentary (SED); bdifferent from HCR-
SED; cdifferent from LCR-exercise trained (EX); ddifferent from HCR-EX.
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compared with HCR-SED rats (P ! 0.03) and 25% greater in
HCR-EX compared with HCR-SED rats (P ! 0.002). The
protein content of CGI-58 (which binds to and activates ATGL
triglyceride lipase activity) was increased by 15% in HCR-
SED compared with LCR-SED rats and 15% greater in
LCR-EX compared with LCR-SED rats, although neither of
these values attained statistical significance (P! 0.08 and P!
0.1, respectively; Fig. 3E). There were main effects for both
running capacity and exercise training for CGI-58 protein
content (P ! 0.04 and P ! 0.03, respectively; Fig. 3E). No
difference in FABP4 expression was observed between groups
(data not shown).
NOR1, NUR77, and GLUT4 expression. A main effect of
exercise training was observed for NOR1 expression (P $
0.0001; Fig. 4A). Post hoc analyses revealed that NOR1 ex-
pression was increased by 24% in LCR-SED compared with
LCR-EX rats (P ! 0.008) and 21% in HCR-SED compared
with HCR-EX rats (P ! 0.01). Intrinsic running capacity did
not influence the expression pattern of NOR1, whereas the
expression of NUR77 was similar in LCR and HCR rats with
or without exercise training (results not shown). The expres-
sion of GLUT4 was elevated with high intrinsic running
capacity (P$ 0.0001; Fig. 4B) and with exercise training (P!
0.007), with post hoc analyses revealing that GLUT4 protein
content was increased by 16% n HCR-EX compared with
HCR-SED rats (P ! 0.01). Compared with LCR-EX rats,
GLUT4 protein content was 22% greater in HCR-EX rats (P!
0.0007).
Stress kinase activation. We investigated several stress-acti-
vated kinases to determine their involvement in the adaptive
response of WAT metabolism to exercise training. Total p38
MAPK expression was reduced with training (P! 0.03; Fig. 5A),
whereas there was a tendency for phosporylation of p38
MAPK on the Thr180 and Tyr182 residues to be reduced by
training (P ! 0.07). There was a main effect of exercise
training on the ratio of phospho-p38 MAPKT180/Y182 to total
p38 MAPK (P ! 0.03). No differences were observed in total
JNK1/2 expression; however, training increased phospho-
JNK1/2T183/Y185 (P ! 0.02) and the ratio of phospho-JNK1/
2T183/Y185 to total JNK1/2 (P! 0.002; Fig. 5B). No differences
were observed in total ERK1/2 expression (Fig. 5C), although
a significant main effect of running capacity was observed for
phospho-ERK1/2T202/Y204 (P ! 0.03). There was also a ten-
dency for the ratio of phospho-ERK1/2T202/Y204 to total
ERK1/2 to be affected by running capacity (LCR# HCR, P!
0.06). No differences were observed in total or phospho-
AMPKT172 expression, or the ratio of phospho-AMPKT172 to
total AMPK expression (data not shown).
DISCUSSION
Using a rat model of divergent running ability, we present
novel data demonstrating that 1) the mitochondrial protein
content of visceral WAT is not related to intrinsic exercise
capacity, 2) a short-term (6 wk) program of endurance exercise
training does not modulate visceral WAT mitochondrial pro-
tein expression (despite training-induced increases in citrate
synthase activity), 3), intrinsic running capacity and training
status are associated with the differential WAT expression of
several key lipolytic proteins, and 4) irrespective of intrinsic
running capacity, exercise training induces alterations in the
activity and expression of a number of proteins essential to the
intracellular regulation of WAT lipid metabolism.
In humans, low aerobic capacity is a strong predictor of
early mortality (48, 73). This important clinical association
suggests that the capacity for oxygen metabolism is the under-
lying determinant of the divide between complex disease and
health (aerobic hypothesis; see Ref. 31). We used artificial
selection for aerobic capacity as an unbiased test of this theory.
Along with cardiovascular disease risk (75) and reduced lifes-
pan (33), LCR rats express a number of characteristics com-
mon to metabolic disease phenotypes, such as increased body
mass and adiposity (49, 61), hyperinsulinemia (49, 61, 75), and
impaired glucose tolerance (49, 56, 61). In contrast, HCR rats
live 6–8 mo longer (33) and present with superior metabolic
health characterized by resistance to weight gain in the face of
a high-fat diet (49, 50) and an increased capacity for the uptake
and oxidation of glucose (39, 56, 61) and FAs (39, 49, 56, 61).
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Although the differential expression of these key characteris-
tics appears to be linked to the oxidative capacity of the
skeletal muscle (61), less is known about the metabolic char-
acteristics of the adipose tissue from these divergent aerobic
phenotypes.
We have shown previously that the skeletal muscle of LCR
rats contains fewer mitochondria than HCR rats (56, 61).
Furthermore, we have also observed impaired "-adrenergic
signaling and lipolysis in the muscle of LCR rats (38, 39).
Given the divergent metabolic characteristics observed in LCR
and HCR rats and the importance of WAT in regulating
circulating concentrations of FAs and glucose (1, 27, 76), we
sought to determine whether differences similar to those seen
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in muscle could also be identified in the WAT. Unlike previous
investigations that reported reduced expression of a selection
of mitochondrial genes and proteins in the visceral WAT of
insulin-resistant rodents (58, 63) and humans with type 2
diabetes (70), we did not detect differences in the expression of
the key proteins involved in oxidative phosphorylation and the
tricarboxylic acid cycle in visceral WAT from LCR and HCR
phenotypes (Fig. 2B). Although we cannot rule out the possi-
bility that differences in mitochondrial protein expression were
masked due to equal amounts of protein being analyzed in each
experiment (particularly since LCR-SED rats have less protein
per gram of adipose tissue compared with the other 3 groups;
Fig. 1C), the level of expression of all mitochondrial proteins
measured was consistent for both sedentary and exercise-
trained cohorts, suggesting that the abundance of oxidative
enzymes in visceral WAT may not be an important factor for
determining running capacity and the associated phenotypes of
the LCR-HCR rat model system.
Chronic "-adrenergic stimulation as a result of increased
physical activity (9, 62) or pharmacological activation (20) has
been shown to enhance the oxidative capacity of WAT by
upregulating the expression of genes involved in oxidative
phosphorylation and fat oxidation. Although the training pro-
gram employed in this study was successful in ameliorating
many of the metabolic differences observed in the skeletal
muscle of LCR compared with HCR rats (39), including a
reduction in body mass and adiposity (Fig. 1), it had little effect
on oxidative enzyme expression in the WAT of either pheno-
type, an observation that is consistent with previous findings
from our laboratory in human subcutaneous WAT (8). Al-
though mitochondrial protein content was not different, we
observed a marked training-induced increase in citrate synthase
activity in both LCR and HCR phenotypes (Fig. 2A). Although
this might appear to be in contrast to our earlier findings
(especially given that citrate synthase protein expression was
unchanged), it is important to note that citrate is essential for
replenishing the extramitochondrial pool of acetyl-CoA, a
substrate essential to de novo lipogenesis (44). Furthermore,
lipogenic pathways are energetically costly processes. There-
fore, although training may not have altered the amount of
mitochondrial protein, changes in cellular energy needs in
response to physiological demand are likely to have induced
tighter allosteric control and a number of posttranslational
changes that increase the maximal capacity of mitochondrial
enzymes involved in the different energy-producing pathways
(26). A limitation of the current study is the absence of
additional measures representing the coordinated activities of
"-oxidation, the TCA cycle, and oxidative phosphorylation.
Glucose incorporation into triglycerides (TG) is an essential
component of lipid synthesis, and intracellular glucose avail-
ability in adipocytes is dependent on plasma membrane glu-
cose transport efficiency [a process that is associated directly
with the intracellular pool of GLUT4 (22, 59, 64)]; training-
induced increases in WAT GLUT4 expression may be associ-
ated with an increased capacity for WAT TG synthesis. Indeed,
adipose-specific GLUT4 overexpression induces an increase in
the capacity for TG synthesis via both reesterification and de
novo lipogenic pathways, leading to an increase in total adi-
pose mass in sedentary animals (59, 67). Although we were
unable to measure lipogenic activity in the present study, we
demonstrate that both running capacity and training status
affect GLUT4 content in visceral WAT (Fig. 4B), with LCR
rats having reduced WAT GLUT4 content compared with
HCR rats. Whether or not other adipose depots show similar
changes remains to be determined. Either way, differences in
adipose GLUT4 content in both sedentary and trained animals
could have important implications on whole body adiposity in
these divergent rat phenotypes (1). It is also worth noting that
exercise training has been reported to increase subcutaneous
WAT GLUT4 expression in type 2 diabetic humans (25).
Whether the same changes are observed in human visceral WAT
is unclear, since subcutaneous and visceral adipose depots may
have distinct responses to exercise (18). Similarly, it is possible
that the different visceral adipose depots may respond disparately
to training. Thus, another limitation of the current study is limiting
our analyses to the epididymal WAT depot.
TG synthesis is tightly coupled with TG catabolism; there-
fore, it is not surprising that exercise training induces an
increase in the capacity of both basal and catecholamine-
stimulated WAT lipolysis (51). This is attributed predomi-
nantly to repeated transient elevations in circulating cat-
echolamines acting via "-adrenergic signaling pathways (66).
The "3-AR plays an important role in regulating energy bal-
ance, particularly in WAT (35). The expression of the "3-AR
was reduced in LCR-SED compared with HCR-SED rats (Fig.
3A), which agrees with studies in both obese rodents (12, 45)
and humans (30) that report impaired "-adrenergic signaling as
an important factor in obesity development. Indeed, functional
"-adrenergic signaling is essential for obesity resistance (29).
In line with this, exercise training “rescued” the reduction in
"3-AR in LCR-EX rats (Fig. 3A) while concomitantly reducing
fat pad and total body mass (Fig. 1). Conversely, training did
not effect "3-AR levels in HCR-EX rats (Fig. 3A), nor did it
affect fat pad or total body mass (Fig. 1). These findings are
similar to our previous observation of impaired "-adrenergic
signaling in the skeletal muscle of LCR compared with HCR
rats (38), an impairment that is also ameliorated with exercise
training (39).
"3-AR stimulation by catecholamines increases lipolysis by
activating protein kinase A (PKA), which phosphorylates both
ATGL (53) and HSL (3) to increase lipase activity. Further-
more, PKA phosphorylation of PLIN1 facilitates the dissocia-
tion of CGI-58 from PLIN1, thereby allowing CGI-58 to
interact with ATGL to maximally activate lipolysis (72). Given
that the primary hypotheses of the current study were mito-
chondrially focused, we did not measure lipolysis directly.
Instead, we determined the phosphorylation state of ATGL and
HSL at key activating serine residues as well as the protein
abundance of other key lipolytic proteins. ATGL Ser406 phos-
phorylation and total ATGL content were increased in HCR vs.
LCR rats and by exercise training in both groups (Fig. 3, B and
C). Similarly, CGI-58 was increased in HCR vs. LCR rats and
by exercise training in both groups (Fig. 3E). Based on our
knowledge of protein function and results from knockout mice
studies (24), the changes reported herein would predict in-
creased lipolysis in high-capacity runners and following exer-
cise training. Such a response would match fatty acid avail-
ability with the increased fatty acid oxidation capacity/rates
observed in HCR compared with LCR rats (38, 56, 61) and is
consistent with an endurance-trained individual’s reliance on
FA as an energy source (28).
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Previous investigations have reported links between "-ad-
renergic signaling, the expression of the orphan nuclear recep-
tor NOR1, and whole body lipid and carbohydrate metabolism
(54). Although its targets are largely unknown, NOR1 is
purported to play an important role in regulating oxidative
metabolism and glucose transport in a number of tissues (54).
Notably, NOR1 is a cAMP-dependent target of PKA that is
upregulated upon HSL and ATGL inhibition (36, 46). We have
shown recently that NOR1 expression is reduced in the skeletal
muscle of LCR compared with HCR rats and have suggested
that this may be linked to the oxidative capacity of the tissue
(61). Here, we demonstrate that the difference in NOR1 ex-
pression is tissue specific, as LCR-SED and HCR-SED rats
displayed a similar abundance of NOR1 in WAT. This is
incongruous with human studies that demonstrate that NOR1 is
more highly expressed in the WAT of obese compared with
healthy humans (69). However, following weight loss the
expression of NOR1 in human WAT is “normalized” to levels
similar to healthy control subjects (69). Similarly, we have
observed a reduction in NOR1 expression of a similar magni-
tude for both LCR and HCR rats following exercise training
(24 and 21% respectively; Fig. 4A). Taken collectively, our
observation of reduced NOR1 expression following exercise
training in both LCR and HCR rats suggests a principal role for
NOR1 in the metabolic regulation of WAT.
Given the role of "-adrenergic signaling in WAT metabo-
lism and our finding that the expression of several proteins
downstream of "-adrenergic stimulation is dependent on run-
ning capacity and/or training status (Fig. 5), we sought to
characterize the phosphorylation of several stress kinases that
are purported to interact with "-adrenergic signaling pathways
to influence intracellular metabolism (7, 26, 68). To our knowl-
edge, we are the first to report that a short-term exercise
training program induces distinct changes in the activity of the
stress kinases p38 MAPK and JNK in visceral WAT. Both p38
MAPK and JNK are activated by FAs (11, 21), and both are
increased in response to elevated lipolytic activity (47). Impor-
tantly, the "-adrenergic activation of p38 MAPK has been
shown to occur through cAMP-dependent mechanisms involv-
ing PKA (10), and both p38 MAPK and JNK phosphorylation
are known to be elevated in visceral WAT during human
obesity (5). Here, we have observed a modest reduction in the
phosphorylation of p38 MAPK in visceral WAT following
exercise training (Fig. 5A), a finding that is consistent with
observations in human and rodent skeletal muscle, where
training-induced attenuation of resting p38 MAPK activity is
associated with the adaptive response to exercise training (41,
42). It is also worth noting that p38 MAPK is a known
activator of PGC-1* (and therefore mitochondrial biogenesis)
(2, 77), and as such, training-induced reductions in p38 MAPK
activity may partially explain why we did not see changes in
mitochondrial protein expression in the current study. In con-
trast to the findings for p38 MAPK, phosphorylation of JNK
was elevated as a result of exercise training (Fig. 5B). This is
also consistent with findings in skeletal muscle (42) but incon-
sistent with reports that diet-induced elevations in JNK phos-
phorylation are attenuated by swim training in obese rats (13,
52). Although the individual roles of JNK and p38 MAPK in
adipocyte metabolism are no doubt complex, our findings
indicate that in WAT both kinases are exercise responsive (in
a manner similar to findings in skeletal muscle), thus implicat-
ing them in the array of signaling responses associated with
changes in energy demand.
In summary, we have investigated the relationship between
exercise capacity and WAT metabolism in relation to whole
body metabolic health. We have presented novel data showing
that the content of selected mitochondrial proteins in visceral
WAT does not differ in relation to intrinsic exercise capacity or
exercise training status, and as such, we propose that tighter
allosteric control and/or posttranslational regulation of oxida-
tive enzymes may be important for coordinating aerobic energy
metabolism in WAT. We also show that running capacity and
training state regulate the expression and activity of a number
of proteins downstream of "-adrenergic signaling pathways,
particularly those that are essential to WAT lipolysis. We
suggest that training-induced changes in the expression of the
orphan nuclear receptor NOR1 and the activities of the stress
kinases p38 MAPK and JNK may be important factors for
determining the expression and activity of metabolic proteins
following exercise training. Further studies are necessary to
provide mechanistic support for these purported relationships.
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